Text

CY-CL-170-301, Revision 26, Offsite Dose Calculation Manual
	ML23122A066
Person / Time
Site:	Clinton ; (NPF-062)
Issue date:	09/30/2022
From:	; Exelon Generation Co
To:	; Office of Nuclear Reactor Regulation
References
	U-604760 CY-CL-170-301, Rev 26
	Download: ML23122A066 (1)
	v • d • e

A'. 1

~ Exelon Generation CY-CL-170-301 Revision 26 September 2022 OFFSITE DOSE CALCULATION MANUAL CLINTON POWER STATION

Change Matrix CY-CL-170-301 Revision 26 September 2022 The following table details the linkage between the Revision 23 (pre-ITS format} of the ODCM and the current revision (post-ITS format) of the ODCM regarding the re-numbering of the various sections. The purpose of this section is to permit a cross-reference from the old to new revision of the ODCM for procedures and surveillance tests. Changes to procedures to address the new numbering will occur as the procedures are revised on their normal revision process cycle.

Rev.23 Revision 23 (old) page Current Revision of 195 Part I - Radiological Effluent Controls 1.0 General Information/Preface 12 Part I Section 1.0 1.1 Definitions 12 1.0 Definitions 1.2 General Operating Requirements 16 3/4.3.0 1.3 General Surveillance Requirements 17 3/4.4.0 2.3.1 Liquid Effluent Concentration Reauirements 20 3/4.3.1 Table 2.3-1 Radioactive Liquid Waste Sampling and Analysis 21 Table 4.3.1-1 Prooram 2.4.1 1 0CFR50, ADP. I, Dose Limits 31 3/4.3.2 2.5.1 Liquid Radwaste Treatment Svstem 43 3/4.3.3 2.5.1.1 Liquid Effluent Dose Proiections 44 4.3.3.1 2.7.1 Liquid Effluent Monitoring Instrumentation 45 3/4.1 Table 2.7-1 Radioactive Liquid Effluent Monitoring Instrumentation 46 Table 3.1-1 Table 2.7-2 Radioactive Liquid Effluent Monitoring Instrumentation 50 Table 4.1-1 Surveillance Reauirements 3.4.1 (Gaseous) Tech Spec Release Rate Limits 58 3/4.4.1 Table 3.4-1 Radioactive Gaseous Waste Sampling and Analysis 59 Table 4.4.1-1 Program 3.5.1 Noble Gas Dose Limits 68 3/4.4.2 3.5.2 (Gaseous) Effluent Iodine, Tritium, Particulate Dose Limits 69 3/4.4.3 3.6.1 Gaseous Radwaste (Offaas Treatment) Svstem 79 3/4.4.4 3.7.1 Ventilation Exhaust Treatment Svstem 80 3/4.4.5 3.9.1 Offgas Radiation Monitoring Instrumentation 86 3/4.2.1 Table 3.9.1-1 Qffgas Radiation Monitorino Instrumentation 87 Table 3.2-1 Table 3.9.1-2 Offgas Radiation Monitoring Instrumentation 92 Table 4.2-1 Surveillance Reauirements 3.9.2 Radioactive Gaseous Effluent Monitoring Instrumentation 93 3/4.2.2 Table 3.9.2-1 Radioactive Gaseous Effluent Monitoring 94 Table 3.2-2 Instrumentation Table 3.9.2-2 Radioactive Gaseous Effluent Monitoring 98 Table 4.2-2 Instrumentation Surveillance Requirements 4.1 Total Dose 134 3/4.5 ii

Rev.23 Revision 23 (old) page of195 5.1 REMP - Radioloqical Environmental Monitorinq Proqram 137 Table 5.1-1 Radioloqical Environmental Monitoring Program 139 Table 5.1-2 Reporting Levels for Radioactivity concentrations in 152 Environmental Samples Table 5.1-3 Detection Levels for Environmental Sample Analysis 153 5.2 REMP - Land Use Census 156 5.3 REMP - lnterlab Comparison Proqram 158 6.0 Bases for Operation and Surveillance Requirements 163 6.1 General Operation and Surveillance Requirements 163 6.2 Monitoring Instrumentation 164 6.3.1 Liquid Effluents 166 6.3.2 Gaseous Effluents 169 6.3.3 Total Dose 173 6.4 REMP 174 7.0 Reporting Requirements 176 7.1 Annual Radioactive Environmental Operating Report (AREOR) 176 7.2 Radioactive Effluent Release Report (ARERR) 177 8.0 Adjustment of the CPS ODCM Methodoloqy 182 Part II - Methodoloav and Parameters 1.0 General Information/Preface 12 2.1 Liquid Effluents Introduction 19 2.3.2 Liquid Radwaste Discharge PRM Setpoints 24 2.3.3 Plant Service Water Effluent PRM Setpoints 29 2.3.4 Shutdown Service Water (SX) Effluent PRM Setpoints 30 2.3.5 Fuel Pool Heat Exchanger Service water Effluent PRM 30 Setpoints 2.3.6 Component Cooling Water PRM Setpoints 31 2.4.2 1 0CFR50 App. I Dose Limits - Discussion 33 2.5.1.1 Liquid Effluent Dose Projection Calculations 44 2.5.1.2 Temporary Liquid Radwaste Hold-up Tanks 44 2.6 Doses From Other Siqnificant Liquid Effluent Pathways 44 3.1 Gaseous Effluents Introduction 54 3.2.1 HVAC Stack Process Radiation Monitoring (PRM) System 55 3.2.2 SGTS Stack Process Radiation Monitorinq (PRM) System 56 3.3.1 Pre-treatment Air Ejector Off-Gas Process Radiation Monitor 56 (PRM) 3.3.2 Post-Treatment Air Ejector Off-Gas Process Radiation Monitor 57 (PRM) iii CY-CL-170-301 Revision 26 September 2022 Current Revision 3/4.6 Table 4.6-1 Table 4.6-2 Table 4.6-3 3/4.7 3/4.8 5.0 5.01 Liquid - 5.1, Gaseous - 5.2.1, 5.2.2 5.3 5.4 5.5 5.6, 5.7, 5.8 6.0 6.1 6.2 5.02 Part 11 Section 1.1 4.1 2.1 2.2 2.3 2.4 2.5 4.3 4.3.1 4.3.2 4.3 5.1 3.1 3.2 3.3.1 3.3.2

Revision 23 (old) 3.4.2 Dose Rate Due To Noble Gases 3.4.3 Dose Rate Due to Radioiodines, Particulates and Tritium 3.5.3 1 0CFR50 App. I Release Rate Limits - Noble Gas Air Dose Equations 3.5.4 1 0CFR50 App. I Release Rate Limits - Radioiodines, Particulate and Tritium Dose Equations 3.7.2 Gaseous Effluent Dose Projections Calculations 3.8.1 Gaseous Effluent PRM Total Body Dose Rate Setpoint 3.8.2 Gaseous Effluent PRM Skin Dose Rate Setpoint 5.0-1 REMP Locations Within 1 Mile of CPS 5.0-2 REMP Locations 1-2 Miles From CPS 5.0-3 REMP Locations 2-5 Miles From CPS 5.0-4 REMP Locations Greater Than 5 Miles From CPS 9.0 Atmospheric Transport and Dispersion Model iv Rev.23 page of 195 62 62 70 71 81 83 85 159 160 161 162 183 CY-CL-170-301 Revision 26 September 2022 Current Revision 5.3 5.4 5.5.1 5.5.2 5.6 3.4.1 3.4.2 FiQure 7-1 Figure 7-2 Figure 7-3 Figure 7-4 10.0

TABLE OF CONTENTS SECTION TITLE PART I - RADIOLOGICAL EFFLUENT CONTROLS CY-CL-170-301 Revision 26 September 2022 PAGE 1.0 Definition.......................................................................................................................................... 2 2.0 Not Used.......................................................................................................................................... 8 3/4 Controls and Surveillance Requirements....................................................................................... 10 3/4.1 Radioactive Liquid Effluent Monitoring Instrumentation.............................................................. 12 3/4.2 Radioactive Gaseous Effluent Monitoring Instrumentation......................................................... 21 3/4.2.1 Offgas Radiation Monitoring Instrumentation Controls................................................ 21 3/4.2.2 Radioactive Gaseous Effluent Monitoring Instrumentation Controls............................ 28 3/4.3 Liquid Radwaste Effluents.......................................................................................................... 35 3/4.3.1 Liquid Effluent Concentration....................................................................................... 35 3/4.3.2 Dose From Liquid Effluents.......................................................................................... 39 3/4.3.3 Liquid Radwaste Treatment Systems..........................................................................40 3/4.4 Radioactive Gaseous Effluents...................................................................................................41 3/4.4.1 Gaseous Effluent Dose Rates...................................................................................... 41 3/4.4.2 Dose from Noble Gases............................................................................................... 45 3/4.4.3 Dose from lodine-131, lodine-133, Tritium,-and Radioactive Materials in Particulate Form............................................................................................................................................ 46 3/4.4.4 Gaseous Radwaste (Offgas) Treatment System.........................................................47 3/4.4.5 Ventilation Exhaust Treatment System........................................................................48 3/4.5 Total Dose.................................................................................................................................. 50 3/4.6 Radiological Environmental Monitoring Program........................................................................ 52 3/4.7 Land Use Census...........................................................,........................................................... 70 3/4.8 Inter-Laboratory Comparison Program......................................... :............................................. 73 3/4.9 Meteorological Monitoring Program............................................................................................ 74 5.0 Bases............................................................................................................................................ 74 5.0.1 Controls and Surveillance Requirements........................................................................ 7 4 5.0.2 Adjustment of the CPS ODCM Methodology.................................................................. 7 4 5.1 Radioactive Liquid Effluent Monitoring Instrumentation................................................................. 76 5.2 Radioactive Gaseous Effluent Monitoring Instrumentation............................................................ 76 5.2.1 Offgas Radiation Monitoring Instrumentation.................................................................. 76 5.2.2 Radioactive Gaseous Effluent Monitoring Instrumentation............................................. 76

SECTION TITLE PART I - RADIOLOGICAL EFFLUENT CONTROLS CY-CL-170-301 Revision 26 September 2022 PAGE 5.3 Liquid Radwaste Effluents............................................................................................................. 76 5.3.1 Liquid Effluent Concentration.......................................................................................... 76 5.3.2 Dose from Liquid Effluents.............................................................................................. 77 5.3.3 Liquid Radwaste Treatment Systems.........'.................................................................... 77 5.4 Radioactive Gaseous Effluents...................................................................................................... 78 5.4.1 Gaseous Effluent Dose Rates......................................................................................... 78 5.4.2 Dose from Noble Gases.................................................................................................. 78 5.4.3 Dose from lodine-131, lodine-133, Tritium and Radioactive Materials in Particulate Form............................................................................................................................................ 79 5.4.4 Gaseous Radwaste Treatment (Off-Gas) System.......................................................... 80 5.4.5 Ventilation Exhaust Treatment System........................................................................... 80 5.5 Total Dose..................................................................................................................................... 80 5.6 Radiological Environmental Monitoring Program........................................................................... 81 5.7 Land Use Census.......................................................................................................................... 82 5.8 lnterlaboratory Comparison Program........ :..................................................................................... 82 5.9 Meteorological Monitoring Program............................................................................................... 82 6.0 Reporting Requirements............................................................................. :**********************************83 6.1 Annual Radiological Environmental Operating Report................................................................... 83 6.2 Radioactive Effluent Release Report............................................................................................. 83 ii

SECTION TITLE PART II - OFFSITE DOSE CALCULATION MANUAL CY-CL-170-301 Revision 26 September 2022 PAGE 1.0 General Information....................................................................................................................... 88 1.1 Introduction.................................................................................................................................... 88 1.2 MCR ARPR LAN............................................................................................................................ 88 2.0 Radioactive Liquid System Effluent Monitoring System................................................................. 89 2.1 Liquid Radwaste Discharge Process Radiation Monitoring (PRM) Instrumentation...................... 89 2.1.1 Liquid Radwaste Discharge PRM Setpoints................................................................... 89 2.2 Plant Service Water Effluent PRM................................................................................................. 92 2.2.1 Plant Service Water Effluent PRM Setpoints.................................................................. 92 2.3 Shutdown Service Water (SX) Effluent PRM................................................................................. 93 2.3.1 Shutdown Service Water (SX) Effluent PRM Setpoints.................................................. 93 2.4 Fuel Pool Heat Exchanger Service Water Effluent PRM............................................................... 93 2.4.1 Fuel Pool Heat Exchanger Service Water Effluent PRM Setpoints................................ 93 2.5 Component Cooling Water PRM.................................................................................................... 94 2.5.1 Component Cooling Water PRM Setpoints..................................................................... 94 3.0 Radioactive Gaseous Effluent Monitoring System......................................................................... 99 3.1 HVAC Stack Process Radiation Monitoring (PRM) Instrumentation.............................................. 99 3.2 SGTS Stack Process Radiation Monitoring (PRM) Instrumentation.............................................. 99 3.3 Main Condenser Off-Gas Monitoring Instrumentation................................................................. 100 3.3.1 Pre-Treatment Air Ejector Off-Gas Process Radiation Monitor (PRM)......................... 100 3.3.2 Post-Treatment Air Ejector Off-Gas Process Radiation Monitor (PRM)........................ 100 3.4 Gaseous Effluent Monitor Setpoint Calculations.......................................................................... 101 3.4.1 Total Body Dose Rate Setpoint..................................................................................... 101 3.4.2 Skin Dose Rate Setpoint............................................................................................... 102 4.0 Liquid Effluents............................................................................................................................ 105 4.1 Introduction.................................................................................................................................. 105 4.2 1 0CFR20 Release Concentration Limits...................................................................................... 105 4.3 10CFR50, Appendix I Dose Limits............................................................................................... 105 4.4 Liquid Effluent Dose Projection Calculations............................................................................... 107 4.5 Temporary Liquid Radwaste Hold-Up Tanks............................................................................... 107 iii

SECTION TITLE PART II - OFFSITE DOSE CALCULATION MANUAL CY-CL-170-301 Revision 26 September 2022 PAGE 5.0 Radioactive Gaseous Effluents.................................................................................................... 115 5.1 Introduction.................................................................................................................................. 115 5.2 Technical Specification Release Rate Limits............................................................................... 117 5.3 Dose Rate Due To Noble Gases................................................................................................. 117 5.4 Dose Rate due to Radioiodines, Particulates and Tritium........................................................... 117 5.5 10CFR50, Appendix I Release Rate Limits................................................................................. 122 5.5.1 Noble Gas Air Dose Equations..................................................................................... 122 5.5.2 Radioiodines, Particulates and Tritium Dose Equations............................................... 123 5.6 Gaseous Effluent Dose Projection Calculations............................................................ :............. 129 6.0 Total Dose................................................................................................................................... 165 7.0 Radiological Environmental Monitoring Program...........................-.............................................. 166 8.0 Land Use Census........................................................................................................................ 171 9.0 lnterlaboratory Comparison Program........................................................................................... 170 10.0 Atmospheric Transport and Dispersion Model............................................................................. 171 10.1 lntroduction................................ :............................................................................. :................... 171 10.2 Concurrent Meteorological Data Processing............................................................................... 171 10.2.1 Determinatino of Pasquill Stability Class.................................................................... 172 10.2.2 Calculation of Stack Height Wind Speed.................................................................... 172 10.2.3 Determination of Release Mode and the Entrainment Coefficient.............................. 17 4 10.2.4 Calculation of Vertical Standard Deviation.................................................................. 174 10.2.5 Calculation of the Building Wake Correction............................................................... 174 10.2.6 Calculation of Momentum Plume Rise........................................................................ 175 10.2.7 Calculation of the Effective Plume Height................................................................... 176 10.2.8 Determination of Affected Sectors.............................................................................. 176 10.2.9 Calculation of Depletion and Deposition Factors........................................................ 177 10.2.10 Ground Level X/Q, D2DPXQ, D1 XQ, D/Q Analysis.................................................... 180 10.2.11 ElevatedX/Q, D2DPXQ, D1XQ, D/QAnalysis........................................................... 181 iv

SECTION TITLE CY-CL-170-301 Revision 26 September 2022 PAGE PART I - RADIOLOGICAL EFFLUENT CONTROLS - TABLES Table 1-1 Surveillance Frequency Notation................................................................................... 6 Table 3.1-1 Radioactive Liquid Effluent Monitoring Instrumentation............................................... 16 Table 4.1-1 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements... 19 Table 3.2-1 Offgas Radiation Monitoring Instrumentation............................................................... 25 Table 4.2-1 Offgas Radiation Monitoring Instrumentation Surveillance Requirements................... 27 Table 3.2-2 Radioactive Gaseous Effluent Monitoring Instrumentation.......................................... 31 Table 4.2-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements............................................................................................................... 33 Table 4.3.1-1 Radioactive Liquid Waste Sampling and Analysis Program......................................... 37 Table 4.4.1-1 Radioactive Gaseous Waste Sampling and Analysis Program....................................42 Table 4.6-1 Radiological Environmental Monitoring Program......................................................... 57 Table 4.6-2 Reporting Levels for Radioactivity Concentrations in Environmental Samples............ 67 Table 4.6-3 Detection Capabilities for Environmental Sample Analysis Lower Limit of Detection (LLD)............................................................................................................ 68 PART II - OFFSITE DOSE CALCULATION MANUAL - TABLES Table 4-1 Table 4-2 Table 4-3 Table 5-1 Table 5-2 Table 5-3 Table 5-4 Table 5-5 Table 5-6 Table 5-7 Table 5-8 Table 5-9 Table 5-10 Table 5-11 Table 5-12 Adult Ingestion Dose Commitment Factors_ Aii (mrem/hr per µCi/ml)....................... 110 Bioaccumulation Factors - BFi (pCi/kg per pCi/liter).................................................. 112 Adult Ingestion Dose Factors - DFi (mrem/pCi ingested)........................................... 113 Dose Factors for Noble Gases and Daughters.......................................................... 119 Inhalation Pathway Dose Rate Factors (Child) - Pij(mrem/yr per µCi/m3).*.*..***......... 120 Location of Members of the Public within the CPS Site Boundary and their Associated Occupancy Factors.................................................................................. 121 Inhalation Dose Factors for Infant - (DFAi)a (mrem per µCi inhaled)........................ 131 Inhalation Dose Factors for Child - (DFAi)a (mrem per µCi inhaled)......................... 132 Inhalation Dose Factors for Teen - (DFAi)a (mrem per µCi inhaled)......................... 133 Inhalation Dose Factors for Adult - (DFAi)a (mrem per µCi inhaled)......................... 134 Ground Plane Dose Factors - DFGi (mrem/hr per µCi/m2)....................................... 135 Ingestion Dose Factors for Infant - (DFLi)a (mrem per µCi ingested)....................... 136 Ingestion Dose Factors for Child - (DFLi)a (mrem per µCi ingested)........................ 137 Ingestion Dose Factors for Teen - (DFLi)a (mrem per µCi ingested)........................ 138 Ingestion Dose Factors for Adult - (DFLi)a (mrem per µCi ingested)........................ 139 V

Table 5-13 CY-CL-170-301 Revision 26 September 2022 Input Parameters for Calculating RC aij...................................................................... 140 vi

SECTION TITLE CY-CL-170-301 Revision 26 September 2022 PAGE PART II - OFFSITE DOSE CALCULATION MANUAL-TABLES Table 5-14 Table 5-15 Table 5-16 Table 5-17 Table 5-18 Table 5-19 Table 5-20 Table 5-21 Table 5-22 Table 5-23 Table 5-24 Table 5-25 Table 5-26 Table 5-27 Table 5-28 Table 5-29 Table 5-30 Table 5-31 Table 5-32 Table 5-33 Table 5-34 Table 5-35 Input Parameters for Calculating RMaij********************************************************************** 141 Input Parameters for Calculating RV aij...................................................................... 142 Inhalation Pathway Factors - R1aij (Infant) (mrem/yr per µCitm3).............................. 143 Inhalation Pathway Factors - R1aij (Child) (mrem/yr per µCi/m3)............................... 144 Inhalation Pathway Factors - R1aij (Teen) (mrem/yr per µCi/m3)............................... 145 Inhalation Pathway Factors - R1aij (Adult) (mrem/yr per µCi/m3)............................... 146 Cow Milk Pathway Factors - RC aij (Infant) (m2rem/yr per µCi/sec)........................... 147 Cow Milk Pathway Factors - RC aij (Child) (m2mrem/yr per µCi/sec)......................... 148 Cow Milk Pathway Factors - RC aij (Teen) (m2mrem/yr per µCi/sec)......................... 149 Cow Milk Pathway Factors - RC aij (Adult) (m2mrem/yr per µCi/sec)......................... 150 Goat Milk Pathway Factors - RC aij (Infant) (m2rem/yr per µCi/sec).......................... 151 Goat Milk Pathway Factors - RC aij (Child) (m2mrem/yr per µCi/sec)........................ 152 Goat Milk Pathway Factors - RC aij (Teen) (m2mrem/yr per µCi/sec)........................ 153 Goat Milk Pathway Factors - RC aij (Adult) (m2mrem/yr per µCi/sec)........................ 154 Meat Pathway Factors - RM aij (Child) (m2mrem/yr per µCi/sec)............................... 155 Meat Pathway Factors - RM aij (Teen) (m2mrem/yr per µCi/sec)............................... 156 Meat Pathway Factors - RM aij (Adult) (m2mrem/yr per µCi/sec)............................... 157 Vegetation Pathway Factors - RV aij (Child) (m2mrem/yr per µCi/sec)...................... 158 Vegetation Pathway Factors - RV aij (Teen) (m2mrem/yr per µCi/sec)...................... 159 Vegetation Pathway Factors - RV aij (Adult) (m2mrem/yr per µCi/sec)...................... 160 Ground Plane Pathway Factors - RGi (m2mrem/yr per µCi/sec)............................... 161 XIQ, D/Q at the Site Boundary 5-Year Average Values from 2017-2021 MET Data................................................................................................................... 162 vii

Table 5-36 Table 5-37 SECTION CY-CL-170-301 Revision 26 September 2022 XIQ, D/Q at Specific Locations with the CPS Site Boundary 5-Year Average Values from 2017-2021 MET Data......................................................................................... 163 X/Q, D/Q at Residences and Air Samplers in Each Sector 5-year Average Values from 2017-2021 MET Data..............................................................'................................... 162 TITLE PAGE PART II - OFFSITE DOSE CALCULATION MANUAL - TABLES Table 10.2-1 a-2 Values.................................................................................................................... 174 Table 10.2-2 Wind Direction Table.................................................................................................. 176 Table 10.2-3 DPF-Depletion Factors from figures 2 through 5 of Regulatory Guide 1.111............. 178 Table 10.2-4 DPSF-Deposition Factors from figures 6 through 9 of Regulatory Guide 1.111......... 179 Table 10.2-5 Gaseous Effluent Release Point Characteristics........................................................ 183 viii

SECTION TITLE PART I - RADIOLOGICAL EFFLUENT CONTROLS - FIGURES CY-CL-170-301 Revision 26 September 2022 PAGE Figure 1-1 Unrestricted Area Boundary for Liquid Effluents................................ -.................................. 7 PART II - OFFSITE DOSE CALCULATION MANUAL - FIGURES Figure 2-1 Unrestricted Area Boundary for Liquid Effluents................................................................ 95 Figure 2-2 Liquid Radwaste Treatment System................................................................................... 96 Figure 2-3 Shutdown and Fuel Pool Heat Exchanger Service Water Effluent Monitors...................... 97 Figure 2-4 Solid Radwaste System Simplified Flow Diagram.............................................................. 98 Figure 3-1 Main Condenser Off-Gas Treatment System................................................................... 104 Figure 4-1 Unrestricted Area Boundary for Liquid Effluents.............................................................. 108 Figure 5-1 CPS Site Boundary for Gaseous Effluents....................................................................... 130 Figure 7-~

REMP Locations within 1 Mile of CPS.............................................................................. 167 Figure 7-2 REMP Locations 1-2 Miles from CPS............................................................................... 168 Figure 7-3 REMP Locations 2-5 Miles from CPS............................................................................... 169 Figure 7-4 REMP Locations Greater than 5 Miles from CPS............................................................. 170 ix

CY-CL-170-301 Revision 26 September 2022 OFFSITE DOSE CALCULATION MANUAL CLINTON POWER STATION

CY-CL-170-301 Revision 26 September 2022 PART I - RADIOACTIVE EFFLUENT CONTROLS OFFSITE DOSE CALCULATION MANUAL CLINTON POWER STATION Page 1

~ Exelon Generation OFFSITE DOSE CALCULATION MANUAL (ODCM) 1.0 DEFINITIONS CY-CL-170-301 Revision 26 September 2022 The following terms are defined so that uniform interpretation of this manual's requirements may be achieved. The defined terms appear in capitalized type and shall be applicable throughout this manual.

1.1 ACTION ACTION shall be that part of a Control that prescribes remedial measures required under designated conditions.

1.2 CHANNEL CALIBRATION A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel output such that it responds within the necessary range and accuracy to known values of the parameter that the channel monitors. The Channel Calibration shall encompass the entire channel, including the required sensor, alarm, display and trip functions, and shall include the CHANNEL FUNCTIONAL TEST. Calibration of instrument channels with resistance temperature detector (RTD) or thermocouple sensors may consist of an in-place qualitative assessment of sensor behavior and normal calibration of the remaining adjustable devices in the channel. The CHANNEL CALIBRATION may be performed by means of any series of sequential, overlapping, or total channel steps so that the entire channel is calibrated.

1.3 CHANNEL CHECK A CHANNEL CHECK shall be a qualitative assessment, by observation, of channel behavior during operation. This determination shall include, where possible, comparison of the channel indication and status to other indications or status derived

from independent instrument channels measuring the same parameter.

1.4 CHANNEL FUNCTIONAL TEST A CHANNEL FUNCTIONAL TEST shall be the injection of a simulated or actual signal into the channel as close to the sensor as practicable to verify Functionality, including required alarm, interlock, display, and trip functions, and channel failure trips. The CHANNEL FUNCTIONAL TEST may be performed by means of any series of sequential, overlapping, or total channel steps so that the entire channel is tested.

1.5 DOSE EQUIVALENT 1-131 DOSE EQUIVALENT 1-131 shall be as defined in the Clinton Power Station Page 2

Technical Specifications.

1.6 FREQUENCY NOTATION CY-CL-170-301 Revision 26 September 2022 The FREQUENCY NOTATION specified for the performance of surveillance.

requirements shall correspond to the intervals defined in TABLE 1-1.

1.7 FUNCTIONAL-FUNCTIONALITY Functionality is an attribute of structures, systems, and components (SSCs) that is not controlled by Technical Specifications (TSs). An SSC is FUNCTIONAL or has FUNCTIONALITY when it is capable of performing its specified safety function, as set forth in the Current Licensing Basis. FUNCTIONALITY does not apply to specified safety functions, but does apply to the ability of non-TS SSCs to perform other specified functions that have a necessary support function.

1.8 GASEOUS RADWASTE TREATMENT SYSTEM A GASEOUS RADWATE TREATMENT SYSTEM is any system designed and installed to reduce radioactive gaseous effluents by collecting primary coolant system offgases from the main condenser evacuation system and providing for delay or holdup for the purpose of reducing the total radioactivity prior to release to the environment.

1.9 IMMEDIATELY When IMMEDIATELY is used as a Completion Time, the Required ACTION should be pursued without delay and in a controlled manner.

1.10 MEMBER(S) OF THE PUBLIC An individual in a controlled or unrestricted area. However, an individual is not a MEMBER OF THE PUBLIC during any period in which the individual receives an occupational dose.*

1.11 MODE A MODE shall correspond to any one inclusive combination of mode switch position, average reactor coolant temperature, and reactor vessel head closure bolt tensioning specified in Technical Specifications in Table 1.1-1 with fuel in the reactor vessel.

Page 3

1.12 OFFSITE DOSE CALCULATION MANUAL (ODCM)

CY-CL-170-301 Revision 26 September 2022 The OFFSITE DOSE CALCULATION MANUAL (ODCM) contains the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluent, in the calculation of gaseous and liquid effluent monitoring Alarm/Trip Setpoints, and in the conduct of the Radiological Environmental Monitoring Program. The ODCM also contains (1) the Radiological Effluent Controls, (2) the Radiological Environmental Monitoring Program and (3) descriptions of the information that should be included in the Annual Radiological Environmental Operating and Annual Radioactive Effluent Release Reports.

1.13 PURGE - PURGING PURGE or PURGING is the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating conditions in such a manner that replacement air or gas is required to purify the confinement.

1.14 SITE BOUNDARY The SITE BOUNDARY shall be that line beyond which the land is neither owned, nor leased, nor otherwise controlled by the licensee. See FIGURE 1-1.

1.15 SOURCE CHECK A SOURCE CHECK shall be the qualitative assessment of channel response when the channel sensor is exposed to a source of increased radioactivity.

1.16 UNRESTRICTED AREA UNRESTRICTRED AREA means an area, access to which is neither limited nor controlled by the licensee.

Page 4

1.17 VENTILATION EXHAUST TREATMENT SYSTEM CY-CL-170-301' Revision 26 September 2022 A VENTILATION EXHAUST TREATMENT SYSTEM is any system designed and installed to reduce gaseous radioiodine or radioactive material in particulate form in effluents by passing ventilation or vent exhaust gases through charcoal adsorbers and/or HEPA filters for the purpose of removing iodine or particulates from the gaseous exhaust system prior to the release to the environment. Such a system is not considered to have any effect on noble gas effluents. Engineered Safety Feature (ESF) atmospheric cleanup systems are not considered to be VENTILATION EXHAUST TREATMENT SYSTEMS.

The following systems are designated VENTILATION EXHAUST TREATMENT SYSTEMS:

1)

Machine Shop HVAC (VJ)

2)

Laboratory HVAC (VL)

3)

Drywell Purge (VQ)

4)

Radwaste Bldg. HVAC (VW) 1.18 VENT - VENTING VENTING is the controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating conditions in such a manner that replacement air or gas is not provided. Vent used in a system name does not imply a VENTING process.

Page 5

CY-CL-170-301 Revision 26 September 2022 TABLE 1-1 SURVEILLANCE FREQUENCY NOTATION Notation S (Shiftly)

D (Daily)

W (Weekly)

B (Biweekly)

M (Monthly)

Q (Quarterly)

SA (Semi-Annually)

A (Annually)

R (Refueling Cycle)

R24 (Refueling Cycle)

S/U (Startup)

P (Prior)

N/A (NA)

Frequency Once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months Once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months Once per 7 days Once per 14 days Once per 31 days Once per 92 days Once per 184 days Once per 366 days Once per 18 months (550 days)

Once per 24 months (732 days)

Prior to each reactor startup Completed prior to each release Not applicable NOTE:

A FREQUENCY NOTATION for a composite sample describes the time period over which the sample is to be composited.

Page 6

FIGURE 1-1 UNRESTRICTED AREA BOUNDARY FOR LIQUID EFFLUENTS CPS RESTRICTED AREA NOTE 1 HWY-54 HWY. 48 NOTE :3 NOTES CY-CL-170-301 Revision 26 September 2022 LEGEND

~==: SITE BOUNDARY VZZ2ZZJ UNRESTRICTED AREA f:,::::,j:*::*,:I SPEC(AL UNRESTRICTED AREA(See Note 1)

AREA WITHIN SITE BOUNDARY NOT OWNED SY IPC

1.

The area in the lake between the buoys and the exclusion area boundary is unrestricted at this time. But will be controlled if plant effluent conditions warrant closure.

2.

Land parcel not owned by Clinton Power Station, includes residences.

3.

Land parcel not owned by Clinton Power Station, oil company pipeline pumping station.

4.

Land parcel not owned by Clinton Power Station, agricultural use.

5.

The lake shoreline is approximately 690 ft. Msl elevation line.

Page 7

2.0 NOT USED Page 8 CY-CL-170-301 Revision 26 September 2022

INTENTIONALLY BLANK Page 9 CY-CL-170-301 Revision 26 September 2022

3/4 CONTROLS AND SURVEILLANCE REQUIREMENTS 3/4.0 APPLICABILITY 3.0 CONTROL CY-CL-170-301 Revision 26 September 2022 3.0.1 Compliance with the Controls contained in the succeeding controls is required during the OPERATIONAL MODES or other conditions specified herein, except that upon failure to meet the Control, the associated ACTION requirements.shall be met.

3.0.2 Noncompliance with a control shall exist when the requirements of the Control and associated ACTION requirements are not met within the specified time intervals. If the Control is restored prior to expiration of the specified time intervals, completion of the ACTION requirements is not required.

3.0.3 Equipment removed from service or declared non-functional to comply with ACTION(s) may be returned to service under administrative control solely to perform testing required to demonstrate FUNCTIONALITY or the FUNCTIONALITY of other equipment. This is an exception to CONTROL 3.0.2 for the system returned to service under administrative control to perform the testing required to demonstrate FUNCTIONALITY.

Page 10

4.0 4.0.1 4.0.2 SURVEILLANCE REQUIREMENTS CY-CL-170-301 Revision 26 September 2022 Surveillance Requirements shall be met during the OPERATIONAL MODES or other conditions specified for individual Controls unless otherwise stated in an individual Surveillance Requirement.

Each Surveillance Requirement shall be performed within the specified time interval with:

a.

A maximum allowable extension not to exceed 25% of the surveillance interval.

b.

For surveillance intervals specified as "once", the above interval extension does not apply.

c.

If an ACTION requires periodic performance on a "once per... " basis, the above surveillance interval extension applies to each performance after the initial performance.

Exceptions to this Surveillance Requirement are stated in the individual Surveillance Requirements.

4.0.3 Failure to perform a Surveillance Requirement, whether such failure is experienced during the performance of the surveillance or between performances of the surveillance, within the allowed surveillance interval, defined by Specification 4.0.2, shall constitute noncompliance with the FUNCTIONALITY requirements for a Control. The time limits of the ACTION requirements are applicable at the time it is identified that a Surveillance Requirement has not been performed. The ACTION requirements may be delayed for up to 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months to permit the completion of the surveillance when the allowable outage time limits of the ACTION requirements are less than 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months . Surveillance Requirements do not have to be performed on non-functional equipment.

4.0.4 Entry into an OPERATIONAL MODE or other specified condition shall not be made unless the Surveillance Requirement(s) associated with the Control has been performed within the stated surveillance interval or as otherwise specified.

This provision shall not prevent passage through or to OPERATIONAL MODES as required to comply with ACTION requirements. Exceptions to these requirements are stated in the individual controls.

Page 11

CY-CL-170-301 Revision 26 September 2022 3/4.1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION 3.1 CONTROLS 3.1.1

. The following conditions shall be met:

The radioactive liquid effluent monitoring instrumentation channels shown in TABLE 3.1-1 shall be FUNCTIONAL with their alarm/trip setpoints set to ensure the limits of 3.3.1 are not exceeded;

a.

The effluent monitoring instrument alarm/trip setpoints shall be determined and adjusted in accordance with the methodology and parameters described in the ODCM.

APPLICABILITY:

At all times.

NOTE:

Separate condition entry is allowed for each instrument.

ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A.

Number of instrument A.1 Enter the ACTION Immediately channels FUNCTIONAL referenced in Table 3.1-1 less than required by for the instrument channel.

Table 3.1-1.

B.

Radioactive liquid 8.1 Suspend the release of Immediately effluent monitoring radioactive liquid effluents instrumentation channel monitored by the affected alarm/trip setpoint less channel.

conservative than required.

OR B.2 Declare the affected Immediately instrument non-functional.

Page 12

CONDITION C.

As required by Action A.1 and referenced in Table 3.1-1.

D.

As required by Action A.1 and referenced in Table 3.1-1.

REQUIRED ACTION C.1 Return the instrument to FUNCTIONAL status.

AND C.2.1.1 Analyze at least two independent samples of tank's contents per 4.3.1.1.

AND C.2.1.2 At least two technically qualified individuals independently verify the release rate calculations and discharge line valving.

OR C.2.2 Suspend release of radioactive effluents via this pathway.

D.1 Return the instrument to FUNCTIONAL status.

AND D.2 Estimate tank liquid leveL Page 13 CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME Within 30 days Prior to release Prior to release Immediately 30 days During all liquid additions to the tank.

CONDITION E.

As required by Action A.1 and referenced in Table 3.1-1.

REQUIRED ACTION E.1 Return the instrument to FUNCTIONAL status.

E.2.1 Perform CHANNEL CHECK using local monitor indication.

OR CY -CL-170-301 Revision 26 September 2022 COMPLETION TIME 30 days Within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months of declaring non-functional, Every 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter.

E.2.2 Collect and analyze grab Once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months samples for radioactivity at an LLD of s 5.00E-07 µCi/ml for the Principal Gamma Emitters (see TABLE 4.3.1-1 Note (c)),

an LLD of s 5.00E-06 µCi/ml for Ce-144, and an LLD of s 1.00E-05 µCi/ml for dissolved and entrained gases (gamma emitters only, see TABLE 4.3.1-1 Note (e))

Page 14

CONDITION F. One or more flow measurement device channels non-functional.

G.

Radioactive liquid effluent monitoring instrumentation not returned to FUNCTIONAL status in the time specified in Conditions C, D, E or F.

REQUIRED ACTION F.1 Restore the channel to FUNCTIONAL status.

AND

NO TE

1. Pump performance curves generated in place may be used to estimate flow.

2. CW flow may also be estimated from the number of CW pumps in operation.

3. All flows diverted from Plant Service Water must be taken into account when estimating dilution flow when Plant Service Water is the only dilution source.

F.2 Estimate the effluent release flow rate via th is pathway G.1 Explain why the non-FUNCTIONALITY was not corrected in a timely manner in the next Radioactive Effluent Release Report.

Page 15 CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME 30 days Once per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months during actual releases.

As part of the next Radioactive Effluent Release Report submittal.

TABLE 3.1-1 CY -CL-170-301 Revision 26 September 2022 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION MINIMUM INSTRUMENT CHANNELS ACTION APPLICABILITY FUNCTIONAL(e)

1. Radioactive Monitors Providing Alarm and Automatic Termination of Release

a. Liquid Radwaste Discharge Process 1 (a)

C (b)

Radiation Monitor 0RIX-PR040

2. Radioactivity Monitors Providing Alarm but Not Providing Automatic Termination of Release

a. Plant Service Water Effluent Process 1 (a)

E (c)

Radiation Monitor 1 RIX-PR036

b. Shutdown Service Water Effluent Process Radiation Monitor 1/Division* (a)

E (c)

Div1: 1 RIX-PR038 Div2: 1 RIX-PR039 C.

Fuel Pool Heat Exchanger Service 1/On Service Heat Water Radiation Monitor Exchanger (a)

E (c) trainA: 1 RIX-PR004 trainB:1 RIX-PR005

d. Component Cooling Water Process 1 (a)

E (c)

Radiation Monitor 1 RIX-PR037

3. Flow Rate Measurement Devices (0UIX-PR052)

a. Liquid Radwaste Effluent Line 1

F (b)

(Channel 1..:tow, Channel 2-high)

b. Plant Service Water Effluent Line (Ch 3) 1 F

(b)

C.

Plant Circulation Water Line** (Ch 5) 1 F

(b)

4. Tank Level Indicating Devices

a. Cycled Condensate Storage (meter indication at panel 1 H 13-P870 or 1

D (d) computer point CY-BA401)

b. Reactor Core Isolation Cooling Storage 1

D (d)

(meter indication at panel 1 H 13-P862)

Division I and Division II only.

The plant circulation water (CW) flow rate measurement device is based upon the CW pump breaker position and an analog signal that specifies a preset flow rate.

TABLE NOTATION (a)

Channel FUNCTIONALITY shall include the capability of the MCR ARPR LAN to provide the alarm status of the applicable radiation monitor channel(s).

(b)

Required only during radioactive discharge.

(c)

Any time system is in service.

(d)

During additions to the tank.

Page 16

CY-CL-170-301 Revision 26 September 2022 (e)

When a channel is placed in non-functional status solely for the performance of required surveillances (source checks, sampling) entry into the associated Required Action may be delayed for up to one hour.

Page 17

SURVEILLANCE REQUIREMENTS CY-CL-170-301 Revision 26 September 2022 SURVEILLANCE REQUIREMENT FREQUENCY 4.1.1 Perform SOURCE CHECK of radioactive liquid effluent monitoring Per TABLE 4.1-1 instruments.

4.1.2 Perform CHANNEL CHECK of radioactive liquid effluent Per TABLE 4.1-1 monitoring instruments.

4.1.3 Perform CHANNEL CALIBRATION of radioactive liquid effluent Per TABLE 4.1-1 monitoring instruments.

4.1.4 Perform CHANNEL FUNCTIONAL TEST of radioactive liquid Per TABLE 4.1-1 effluent monitoring instruments.

Page 18

1.

2.

3.

4.

TABLE 4.1-1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS Page 1 of 2 CHANNEL SOURCE CHANNEL INSTRUMENT CHECK CHECK CALIBRATION Radioactivity Monitors Providing Alarm and Automatic Termination of Release

a. Liquid Radwaste Discharge Process Radiation Monitor S (4,5) p R (3)

Effluent Line Radioactivity Monitors Providing Alarm but Not Providing Automatic Termination of Release

a. Plant Service Water Effluent S (5)

M R (3)

Process Radiation Monitor

b. Shutdown Service Water Effluent Process Radiation S (5)

M R (3)

Monitor

c.

Fuel Pool Heat Exchanger Service Water Radiation S (5)

M R (3)

Monitor

d. Component Cooling Water S (5)

M R (3)

Process Radiation Monitor Flow Rate Measurement Devices

a. Liquid Radwaste Effluent Line S (4)

NA R

b. Plant Service Water Effluent S (4)

NA R

Line C.

Plant Circulation Water Line S (4)

NA NA Tank Level Indicating Devices

a. Cycled Condensate Storage D*

NA R

b. Reactor Core Isolation D*

NA R

Cooling During liquid additions to the tank.

Page 19 CY-CL-170-301 Revision 26 September 2022 CHANNEL FUNCTIONAL TEST Q (1)

Q (2)

Q Q

R NA NA

TABLE 4.1-1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS Page 2 of 2 TABLE NOTATION CY -CL-170-301 Revision 26 September 2022 (1)

The CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway occurs and that the MCR ARPR LAN provides annunciation and event display in response to each of the following conditions:

1.

Instrument indicates measured levels above the alarm/trip (HIGH) setpoint.

2.

Detector failure (LOW FAIL, HI FAIL).

3.

Sample flow failure (EXTERNAL FAIL).

4.

Instrument not set in normal operate mode (CALIBRATE, MAINTENANCE, or STANDBY.). A demonstra~ion of automatic isolation of the release pathway is not applicable to this condition.

(2)

The CHANNEL FUNCTIONAL TEST shall also demonstrate that the MCR ARPR LAN responds with annunciation and event display to each of the following conditions:

1.

Instrument indicates measured levels above the alarm (HIGH) setpoint.

2.

Detector failure (LOW FAIL, HI FAIL).

3.

Sample flow failure (EXTERNAL FAIL).

4.

Instrument not set in normal operate mode (CALIBRATE, MAINTENANCE, or STANDBY.). A demonstration of automatic isolation of the release pathway is not applicable to this condition.

(3)

The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

(4)

CHANNEL CHECK shall consist of verifying indication of flow during periods of discharge. CHANNEL CHECKS are required when continuous, periodic, or batch releases are made.

(5)

The CHANNEL CHECK performed from the MCR ARPR LAN also verifies communication.

Page 20

CY-CL-170-301 Revision 26 September 2022 3/4.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION 3/4.2.1 OFFGAS RADIATION MONITORING INSTRUMENTATION CONTROLS 3.2.1 CONTROLS 3.2.1.1 The following conditions shall be met:

a.

The offgas radiation monitoring instrumentation channels shown in TABLE 3.2-1 shall be FUNCTIONAL with alarm/trip setpoints within the specified limits.

APPLICABILITY:

During operation of the main condenser air ejectors.

NOTE:

Separate condition entry is allowed for each instrument.

ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A.

Number of instrument A.1 Enter the Action Immediately channels FUNCTIONAL referenced in Table 3.2-1 less than required by for the instrument Table 3.2-1.

channel.

B.

Offgas radiation 8.1 Suspend the release of Immediately monitoring radioactive gaseous instrumentation channel effluents monitored by the alarm/trip setpoint affected channel.

exceeding the TABLE 3.2-1 value.

OR B.2 Declare the affected Immediately channel non-functional.

Page 21

CONDITION C.

As required by Required Action A.1 and referenced in Table 3.2-1.

REQUIRED ACTION C.1 Return the instrument to FUNCTIONAL status CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME 30 days C.2.1.1 Perform a CHANNEL Within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months CHECK using local monitor indication.

AND Once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months AND thereafter.

NOTE--------------------

This requirement is to provide sample indication to initiate Tech.

Spec. Surveillance Requirement 3.7.5.1.

C.2.1.2 Locally check for TREND alarm.

OR C.2.2.1 Ensure the offgas treatment system is not bypassed (filtration system bypass is allowed during plant start-ups);

AND

NOTE--------------------

The following step ensures compliance with Technical Specification Surveillance Requirement 3.7.5.1.

Page 22 Within 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months Once per 2 hours2.314815e-5 days 5.555556e-4 hours 3.306878e-6 weeks 7.61e-7 months thereafter.

lmme~iately

CONDITION REQUIRED ACTION C.

(continued)

C.2.2.2 Perform grab samples until the monitor is returned to FUNCTIONAL status.

AND C.2.2.3 Perform noble gas gamma isotopic analysis D.

As required by Required D.1 Return the instrument to Action A 1 and FUNCTIONAL status referenced in Table 3.2-1.

AND D.2.1 Perform a CHANNEL CHECK using local monitor indication.

OR D.2.2.1 Perform grab samples until the monitor is returned to FUNCTIONAL status.

AND D.2.2.2 Perform noble gas gamma isotopic analysis E.

As required by Required E.1 Estimate the flow rate via the Action A 1 and applicable release pathways.

referenced in Table 3.2-1.

Page 23 CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months AND Once per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months thereafter.

Within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of samplinQ 30 days Within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months AND Once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter.

8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months AND Once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter Within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of sampling Once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months

CONDITION F.

Instrumentation not returned to FUNCTIONAL status in the time specified in Conditions C or D.

F.1 REQUIRED ACTION Explain why the non-FUNCTIONALITY was not corrected in a timely manner in the next Radioactive Effluent Release Report.

Page 24 CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME As part of the next Radioactive Effluent Release Report submittal.

TABLE 3.2-1 CY-CL-170-301 Revision 26 September 2022 OFFGAS RADIATION MONITORING INSTRUMENTATION MINIMUM ALARM/TRIP INSTRUMENTATION CHANNELS SETPOINT Action FUNCTIONAL 0

1.

Pre-treatment Off-gas PRM - Noble Gas Activity 1 d

~ 50 µCi/cca,b C

Monitor 1 RIX-PR034

2.

Post-treatment Off-gas PRM 1 RIX-PR035/41

a. High-Range Noble Gas Activity Monitor Providing Alarm and Automatic Termination 1 d

~ 7.06 µCi/ccc D

of Release (Ch. 7)

b. Effluent System Flow Rate Measuring Device 1 N66R602A or 1 N66R602B or computer 1

NA E

point OG-DA066 C. Sample Flow Rate Measuring Device (Ch 15) 1 NA E

a.

Alarm only.

b.

Radioactivity concentration expected at the monitor location is a noble gas mix with a 2.9-minute decay.

c.

Radioactivity concentration expected at the monitor location is a noble gas mix released from the off-gas treatment system.

d.

Channel FUNCTIONALITY shall include the capability of the MCR ARPR LAN to provide the alarm status of the applicable radiation monitor channel(s).

e.

When a channel is placed in an non-functional status solely for the performance of required surveillances (source checks, sampling) entry into the associated Required Action may be delayed for up to one hour.

Page 25

4.2.1 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT 4.2.1.1 Perform SOURCE CHECK of radiation monitoring instrumentation channels.

4.2.1.2 Perform CHANNEL CHECK of radiation monitoring instrumentation channels.

4.2.1.3 Perform CHANNEL CALIBRATION of radiation monitoring instrumentation channels.

CY-CL-170-301 Revision 26 September 2022 FREQUENCY Per TABLE 4.2-1 Per TABLE 4.2-1 Per TABLE 4.2-1 4.2.1.4 Perform CHANNEL FUNCTIONAL TEST of radiation monitoring Per TABLE 4.2-1 instrumentation channels.

Page 26

1.

2.

TABLE 4.2-1 OFFGAS RADIACTION MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS CHANNEL SOURCE CHANNEL INSTRUMENTATION CHECK CHECK FUNCTIONAL TEST Pre-treatment Off-gas PRM -

Noble Gas Activity Monitor S (3)

M Q (1) 1RIX-PR034 Post-treatment Off-gas PRM 1 RIX-PR035/41

a.

High-Range Noble Gas Activity Monitor Providing S (3) w Q (1)

Alarm and Automatic Termination of Release (ch 7) b.1 Effluent System Flow-Rate Measuring Device D

NA Q

1 N66-R602A/B b.2 OG-DA066 D

NA NA C.

Sample Flow Rate Measuring s

NA Q

Device (ch 15)

TABLE NOTATION CY-CL-170-301 Revision 26 September 2022 CHANNEL CALIBRATION R (2)

R24 (2) a R

R R24

a.

Automatic isolation of valve 1 N66-F060 shall be demonstrated during the CHANNEL CALIBRATION.

(1)

The CHANNEL FUNCTIONAL TEST shall also demonstrate that the MCR ARPR LAN responds with annunciation and event display to each of the following conditions:

1.

Instrument indicates measured levels above the alarm/trip (HIGH) setpoint.

2.

Detector failure (LOW FAIL, HI FAIL).

3.

Sample flow failure (EXTERNAL FAIL).

4.

Instrument not set in normal operate mode (CALIBRATE, MAINTENANCE, or STANDBY).

(2)

The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended energy range and measurement range. Subsequent CHANNEL CALIBRATION shall be performed using the initial radioactive standards or other standards of equivalent quality or radioactive sources that have been related to the initial calibration.

(3)

The CHANNEL CHECK shall also determine that channel communication is established to the MCR ARPR LAN. By system design, the Channel Check from the MCR ARPR LAN verifies communication.

Page 27

CY-CL-170-301 Revision 26 September 2022 3/4.2.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION CONTROLS 3.2.2 CONTROLS 3.2.2.1 The following conditions shall be met:

a.

The radioactive gaseous effluent monitoring instrumentation channels shown in TABLE 3.2-2 shall be FUNCTIONAL with their alarm/trip setpoints set to ensure that the limits of 3.4.1 and Technical Specification 3.7.5 are not exceeded.

b.

The alarm/trip setpoints of these channels shall be determined and adjusted in accordance with the ODCM methodology and parameters.

APPLICABILITY:

As shown in TABLE 3.2-2.

NOTE:

Separate condition entry is allowed for each instrument.

ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A.

Number of instrument A.1 Enter the Action Immediately channels FUNCTIONAL referenced in Table less than required by Table 3.2-2 for the instrument 3.2-2 channel B.

Radioactive gaseous

8.1 Suspend the release of Immediately effluent monitoring radioactive gaseous instrumentation channel effluents monitored by alarm/trip setpoint less the affected channel.

conservative than required.

OR B.2 Declare the channel Immediately non-functional Page 28

CONDITION REQUIRED ACTION C.

As required by Action A.1 C.1 Restore instrumentation to and referenced in Table FUNCTIONAL status.

3.2-2 AND C.2.1 Perform a CHANNEL CHECK using local monitor indication.

OR C.2.2.1 Obtain grab samples; AND C.2.2.2 Analyze grab samples for gross noble gas activity, and then releases via this pathway may continue.

D.

As required by Action A.1 D.1 Restore instrument to and referenced in Table FUNCTIONAL status; 3.2-2 AND D.2 Obtain samples per TABLE 4.4.1-1 with auxiliary sampling equipment, then releases via this pathway may continue.

Page 29 CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME 30 days Within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months AND Once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter Within 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months AND Once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months thereafter Within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months of obtaining grab sample.

30 days 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months after channel declared non-functional, AND Continuously thereafter.

CONDITION E.

As required by Action A.1 and referenced in Table 3.2-2 F.

As required by Action A.1 and referenced in Table 3.2-2 G. Radioactive gaseous process and effluent monitoring instrumentation channels not returned to FUNCTIONAL status in the time specified in Conditions, C, D, E or F.

REQUIRED ACTION E.1 Restore instrument to FUNCTIONAL status; AND

, ------NOTE-----------------

Alternate flow instruments or summation of system ventilation flows may be used in the estimation of SGTS and HVAC flow rates.

E.2 Estimate flow rate, then releases via this pathway may continue.

F.1 Restore instrument to FUNCTIONAL status; OR

NOTE--------

Instrument non-FUNCTIONALITY does not preclude changing mode.

F.2 Initiate the preplanned alternate method of monitoring the appropriate parameter(s).

G.1 Explain why the non-FUNCTIONALITY was not corrected in a timely manner in the next Radioactive Effluent Release Report pursuant to Technical Specification 5.6.3.

Page 30 CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME 30 days At least once per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months 72 hours Immediately As part of the next Radioactive Effluent Release Report submittal.

TABLE 3.2-2 CY-CL-170-301 Revision 26 September 2022 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION MINIMUM CHANNEL REQUIRED INSTRUMENT s

APPLICABI ACTION FUNCTION LITY AL (g)

1.

Station HVAC Exhaust PRM 0RIX-PR001/2

a.

High-Range Noble Gas Activity Monitor (Ch 7) 1<c) a C

b.

Low-Range Noble Gas Activity Monitor (Ch 5) 1<c) a C

C.

Iodine Sampler<d>

1 a

D

d.

Particulate Sampler<d>

1 a

D

e.

Sample Flow-Rate Measuring Device (Ch 15) 1 a

C

2.

Standby Gas Treatment System Exhaust PRM ORIX-PR003/4

a.

High-Range Noble Gas Activity Monitor (Ch 9) 1<c) b C

b.

Low-Range Noble Gas Activity Monitor (Ch 6) 1<c) b C

C.

Iodine Sampler<d>

1 b

D

d.

Particulate Sampler<d>

1 b

D

e.

Sample Flow-Rate Measuring Device (Ch 15) 1 b

C

3.

Station HVAC Exhaust AXM 0RIX-PR012

a.

High-Range Noble Gas Activity Monitor (Ch 3) 1 e

F

b.

Intermediate-Range Noble Gas Activity Monitor (Ch 4) 1 e

F C.

Sample Flow-Rate Measuring Device 0FI-PR0128 1

e F

4.

Standby Gas Treatment System Exhaust AXM 0RIX-PR008

a.

High-Range Noble Gas Activity Monitor (Ch 3) 1 e

F

b.

Intermediate-Range Noble Gas Activity Monitor (Ch 4)

1 e

F C.

Sample Flow-Rate Measuring Device 0FI-PR0088 1

e F

5.

Station HVAC Effluent System Flow-Rate Measuring 1

a E

Device 0UIX-PR051 Ch 6

6.

SGTS Effluent System Flow-Rate Measuring Device 0UIX-1 f

E PR051 Ch 1

a.

At all times.

b.

When standby gas treatment system is in standby or operation.

c.

Channel FUNCTIONALITY shall include the capability of the MCR ARPR LAN to provide the alarm status of the applicable radiation monitor channel(s).

d.

Filter media (particulate collection patch for particulates and charcoal cartridge for iodines) in place with an operating sample pump constitutes an functional iodine/particulate sampler.

e.

Modes 1, 2, and 3 only

f.

When Standby Gas Treatment System is in operation.

g.

When a channel is placed in a non-FUNCTIONAL status solely for the performance of required surveillances, entry into associated ACTION may be delayed for up to one hour.

Page 31

4.2.2 SURVEILLANCE REQUIREMENTS CY-CL-170-301 Revision 26 September 2022 SURVEILLANCE REQUIREMENT FREQUENCY 4.2.2.1 Perform SOURCE CHECK of radioactive gaseous effluent Per TABLE 4.2-2 monitoring instrumentation channel.

4.2.2.2 Perform CHANNEL CHECK of radioactive gaseous effluent Per TABLE 4.2-2 monitoring instrumentation channel.

4.2.2.3 Perform CHANNEL CALIBRATION of radioactive gaseous Per TABLE 4.2-2 effluent monitoring instrumentation channel.

4.2.2.4 Perform CHANNEL FUNCTIONAL TEST of radioactive gaseous Per TABLE 4.2-2 effluent monitoring instrumentation channel.

Page 32

1.

2.

3.

4.

5.

6.

7.

TABLE 4.2-2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS Page 1 of 2 CHANNEL SOURCE CHANNEL INSTRUMENT CHECK CHECK CALIBRATION Station HVAC Exhaust PRM 0RIX-PR001/2

a.

High-Range Noble Gas Activity Monitor S (3)

M R (2)

(Ch 7)

b.

Low-Ranae Noble Gas Activitv Monitor (Ch 5)

S (3)

M R(2)

C.

Iodine Sampler w

NA NA

d.

Particulate Sampler w

NA NA

e.

Samole Flow-Rate Measurina Device (Ch 15) s NA R

Standby Gas Treatment System Exhaust PRM 0RIX-PR003/4

a.

Hh:Ih-RanQ Noble Gas Activity Monitor (Ch 9)

S (3)

NA R (2)

b.

Low-Ranae Noble Gas Activitv Monitor (Ch 6)

S (3)

M R (2)

C.

Iodine Samoler w

NA NA

d.

Particulate Sampler w

NA NA

e.

Samole Flow-Rate Measuring Device (Ch 15) s NA R

Station HVAC ExhaustAXM 0R1X-PR012

a.

High-Range Noble Gas Activity Monitor S (3)

M R (2)

(Ch 3)

b.

Intermediate-Range Noble Gas Activity S (3)

M R (2)

Monitor (Ch 4)

C.

Sample Flow-Rate Measuring Device NA R

0Fl-PR0128 Standby Gas Treatment System Exhaust AXM 0RIX-PR008

a.

High-Range Noble Gas Activity Monitor S (3)

M R (2)

(Ch 3)

b.

Intermediate-Range Noble Gas Activity S (3)

M R (2)

Monitor (Ch 4)

C.

Sample Flow-Rate Measuring Device NA R

0FI-PR008B

d.

Automatic Ooeration!4l NA NA NA Station HVAC Effluent System Flow-Rate s

NA R

Measuring Device 0UIX-PR051, Ch 6 SGTS Effluent System Flow-Rate Measuring s

NA R

Device 0UIX-PR051, Ch 1 lnservice Calibrations on Station HVAC Exhaust and Standby Gas Treatment System Exhaust NA NA A (a, b)

PRMs Shiftly when in operation with the pump running.

Page 33 CY-CL-170-301 Revision 26 September 2022 CHANNEL FUNCTIONAL TEST Q (1)

Q (1)

NA NA Q

Q (1)

NA NA Q

NA NA NA NA NA NA NA Q

Q NA

TABLE 4.2-2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS Page 2 of 2 TABLE NOTATION CY-CL-170-301 Revision 26 September 2022

a.

Per Regulatory Guide 1.21, compare the PRM readings with grab sample results for the noble gas and particulate/iodine channels. Modify the channel calibrations as necessary to ensure monitor readings are related to the concentration or release rates of nuclides in the monitored path.

b.

Not applicable if the activity in the sample stream is not high enough to provide a statistically relevant comparison.

(1)

The CHANNEL FUNCTIONAL TEST shall also demonstrate that the MCR ARPR LAN responds with annunciation and event display to each of the following conditions:

1.

Instrument indicates measured levels above the alarm (HIGH) setpoint.

2.

Detector failure (LOW FAIL, HI FAIL).

3.

Sample flow failure (EXTERNAL FAIL).

4.

Instrument not set in normal operate mode (CALIBRATE, MAINTENANCE, or STANDBY).

(2)

The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. Subsequent CHANNEL CALIBRATION shall be performed using the initial radioactive standards or other standards of equivalent quality or radioactive sources that have been related to the initial calibration.

(3)

The CHANNEL CHECK performed from the MCR ARPR LAN also verified communication.

(4)

Verify the SGTS AXM automatically starts upon initiation of DIV I SGTS and remains in service following shutdown of DIV I SGTS. Periodicity= 24 months.

Page 34

3/4.3 LIQUID RADWASTE EFFLUENTS 3/4.3.1 LIQUID EFFLUENT CONCENTRATION 3.3.1 CONTROLS CY-CL-170-301 Revision 26 September 2022 3.3.1.1 The effluent concentration limit (ECL) of radioactive material released in liquid effluent to UNRESTRICTED AREAS (see FIGURE 1-1) shall be limited to:

a.

10 times the concentrations specified in 1 0CFR20, Appendix B, Table 2, Column 2 for radionuclides other than dissolved or entrained noble gases; and

b.

2 x 10-4 µCi/ml total activity concentration for all dissolved or entrained noble gases.

APPLICABILITY:

During all releases via this pathway.

ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A.

Concentration of radioactive A.1 Restore the concentration Immediately material released in liquid to within limits.

effluents to UNRESTRICTED AREAS exceeding limits.

Page 35

4.3.1 SURVEILLANCE REQUIREMENTS CY-CL-170-301 Revision 26 September 2022 SURVEILLANCE FREQUENCY 4.3.1.1 Obtain samples of radioactive liquid wastes and Per TABLE 4.3.1-1 analyze per TABLE 4.3.1-1.

4.3.1.2 Evaluate analysis results to ensure concentrations are Per TABLE 4.3.1-1 within the limits of 3.3.1.1 using the calculational methods of the ODCM.

Page 36

TABLE 4.3.1-1 CY-CL-170-301 Revision 26 September 2022 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM Page 1 of 2 LIQUID RELEASE SAMPLING MINIMUM TYPE OF LOWER LIMIT OF ANALYSIS ACTIVITY TYPE FREQUENCY DETECTION (LLD)(a>

FREQUENCY ANALYSIS

(µCi/ml)

Principal Gamma

.5x10-7 A. Batch Waste P, Each Batch P, Each Batch Emitters(c)

B.

1.

2.

3.

Release Tanks(b) 1-131

.1 x1 o-s Dissolved &

p M

Entrained Gases

.1x1Q-5 One Batch/M (Gamma Emitters)(e)

H-3

.1x10-5 Q

P, Each Batch Composite (d)

Fe-55

.1x10-6 Sr-89, Sr-90

.5x10-8 Gross Alpha

.1x10-7 Continuous Principal Gamma Release

.5x10-7 Q, Grab Emitters (c)

Plant Service Water Q

H-3

.1x10-5 Shutdown Fe-55

.1x10-6 Service Water Component Q

Sr-89, Sr-90

.5x10-8 Composite (d,fl Cooling Water Gross Alpha s1x10-7 NOTE: To comply with the above requirements, setpoints will be calculated to assure that Seal Well concentrations do not exceed CONTROL 3.3.1 Page 37

TABLE 4.3.1-1 CY-CL-170-301 Revision 26 September 2022 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM Page 2 of 2 TABLE NOTATION

a.

The LLD is defined, for purposes of this surveillance, as the smallest concentration of radioactive material in a sample that will yield a net count above system background that will be detected with 95% probability with 5% probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system (which may include radiochemical separation):

LLD=

4.66Sb

[E

V

2.22xl06

Y *exp(-MiJ Where:

LLD is the "a priori" lower limit of detection as defined above (as microcurie per unit mass or volume),

Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (as counts per minute),

Eis the counting efficiency (as counts per disintegration),

V is the sample size (in units of mass or volume),

2.22 x 106 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield (when applicable),

'A, is the radioactive decay constant for the particular radionuclide (sec-1), and At is the elapsed time between midpoint of sample collection and the midpoint of the counting interval.

Typical.values of E, V, Y and At should be used in the calculation It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement.

b.

A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, the tank is isolated from all inputs and recirculated a minimum of two tank volumes at which time a sample is obtained for isotopic analysis.

c.

The principal gamma emitters are: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, and Ce-141. Ce-144 shall also be measured, but with an LLD of :s:5.00E-06 µCi/ml. All identified radionuclides shall be reported in the Radioactive Effluent Release Report pursuant to Technical Specification 5.6.3 ina format outlined in Regulatory Guide 1.21, Appendix B, Revision 1, June 1974.

d.

A composite sample is one in which the quantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which the method of sampling employed results in a specimen that is representative of the liquids released.

e.

Dissolved and Entrained gases are: Xe-133, Xe-135, Xe-138, Kr-85m, Kr-87, and Kr-88.

f.

Analyses on Composite only required if Grab sample has positive gamma or tritium.

Page 38

3/4.3.2 DOSE FROM LIQUID EFFLUENTS 3.3.2 CONTROLS CY-CL-170-301 Revision 26 September 2022 3.3.2.1 The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released to UNRESTRICTED AREAS (see FIGURE 1-1) shall be limited to:

i.

s 1.5 mrem to the total body and s 5 mrem to any organ during any calendar quarter; and ii.

s 3.0 mrem to the total body and s 10 mrem to any organ during *any calendar year, and APPLICABILITY ACTIONS CONDITION At all times.

REQUIRED ACTION COMPLETION TIME A.

Calculated dose from the A.1 Submit a Special Report to the 30 days release of radioactive NRC Regional Office Regional materials in liquid Administrator that identifies effluents exceeds any causes for exceeding limits, limits of 3.3.2.1.

defines corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the limits.

4.3.2 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT FREQUENCY 4.3.2.1 Determine cumulative dose contributions from liquid effluents for 31 days the current calendar quarter and current calendar year in accordance with the methodology and parameters described in the ODCM.

Page 39

3/4.3.3 LIQUID RADWASTE TREATMENT SYSTEMS 3.3.3 CONTROLS 3.3.3.1 The Liquid Radwaste Treatment System shall:

a.

Be FUNCTIONAL.

CY-CL-170-301 Revision 26 September 2022

b.

Be used (appropriate system portions) to reduce the radioactive materials in liquid wastes prior to their discharge when the projected doses due to the liquid effluents to UNRESTRICTED AREAS (see FIGURE 1-1) would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31-day period.

APPLICABILITY:

ACTIONS CONDITION A.

Liquid waste is being discharged without treatment, in excess of the limits of 3.3.3.1, and any portion of the liquid radwaste treatment system not in operation At all times.

REQUIRED ACTION A. 1 Submit a Special Report to the NRC Regional Office Regional Administrator that includes an explanation of why liquid radwaste was being discharged without treatment, non-functional equipment or subsystem identification and reason, action(s) taken to restore the non-functional equipment to FUNCTIONAL status, and a summary description of the action(s) taken to prevent recurrence.

4.3.3 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT 4.3.3.1 Determine projected doses due to liquid releases to UNRESTRICTED AREAS in accordance with the methodology and parameters described in the ODCM.

4.3.3.2 Demonstrate Liquid Radwaste Treatment System FUNCTIONALITY by meeting the requirements of Controls 3.3.1 and 3.3.2 Page40 COMPLETION TIME 30 days FREQUENCY 31 days N/A

3/4.4 RADIOACTIVE GASEOUS EFFLUENTS 3/4.4.1 GASEOUS EFFLUENT DOSE RATES 3.4.1 CONTROLS CY-CL-170-301 Revision 26 September 2022 3.4.1.1 The dose rate due to radioactive materials released in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY (see FIGURE 1-1) shall be limited to the following:

a.

For noble gases, s 500 mrem/year to the total body and s 3000 mrem/year to the skin; and

b.

For iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives> 8 days, s 1500 mrem/year to any organ.

APPLICABILITY:

At all times.

ACTIONS CONDITION A.

Dose rates exceeding any limits of 3.4.1.1.

REQUIRED ACTION A.1 Restore the release rate to within the limits.

4.4.1 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT 4.4.1.1 Determine the dose rate due to noble gases in gaseous effluents is within the limits of 3.4.1.1.a in accordance with the methodology and parameters of the ODCM by obtaining and analyzing representative samples.

4.4.1.2 Determine the dose rate due to iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives

> 8 days in gaseous effluents is within the limits of 3.4.1.1.b in accordance with the methods and procedures of the ODCM by obtaining representative samples and performing analysis.

Page 41 COMPLETION TIME Immediately FREQUENCY In accordance with sampling and analysis program specified in TABLE 4.4.1-1 In accordance with sampling and analysis program specified in TABLE 4.4.1-1

A.

B.

C D.

TABLE 4.4.1-1 CY-CL-170-301 Revision 26 September 2022 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Page 1 of 3 Sampling Analysis Type of Activity Lower Limit of Gaseous Release Type Detection LLD3 Frequency Frequency Analysis

(µCi/cc)

Station HVAC Exhaust W2 Principal Gamma s1.00E-04

1. Noble Gas and Tritium Grab - upon Emitters1 Release initiation of flow W2 without delay in a H-3

o:1.00E-06 controlled manner 1-131

o:1.00E-12

2. Iodines Release Continuous3 W4 1-133

<1.00E-10

3. Particulates Release Continuous3 W4 Principal Gamma

o:1.00E-11 Emitters1 M

Gross Alpha Activity s1.00E-11 Composite Q

Sr-89, Sr-90 Activity

1.D0E-11 Composite Standby Gas Treatment System Exhaust, when flow exists Each Release Principal Gamma s1.00E-04

1. Noble Gas and Tritium Grab - upon Emitters1 Release initiation of flow Each Release without delay in a H-3 s1.00E-06 controlled manner.

2. Iodines Release Continuous3 when 1-131 s1.00E-12 VG system flow W4 exists 1-133 s1.00E-10

3. Particulates Release Continuous3 when Principal Gamma VG system flow W4 s1.00E-11 exists Emitters1 M

Gross Alpha Activity s1.00E-11 Composite Q

Sr-89, Sr-90 Activity s1.00E-11 Composite Drywell Purge and High Volume Containment Ventilation, modes 4 and 5 only 5*6

1. Noble Gas and Tritium Grab-upon Principal Gamma

~1.00E-04 Release initiation of flow Each Release Emitters1 without delay in a H-3

.:::_1.00E-06 controlled manner Mechanical Vacuum Pump 5-6

1. Noble Gas and Tritium Grab - upon Principal Gamma Release initiation of flow Each Release Emitters1

.:::_1.00E-04 without delay in.a controlled manner H-3

<1.00E-06 Page 42

TABLE 4.4.1-1 CY-CL-170-301 Revision 26 September 2022 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Page 2 of 3 TABLE NOTATION

a.

The LLD is defined, for purposes of these specifications, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system, which may include radiochemical separation:

Where:

LLD is the "a priori" lower limit of detection as defined above, as microcuries per unit mass or volume, Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, as counts per minute, s, = R~

Rbkg = background count rate t = the background count time E is the counting efficiency, as counts per disintegration, Vis the sample size in units of mass or volume, 2.22E06 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable,

'A. is the radioactive decay constant for the particular radionuclide (sec-1) and

~t for plant effluents is the elapsed time between the midpoint of sample collection and the midpoint of the counting interval (sec).

Typical values of E, V, Y, and ~t should be used in the calculation.

It should be recognized that the LLD is defined as an 9 priori (before the fact) limit representing the capability of a measurement system and not as an 9 posteriori (after the fact) limit for a particular measurement.

Page 43

TABLE 4.4.1-1 CY-CL-170-301 Revision 26 September 2022 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM Page 3 of 3 TABLE NOTATION

1.

The principal gamma emitters are: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, and Xe-138 in noble gas releases and Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, 1-131, 1-133 Cs-134, Cs-137, Ce-141 and Ce-144 in iodine and particulate releases. Other gamma peaks that are identifiable, together with those of the above nuclides, shall be analyzed and reported in the Radioactive Effluent Release Report pursuant to Technical Specification 5.6.3 in the format outlined in Regulatory Guide 1.21, Appendix B, Revision 1, June 1974.

2.

Sampling and analysis shall also be performed without delay in a controlled manner following shutdown, startup, or a THERMAL POWER change exceeding 15% of RATED THERMAL POWER within a 1-hour period.

3.

The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with Section 3/4.4.

4.

Samples shall be changed at least once per 7 days and analysis shall be completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months after changing, or after removal from sampler. Sampling shall also be performed at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months for at least 7 days following each shutdown, startup, or THERMAL POWER change exceeding 15% of RATED THERMAL POWER in 1-hour period and analyses shall be completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months of changing. When samples collected for 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or less are analyzed, the corresponding LLDs may be increased by a factor of 10. Twenty-four (24) hour sampling requirements do apply if: (1) analysis shows that the DOSE EQUIVALENT 1-131 concentration in the primary coolant has increased more than a factor of 3, and (2) the noble gas monitor on the applicable PRM (HVAC or SGTS) shows that effluent activity has increased more than a factor of 3.

5.

Samples are taken from the in-service HVAC PRM.

6.

Iodines and Particulates released from these discharges are accounted for in the weekly samples taken in accordance with items A2 and A3 in TABLE 4.4.1-1.

Page 44

3/4.4.2 DOSE FROM NOBLE GASES 3.4.2 CONTROLS CY-CL-170-301 Revision 26 September 2022 3.4.2.1 The air dose due to noble gases released in gaseous effluents, from each reactor unit, to areas at and beyond the SITE BOUNDARY (see FIGURE 1-1) shall be limited to the following:

a.

For gamma radiation,::,; 5 mrad during any calendar quarter;

b.

For beta radiation, ::,; 10 mrad during any calendar quarter;_

c.

For gamma radiation,::,; 10 mrad during any calendar year; and

d.

For beta radiation,::,; 20 mrad during any calendar year.

APPLICABILITY:

ACTIONS CONDITION A.

Calculated air dose from radioactive noble gases in gaseous effluents exceeding any of the limits of 3.4.2.1 At all times.

REQUIRED ACTION A.1. Submit a Special Report to the NRC Regional Office Regional Administrator that identifies causes for exceeding limits, defines corrective actions that have been taken to reduce the releases, and proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the limits.

4.4.2 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT 4.4.2.1 Determine cumulative dose contributions for noble gases for the current calendar quarter and current calendar year in accordance with the methodology and parameters described in the ODCM Page 45 COMPLETION TIME 30 days FREQUENCY 31 days

CY-CL-170-301 Revision 26 September 2022 3/4.4.3 DOSE FROM IODINE-131, IODINE-133, TRITIUM, AND RADIOACTIVE MATERIALS IN PARTICULATE FORM 3.4.3 CONTROLS 3.4.3.1 The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium and all radionuclides in particulate form with half-lives > 8 days in gaseous effluents released to areas at and beyond the SITE BOUNDARY (FIGURE 1-1) shall be limited to the following:

a.

~ 7.5 mrem to any erg.an during any calendar quarter; and

b.

15 mrem to any organ during any calendar year.

APPLICABILITY:

At all times.

ACTIONS CONDITION A.

Calculated dose from the A.1 release of iodine-131, iodine-133, tritium and radionuclides in particulate form, with half-lives > 8 days in gaseous effluents exceeding any of the limits of 3.4.3.1 4.4.3 SURVEILLANCE REQUIREMENTS REQUIRED ACTION Submit a Special Report to the NRC Regional Office Regional Administrator that identifies causes for exceeding limits, defines corrective actions that have been taken to reduce the releases, and proposed corrective actions to assure that subsequent releases will be in compliance with the limits.

SURVEILLANCE REQUIREMENT COMPLETION TIME 30 days FREQUENCY 4.4.3.1 Determine cumulative dose contributions for the current 31 days calendar quarter and calendar year for iodine~131, iodine-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days in accordance with the methodology and parameters in the ODCM.

Page 46

3/4.4.4 GASEOUS RADWASTE (OFFGAS) TREATMENT SYSTEM 3.4.4 CONTROLS CY-CL-170-301 Revision 26 September 2022 3.4.4.1 The GASEOUS RADWASTE (Offgas) TREATMENT SYSTEM shall be in operation.

APPLICABILITY:

Whenever the main condenser steam jet air ejector (SJAE) system is in operation.

ACTIONS CONDITION A. Gaseous radwaste from the main condenser air ejector system being discharged without treatment for more than 7 days.

REQUIRED ACTION A.1 Submit a Special Report to the NRC Regional Office Regional Administrator that includes non-functional equipment or subsystem identification and non-functionality reason, actions taken to restore the non-functional equipment to FUNCTIONAL status, and summary description of actions taken to prevent a recurrence.

4.4.4 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT

NOTE------------------------------------

When placing the Offgas Treatment System in the charcoal bypass mode, the alarm setpoints for the Station HVAC Exhaust and the Post-Treatment Offgas radiation monitors may be calculated to account for the increased fractions of short-lived noble gases. The noble gas release fractions shall be based either on actual measured values or on design basis noble gas concentration fractions (30-minute delay) in the primary coolant offgas.

COMPLETION TIME 30 days FREQUENCY 4.4.4.1 Verify the GASEOUS RADWASTE (Offgas) TREATMENT 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months SYSTEM is in operation when the main condenser air ejector system is in use.

Page 47

3/4.4.5 VENTILATION EXHAUST TREATMENT SYSTEM 3.4.5 CONTROLS CY-CL-170-301 Revision 26 September 2022 3.4.5.1 The appropriate portions of the VENTILATION EXHAUST TREATMENT SYSTEM (VETS) shall:

a.

Be FUNCTIONAL

b.

Be used to reduce the radioactiye materials in gaseous waste prior to their discharge when the projected doses due to gaseous effluent releases at and beyond the SITE BOUNDARY (see FIGURE 1-1) would exceed 0.3 mrem to any organ in a 31-day period.

APPLICABILITY:

At all times, other than when the VETS is undergoing routine maintenance.

ACTIONS CONDITION A.

Gaseous waste being discharged without treatment and in excess of the limit of 3.4.5.1.

REQUIRED ACTION A.1 Submit a Special Report to the NRC Regional Office Regional Administrator that includes an explanation of why gaseous radwaste was being discharged without treatment, non-functional equipment or subsystem identification and non-functionality reason, actions taken to restore the non-functional equipment to FUNCTIONAL status, and summary description of actions taken to prevent a recurrence.

Page 48 COMPLETION TIME 30 days

4.4.5 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT 4.4.5.1 Determine projected doses due to gaseous releases to UNRESTRICTED AREAS in accordance with the ODCM methodology when the VETS is not in use.

4.4.5.2 Demonstrate the Ventilation Exhaust Treatment System FUNCTIONALITY by meeting the requirements of Controls 3.4.1, 3.4.2, and 3.4.3.

Page 49 CY-CL-170-301 Revision 26 September 2022 FREQUENCY 31 days N/A

3/4.5 TOTAL DOSE 3.5 CONTROLS - Total Dose CY-CL-170-301 Revision 26 September 2022 3.5.1 The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of radioactivity, radiation from uranium fuel cycle, and ISFSI sources shall be limited to

a.

s 25 mrem to the total body;

b.

s 75 mrem to the thyroid, or

c.

25 mrem to any other organ.

APPLICABILITY:

At all times.

ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A.

Calculated doses from the A.1 Determine if the limits of 3.5.1 Immediately release of radioactive have been exceeded via materials in liquid or calculation, including direct gaseous effluents exceeding radiation contributions from twice the limits of 3.3.2.1, the reactor unit and outside 3.4.2.1, or 3.4.3.1.

storage tanks.

B.

Dose limits of 3.5.1 items a, B.1 Submit a Special Report to 30 days b or c has been exceeded.

the NRC Regional Office Regional Administrator, as defined in 1 0CFR20.2203(4),

that defines the corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding the limits and includes the schedule for achieving conformance with the limits, estimates of each individual's dose, the levels of radiation and concentrations of radioactive material involved, the cause of the elevated exposures, dose rates, or concentrations, ALARA constraints, generally applicable environmental standards, and associated license conditions.

Page 50

4.5.1 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT 4.5.1.1 Determine cumulative dose contributions from liquid and gaseous effluents in accordance with the methodology and parameters described or specified in the ODCM (see note below) 4.5.1.2 Determine cumulative dose contributions from direct radiation from the reactor, from radwaste storage tanks, and ISFSI in accordance with the methodology and parameters described or specified in the ODCM (see note below).

CY-CL-170-301 Revision 26 September 2022 FREQUENCY Under conditions as specified in 3.5.1 ACTIONS A or B Under conditions as specified in 3.5.1 ACTIONS A or B.

NOTE:

The total body and organ doses resulting from liquid effluents will be summed with the doses resulting from gaseous effluents (including non-noble gases) and the doses to the maximum exposed individual from other operations of the uranium fuel cycle. The effluent doses will be based upon releases from CPS during the previous three quarters and from the quarter in which the 3.5.1 Control requirement was exceeded.

Page 51

CY-CL-170-301 Revision 26 September 2022 3/4.6 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 3.6 CONTROLS 3.6.1 The Radiological Environmental Monitoring Program (REMP) shall be conducted as specified in Table 4.6-1.

APPLICABILITY:

At all times.

ACTIONS CONDITION A.

REMP not being conducted as specified in Table 4.6-1.

A.1 REQUIRED ACTION Prepare and submit to the NRG, in the Annual Radiological Environmental Operating Report required by Technical Specification 5.6.2, a description of the reasons for not conducting the program as required and the plans for reventin a recurrence.

Page 52 COMPLETION TIME Submittal of next Annual Radiological Environmental Operating Report

CONDITION B.

,Level of radioactivity in an environmental sampling medium exceeds the reporting levels of TABLE 4.6-2 when averaged over any calendar quarter.

OR More than one radionuclide in TABLE 4.6-2 is detected in the sampling medium, AND Where:

C = concentration RL = reporting level.

OR Radionuclides other than those in Table 4.6-2 are

detected, The potential annual dose to a MEMBER OF THE PUBLIC is greater than or equal to the calendar year limits of 3.3.2, 3.4.2, or 3.4.3 AND Is the result of plant effluents.

CY-CL-170-301 Revision 26 September 2022 REQUIRED ACTION COMPLETION TIME B.1 Submit a Special Report to the Within 30 days NRC Regional Office Regional Administrator that identifies the cause(s) for exceeding the limits and defines the corrective actions to be taken to reduce radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the calendar year reporting level of 3.3.2, 3.4.2, or 3.4.3. The methodology and parameters u.sed to estimate the potential annual dose to a MEMBER OF THE PUBLIC shall be indicated in this report.

Page 53

CONDITION C.

Level of radioactivity in an environmental sampling medium exceeds the reporting levels of TABLE 4.6-2 when averaged over anyca~ndarquarte~

OR More than one radionuclide in TABLE 4.6-2 is detected in the sampling medium, where; C = concentration Rl = reporting level.

OR Radionuclides other than those in Table 4.6-2 are

detected, AND The potential annual dose to a MEMBER OF THE PUBLIC is greater than or equal to the calendar year limits of 3.3.2, 3.4.2, or 3.4.3 AND Is NOT the result of plant effluents.

REQUIRED ACTION C.1 Describe the condition in the Annual Radiological Environmental Operation Report.

Page 54 CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME As part of the next Annual Radiological Environmental Operating Report.

CONDITION D.

Milk or fresh, leafy vegetation samples from one or more of the sample locations required by Table 4.6-1 unavailable.

REQUIRED ACTION D.1 Identify locations for obtaining replacement samples and add them to the REMP.

D.2 Delete the specific locations from which samples were unavailable from the REMP.

D.3 Pursuant to Technical Specification 5.5.1, identify the cause of the sample unavailability, identify the new location(s) for obtaining samples, and include revised figures and tables for the ODCM reflecting the new location(s) in the next Annual Radiological Environmental Operating Report.

Page 55 CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME 30 days 30 days As part of the next Annual Radiological Environmental Operating Report

4.6 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT CY-CL-170-301 Revision 26 September 2022 FREQUENCY 4.6.1 Collect REMP samples pursuant to Table 4.6-1 from the specific In accordance locations given in Table 4.6-1 and ODCM Figures 6-1 through Table 4.6-1.

6-4 and analyze per Table 4.6-1 to the detection capabilities required by Table 4.6-3.

Page 56

EXPOSURE PATHWAY AND/OR SAMPLE

1. DIRECT RADIATIONb TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 1 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND COLLECTION SAMPLE LOCATIONSa FREQUENCY 40 routine monitoring stations either with two or more Quarterly dosimeters or with one instrument for measuring and recording dose rate continuously, placed as follows:

(1) an inner ring of stations, one in each meteorological sector in the general area of the SITE BOUNDARY; DISTANCE from SECTOR CODE station (miles)

N CL-36 0.6 NNE CL-5 0.7 NE CL-22 0.6 ENE CL-23 0.5 E

CL-24 0.5 ESE CL-42 2.8 SE CL-43 2.8 SSE CL-44 2.3 s

CL-45 2.8 SSW CL-46 2.8 SW CL-47 3.3 WSW CL-48 2.3 w

CL-1 1.8 WNW CL-34 0.8 NW CL-35 0.7 NNW CL-63 1.3 Page 57 CY -CL-170-301 Revision 26 September 2022 TYPE AND FREQUENCY OF ANALYSIS Gamma dose quarterly

EXPOSURE PATHWAY AND/OR SAMPLE

1. DIRECT RADIATIONb (continued)

TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 2 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND COLLECTION SAMPLE LOCATIONSa FREQUENCY (2) an outer ring of stations, one in each meteorological sector in the 6 to 8 km (3.7 miles to 5.0 miles) range from the site; DISTANCE from station SECTOR CODE (miles)

N CL-76 4.6 NNE CL-77 4.5 NE CL-78 4.8 ENE CL-79 4.5 E

CL-53 4.3 ESE CL-54 4.6 SE CL-55 4.1 SSE CL-56 4.1 s

CL-57 4.6 SSW CL-58 4.3 SW CL-60 4.5 WSW CL-61 4.5 w

CL-80 4.1 WNW CL-81 4.5 NW CL-51 4.4 NNW CL-52 4.3 Page 58 CY-CL-170-301 Revision 26 September 2022 TYPE AND FREQUENCY OF ANALYSIS

EXPOSURE PATHWAY AND/OR SAMPLE

1. DIRECT RADIATIONb (continued)

TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 3 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND COLLECTION SAMPLE LOCATIONSa FREQUENCY (3) the balance of the stations to be placed in special interest areas such as population centers, nearby residences, schools, and in 1 or 2 areas to serve as control stations.

DISTANCE from SECTOR CODE station (miles)

N CL-37 3.4 N

CL-75 0.9 ENE CL--65 2.6 E

CL-41 2.4 S (control)

CL-11 16 w

CL-49 3.5 w

CL-74 1.9 WNW CL-64 2.1 Page 59 CY-CL-170-301 Revision 26 September 2022 TYPE AND FREQUENCY OF ANALYSIS

EXPOSURE PATHWAY AND/OR SAMPLE

2. AIRBORNE Radioiodine and Particulates TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 4 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND COLLECTION SAMPLE LOCATIONSa FREQUENCY Samples from 5 locations:

Continuous sampler operations with sample collection weekly, or

a.

3 samples from close to the 3 SITE BOUNDARY more frequently if required by locations in different sectors of the highest dust loading.

calculated annual average ground-level D/Q.

DISTANCE from station SECTOR CODE (miles}

NNE CL-2 0.7 NE CL-3 0.7 N

CL-15 0.9

b.

1 sample from the vicinity of a community having the highest calculated annual average ground-level D/Q.

DISTANCE from station SECTOR CODE (miles)

E CL-8 2.2 Page 60 CY-CL-170-301 Revision 26 September 2022 TYPE AND FREQUENCY OF ANALYSIS Radioiodine Canister: 1-131 analysis weekly.

Particulate Sam12ler: Gross beta radioactivity analysis following filter changed; Gamma isotopic analysise of composite (by location) quarterly.

EXPOSURE PATHWAY AND/OR SAMPLE

2. AIRBORNE (continued)

3.

WATERBORNE

a.

Surface1 TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 5 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND SAMPLE LOCATIONSa COLLECTION FREQUENCY C.

1 sample from a control location, as for example 15-30 km (9.3 miles to 18.6 miles) distant and in the least prevalent wind direction c_

DISTANCE from station SECTOR CODE (miles)

S (control)

CL-11 16 1 sample upstream Composite sample over 1 1 sample downstream month periodg DISTANCE from SECTOR CODE station (miles)

ENE (upstream)

CL-91 6.1 SE (downstream)

CL-90 0.4 Page 61 CY-CL-170-301 Revision 26 September 2022 TYPE AND FREQUENCY OF ANALYSIS Gamma isotopic analysise monthly. Composite for tritium analvsis auarterlv.

EXPOSURE PATHWAY AND/OR SAMPLE

3. WATERBORNE (continued)

b.

Ground C.

Drinking TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 6 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND SAMPLE LOCATIONSa COLLECTION FREQUENCY Samples from 1 or 2 sources, only if likely to be affectedh.

Quarterly DISTANCE from station SECTOR CODE (miles)

E CL-12 1.6*

ESE CL-7D 2.3 CY-C L-170-301 Revision 26 September 2022 TYPE AND FREQUENCY OF ANALYSIS Gamma isotopic0 and tritium analysis quarterlv.

Sample location is in pump station distant from well. Well located 1.0 mile S of plant on the edge of the lake.

1 sample of each of 1 to 3 of the nearest water Composite sample over 2-week 1-131 analysis on each supplies that could be affected by its discharge.*

period9 when 1-131 analysis is composite when the dose performed, monthly composite calculated for the consumption otherwise.

of the water is greater than 1

No municipal or public drinking water supplies are mrem per yea~. Composite for taken from Clinton Lake or downstream for 200 miles.

gross beta and gamma Drinking water for Clinton Power Station is supplied isotopic analyses0 monthly.

by Clinton Lake.

Composite for tritium analysis quarterlv.

DISTANCE from SECTOR CODE station (miles)

WNW CL-14 within Service Buildino 1 sample from a control location**

- No control location necessary Page 62

EXPOSURE PATHWAY AND/OR SAMPLE

3. WATERBORNE (continued)

d.

Sediment from shoreline

4.

INGESTION

a.

Milk TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 7 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND SAMPLE LOCATIONSa COLLECTION FREQUENCY 1 sample from downstream area with existing or Semiannually potential recreational value.

DISTANCE from station SECTOR CODE (miles)

SE CL-7B 2.1 Samples from milking animals in 3 locations within 5-Semimonthly when animals km distance having the highest dose potential. If there are on pasture, monthly at are none, 1 sample from milking animals in each of 3 other times areas between 5 to 8 km distant where doses are calculated to be in greater than 1 mrem per yeark. *

This sample requirement is checked annually as part of the annual land use survey.

Page 63 CY-CL-170-301 Revision 2o September 2022 TYPE AND FREQUENCY OF ANALYSIS Gamma isotopic analysise Semiannually Gamma isotopice and 1-131 analysis semimonthly when animals are on pasture; monthly at other times.

EXPOSURE PATHWAY AND/OR SAMPLE

4. INGESTION (continued)

a.

Milk {continued)

b.

Fish and Invertebrates TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 8 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND SAMPLE LOCATIONSa COLLECTION FREQUENCY 1 sample from milking animals at a control location, 15-30 km {9.3 miles to 18.6 miles) distant and in the least prevalent wind direction<c>.

DISTANCE from station SECTOR CODE (miles)

WSW (control)

CL-116

14.

1 sample each of 3 important species (such as bass, Sample in season, or crappie, carp, or bluegill) in vicinity of plant discharge semiannually if they are not area.

seasonal DISTANCE from station SECTOR CODE (miles)

E CL-19 3.4 1 sample of same species in areas not influenced by plant discharge.

DISTANCE from station SECTOR CODE (miles)

S (control)

CL-105 50 Page 64 CY-CL-170-301 Revision 26 September 2022 TYPE AND FREQUENCY OF ANALYSIS Gamma isotopic analysise on edible portions.

EXPOSURE PATHWAY AND/OR SAMPLE

4. INGESTION (continued)

C.

Food Products TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 9 of 10 NUMBER OF REPRESENTATIVE SAMPLES AND SAMPLING AND SAMPLE LOCATIONS0 COLLECTION FREQUENCY 1 sample of each principal class of food products from At time of harves~

any area that is irrigated by water in which liquid plant wastes have been discharged.*

CY-CL-170-301 Revision 26 September 2022 TYPE AND FREQUENCY OF ANALYSIS Gamma isotopic analysise on edible portion.

No known usage of Salt Creek water for irrigation in DeWitt, Logan, Menard, or Cass Counties. This information is checked annuallv as oart of the land use survev.

Samples of 3 different kinds of broad leaf vegetation Monthly during growing Gamma isotopice and 1-131 (such as lettuce, cabbage, and Swiss chard) grown season.1 analysis.

nearest each of two different offsite locations of highest predicted annual average ground-level D/Q if milk sampling is not performed.

DISTANCE from station SECTOR CODE (miles)

NE CL-115 0.7 NNE CL-118 0.7 1 sample of each of the similar broad leaf vegetation Monthly during growing Gamma isotopice and 1-131 grown 15-30 km (9.3 miles to 18.6 miles) distant in the season 1 least prevalent wind direction<c) if milk sampling is not performed.

DISTANCE from station SECTOR CODE (miles)

WSW CL-114 12.5 (Control)

Page 65

TABLE 4.6-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Page 10 of 10 TABLE NOTATIONS

a.

Refer to NUREG-1302, "Offsite Dose Calculation Manual Guidance: Standard Radiological Effluent Controls For Boiling Water Reactors" April 1991, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979. Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling period. All deviations from the sampling schedule shall be documented in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2. It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen for the particular pathway in question and appropriate substitutions made within 30 days in the radiological environmental monitoring program given in the ODCM. Pursuant to Technical Specification 5.5.1, identify the cause of the unavailability of samples for that pathway and identify the new location{s) for obtaining replacement samples in the next annual Radiological Environmental Oper1:1ting Report and also include in the report a revised figure(s) and table for the ODCM reflecting the new location(s).

b.

One or more instruments, such as a pressurized ion chamber, for measuring and recording dose rate continuously may be used in place of, or in addition to, integrating dosimeters. For the purposes of this table, a dosimeter is considered one detection instrument; two or more detection instruments in a packet are considered as two or more dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation. The 40 stations is not an absolute number. The number of direct radiation monitoring stations may be reduced according to geographical limitations; e.g., at an ocean site, some sectors will be over water so that the number of dosimeters may be reduced accordingly. The frequency of analysis or readout for dosimeter systems will depend upon the characteristics of the specific system used and should be selected to obtain optimum dose information with minimal fading.

c.

The purpose of this sample is to obtain background information. If it is not practical to establish control locations in accordance with the distance and wind direction criteria, other sites that provide valid background data may be substituted.

d.

Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or more after sampling to allow for radon and thoron daughter decay. If gross beta activity in air particulate samples is greater than ten times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples.

e.

Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility.

f.

The "upstream sample" shall be taken at a distance beyond significant influence of the discharge. The "downstream" sample shall be taken in an area beyond but near the mixing zone. "Upstream" samples in an estuary must be taken far enough upstream to be beyond the plant influence.

g.

A composite sample is one in which the quantity (aliquot) of liquid sampled is proportional to the quantity of flowing liquid (or time) and in which the method of sampling employed results in a specimen that is representative of the liquid flow. In this program composite sample aliquots shall be collected at time intervals that are very short (e.g., hourly) relative to the compositing period (e.g., monthly) in order to assure obtaining a representative sample.

h.

Groundwater samples shall be taken when this source is tapped for drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination.

i.

The dose shall be calculated for the maximum organ and age group, using the methodology and parameters in the ODCM.

j.

If harvest occurs more than once a year, sampling shall be performed during each discrete harvest. If harvest occurs continuously, sampling shall be monthly. Attention shall be paid to including samples of tuberous and root food products.

k.

The dose shall be calculated for the maximum organ and age group: using the methodology and parameters in the ODCM.

I.

Where access to green leafy vegetables from private gardens is not possible, non-edible plants with similar leaf characteristics from the same vicinity may be substituted.

Page 66

ANALYSIS H-3 Mn-54 Fe-59 Co-58 Co-60 Zn-65 Zr-Nb-95 1-131 Cs-134 Cs-137 Ba-La-140 TABLE 4.6-2 CY-CL-170-301 Revision 26 September 2022 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES WATER AIRBORNE PARTICULATE FISH MILK FOOD PRODUCTS (pCi/1)

OR GASES (pCi/m3)

(pCi/kg, wet)

(pCi/1)

(pCi/kg, wet) 20,000*

1,000 30,000 400 10,000 1,000 30,000 300 10,000 300 20,000 400***

2**

0.9 3

100 30 10 1,000 60 1,000 50 20 2,000 70 2,000 200***

300 For drinking water samples. This is 40CFR Part 141 value. If no drinking water pathway exists, a value of 30,000 pCi/1 may be used.

If no drinking water pathway exists, a value of 20 pCi/1 may be used.

Total for parent and daughter.

Page 67

ANALYSIS Gross beta H-3 Mn-54 Fe-59 Co-58,60 Zn-65 Zr-95 Nb-95 1-131 Cs-134 Cs-137 Ba-140 La-140 TABLE 4.6-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANAL YSISa LOWER LIMIT OF DETECTION (LLD)b,c Page 1 of 2 WATER AIRBORNE PARTICULATE FISH MILK FOOD PRODUCTS (pCi/I)

OR GAS (pCi/m3)

(pCi/kg, wet)

(pCi/I)

(pCi/kg, wet) 4 0.01 2000*

15 130 30 260 15 130 30 260 30 15 1 **

0.07 1

60 15 0.05 130 15 60 18 0.06 150 18 80 60 60 15 15 If no drinking water pathway exists, a value of 3000 pCi/I may be used.

If no drinking water pathway exists, a value of 15 pCi/I may be used.

Page 68 CY-CL-170-301 Revision 26 September 2022 SEDIMENT (pCi/kg, dry) 150 180

TABLE 4.6-3 CY-CL-170-301 Revision 26 September 2022 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANAL YSISa LOWER LIMIT OF DETECTION (LLD)b,c Page 2 of 2 TABLE NOTATIONS

a.

This list does not mean that only these nuclides are to be considered. Other peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

b.

Required detection capabilities for dosimeters used for environmental measurements shall be in accordance with the recommendations of Regulatory Guide 4.13, Rev. 1, July 1977.

c.

The LLD is defined, for purposes of these specifications, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5%

probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system, which may include radiochemical separation:

LLD = ___

4_.6_6_S_b __ _

E

V

2.22

Y

e(--lAt)

Where:

LLD is the "a priori' lower limit of detection as defined above, as picocuries per unit mass or

volume, Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, as counts per minute, E if the counting efficiency, as counts per disintegration, V is the sample size in units of mass or volume, 2.22 is the number of disintegrations per minute per picocurie, Y is the fractional radiochemical yield, when applicable, A. is the radioactive decay constant for the part4icular radionuclide (sec-1 ), and Llt for environmental samples is the elapsed time between sample collection, or end of the sample collection period, and time of counting (sec).

Typical values of E, V, Y, and Llt should be used in the calculation.

It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement. Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidable small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such cases, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

Page 69

3/4.7 LAND USE CENSUS

3. 7 CONTROLS CY-CL-170-301 Revision 26 September 2022 3.7.1 A Land Use Census shall be conducted and shall identify within a distance of 8 km (5 miles) the location in each of the 16 meteorological sectors of the nearest milk animal, the nearest residence, the nearest garden<1> of greater than 50m2 (500 ft2) producing broad leaf vegetation. The Land Use Census shall also identify within a distance of 5 km (3.1 miles) for elevated or mixed-mode releases, as defined in Regulatory Guide 1.111, the locations in each of the 16 meteorological sectors of all milk animals and all gardens of greater than 50m2 producing broad leaf vegetation. The land use census will also identify the nearest resident to the ISFSI.

Broad leaf vegetation sampling of at least three different kinds of vegetation may be performed at the SITE BOUNDARY in each of two different sectors with the highest predicted D/Qs in lieu of the garden census. Requirements for broad leaf sampling in Table 4.6-1 Item 4.c shall be followed, including analysis of control samples.

APPLICABILITY:

At all times.

ACTIONS CONDITION A.

Land use census identifies A.1 a location that yields a calculated dose or dose commitment that is greater than the values currently being calculated in 4.4.3.1.

REQUIRED ACTION Identify the new location(s) in the Radioactive Effluent Release Report pursuant to Technical Specification 5.6.3.

Page 70 COMPLETION TIME As part of the next Radioactive Effluent Release Report

CONDITION B. Land use census identifies a location that yields a calculated dose or dose commitment, via the same exposure pathway, that is 20% greater than at a location from which samples are currently being obtained in accordance with 3.6.1.

REQUIRED ACTION CY-CL-170-301 Revision 26 September 2022 COMPLETION TIME B.1 Add the new location(s) to the 30 days Radiological Environmental Monitoring Program.

AND

NOTE------------------

The sampling location(s),

excluding the control station location, having the lowest calculated dose or dose commitment(s), via the same exposure pathway, may be deleted from this monitoring program after October 31 of the year in which this Land Use Census was conducted.

B.2 Identify the new location(s),

pursuant to Technical Specification 5.5.1, in the next Radioactive Effluent Release Report and include in the report the revised figures and tables for the ODCM reflecting the new location(s).

Page 71 As part of the next Radioactive Effluent Release Report

4.7 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT CY -CL-170-301 Revision 26 September 2022 FREQUENCY 4.7.1 Conduct the land use census during the growing season using 12 months that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities.

4.7.2 Include the Land Use Census results in the annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

Page 72 As part of the next annual Radiological Environmental Operating Report.

INTER-LABORATORY COMPARISON PROGRAM CONTROLS CY-CL-170-301 Revision 26 September 2022 3/4.8 3.8 3.8.1 Analyses shall be performed on radioactive materials supplied as part of an lnterlaboratory Comparison Program that corresponds to samples required by Table 4.6-

1.

APPLICABILITY:

At all times.

ACTIONS CONDITION A.

Analyses of 3.8.1 not being performed.

REQUIRED ACTION A.1 Report corrective actions taken to prevent a recurrence to the NRC in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

4.8 SURVEILLANCE REQUIREMENTS SURVEILLANCE REQUIREMENT 4.8.1 Include a summary of the lnterlaboratory Comparison Program results obtained in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

Page 73 COMPLETION TIME As part of next Annual Radiological Environmental Operating Report.

FREQUENCY As part of next Annual Radiological Environmental Operating Report.

3/4.9 METEOROLOGICAL MONITORING PROGRAM (NOT USED)

Page 74 CY-CL-170-301 Revision 26 September 2022

5.0 BASES 5.0.1 Control and Surveillance Requirements (3/4.0)

CY-CL-170-301 Revision 26 September 2022 The requirements of 3.0 and 4.0 provide general requirements applicable to each of the Controls and Surveillance Requirements specified within 3.1 through 3.8.

5.0.1.1 The requirement of 3.0.1 is provided to emphasize when each Control is applicable and.

when the associated ACTION should be met.

5.0.1.2 Item 3.0.2 and related items define those conditions necessary to constitute compliance with the terms of an individual Control and associated ACTION.

5.0.1.3 The requirement of 4.0.1 provides that surveillance activities, necessary to ensure the Controls are met, will be performed during the conditions for which the Controls are applicable. Some surveillance activities may be required to be performed without regard to the applicable conditions specified in the associated Control.

5.0.1.4 The provisions of 4.0.2 provide allowable tolerances for performing surveillance activities beyond those specified in the nominal surveillance interval. These tolerances are necessary to provide operational flexibility because of scheduling and performance considerations. The phrase "at least" associated with a surveillance frequency does not negate this allowable tolerance; instead, it permits the more frequent performance of surveillance activities.

The tolerance values, taken either individually or consecutively over three test intervals, are sufficiently restrictive to ensure that the reliability associated with the surveillance activity is not significantly degraded beyond that obtained from the nominal specified interval.

5.0.1.5 The provisions of 4.0.3 set forth the criteria for determination of compliance with the FUNCTIONALITY requirements of the Controls. Under these criteria, equipment, systems, or components are*assumed to be FUNCTIONAL if the associated surveillance activities have been satisfactorily performed within the specified time interval. Nothing in this provision is to he construed as defining equipment, systems or components FUNCTIONAL, when such items are found or known to be non-functional although still meeting the Surveillance Requirements.

5.0.2 Adjustment of the CPS ODCM Methodology Consistent with the NRC Commissioners' opinion on 10CFR50 Appendix I dated April 30, 1975; CPS will use environmental monitoring data to improve dose calculational models and to request CPS ODCM changes on the basis of such operating experience data. Such adjustments are recognized as being especially important for the radioiodine-milk pathway where conservative regulatory guide assumptions have been made. By using environmental monitoring data, uncertainties associated with plume behavior, radioiodine chemical form, deposition and retention of forages, and milk consumption patterns may be circumvented or reduced.

Page 75

CY -CL-170-301 Revision 26 September 2022 5.1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION (3/4.1)

The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm/trip setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in this manual to ensure that the alarm/trip will occur prior to exceeding the limits of 1 0CFR Part

20. The FUNCTIONALITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63 and 64 of Appendix A to 10CFR Part 50.

5.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION {3/4.2) 5.2.1 Offgas Radiation Monitoring Instrumentation (3/4.2.1)

The FUNCTIONALITY of the radiation monitoring instrumentation ensures that; (1) the radiation levels are continually measured in the areas served by the individual channels; (2) the alarm or automatic action is initiated when the radiation level trip setpoint is exceeded; and (3) sufficient information is available on selected plant parameters to monitor and assess these variables following an accident. This capability is consistent with 1 0CFR Part 50, Appendix A, General Design Criteria 19, 60, 61, 63 and 64.

5.2.2 Radioactive Gaseous Effluent Monitoring Instrumentation (3/4.2.2)

The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the release of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm/trip setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in this manual to ensure that the alarm/trip will occur prior to exceeding the limits of 1 0CFR Part 20. The FUNCTIONALITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63 and 64 of Appendix A to 10CFR Part 50.

The sensitivity of any noble gas activity monitors used to show compliance with the gaseous effluent release requirements of 3.4.2 shall be such that concentrations as low as 1 x 1 o-6 µCi/ml are measurable.

5.3 LIQUID RADWASTE EFFLUENTS (3/4.3) 5.3.1 Liquid Effluent Concentration (3/4.3.1)

This requirement is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than ten times the concentration levels specified in 1 0CFR Part 20, Appendix B, Table 2, Column 2.

This limitation provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10CFR Part 50, to a MEMBER OF THE PUBLIC and (2) the limits of 1 0CFR Part 20.1301 to the population. The concentration limit for dis$olved or entrained noble gases is based upon the assumption that Xe-135 is the controlling radioisotope and its ECL in air (submersion) was converted to an Page 76

CY-CL-170-301' Revision 26 September 2022 equivalent concentration in water using the methods described in International Commission on Radiological Protection (ICRP) Publication 2.

This requirement applies to the release of radioactive materials in liquid effluents from the site.

The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in Currie, L.A., "Lower Limit of Detection:

Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300.

5.3.2 Dose from Liquid Effluents (3/4.3.2)

This requirement is provided to implement the requirements of Sections II.A, Ill.A and IV.A of Appendix I, 1 0CFR Part 50. The Control implements the guides set forth in Section II.A of Appendix I. The quarterly limits specified in the CONTROLS represent one-half of the annual design objective of Section II.A of 1 0CFR50, Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." Also, for fresh water sites with drinking water supplies that can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40CFR Part 141. The dose calculation methodology and parameters in this manual implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The equations specified in this manual for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 1 0CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.113, "Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April 1977.

This requirement applies to the release of radioactive materials in liquid effluents from the one reactor unit on the site.

5.3.3 Liquid Radwaste Treatment Systems (3/4.3.3)

The FUNCTIONALITY of the liq*uid radwaste treatment system ensures that this system will be available for use whenever liquid effluents require treatment prior fo release to the environment. The requirement that the appropriate portions of this system be used when specified, provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as is reasonably achievable." This specification implements Page 77

CY-CL-170-301 Revision 26 September 2022 the requirements of 1 0CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10CFR Part 50 and the design objective given in Section I1.D of appendix I to 10CFR Part 50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction_ of the dose design objectives set forth in Section II.A of Appendix I, 1 0CFR Part 50, for liquid effluents.

This requirement applies to the release of radioactive materials in liquid effluents from the one reactor unit on the site.

5.4 RADIOACTIVE GASEOUS EFFLUENTS (3/4.4) 5.4.1 Gaseous Effluent Dose Rates (3/4.4.1)

This requirement is provided to ensure that the dose at any time at and beyond the SITE BOUNDARY from gaseous effluents from all units on the site will be within the annual dose limits of 10CFR Part 20 to UNRESTRICTED AREAS. The annual dose limits are the doses associated with the concentrations of 1 0CFR Part 20, Appendix B, Table 2, Column 1. These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, Table 2 of 1 0CFR Part 20. For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy of that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for any increase in the atmospheric diffusion factor above that for the SITE BOUNDARY. Examples of such MEMBERS OF THE PUBLIC, with the appropriate occupancy factors, shall be given in this manual. Doses for such MEMBERS OF THE PUBLIC are provided in the Radioactive Effluent Release Report.

The specified release rate limits restrict, at all times, the corresponding gamma and beta dose rates above background to a MEMBER OF THE PUBLIC, at or beyond the SITE BOUNDARY, to less than or equal to 500 mrem/year to the whole body or to less than or equal to 3000 mrem/year to the skin. These release rate limits also restrict, at all times, the corresponding thyroid dose rate above background to a child via the inhalation pathway to less than or equal to 1500 mrem/year.

This requirement applies to the release of radioactive materials in gaseous effluents from the one reactor unit on the site.

The required detection capabilities for radioactive materials in gaseous waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD, and other detection limits can be found in Currie, L.A., "Lower Limit of Detection:

Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300.

5.4.2 Dose from Noble Gases (3/4.4.2)

This requirement is provided to implement the requirements of Sections I1.B, Ill.A and IV.A of Appendix I, 1 0CFR Part 50. The Control implements the guides set forth in Page 78

CY-CL-170-301 Revision 26 September 2022 Section I1.B of Appendix I. The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The Surveillance Requirements implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.

The dose calculation methodology and parameters established in this manual for calculating the doses due to the actual release rates for radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 1 0CFR Part 50, Appendix I,"

Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors" Revision 1, July 1977.

This requirement applies to the release of radioactive materials in gaseous effluents from the site.

5.4.3 Dose from lodine-131, lodine-133, Tritium and Radioactive Materials in Particulate Form (3/4.4.3)

This requirement is provided to implement the requirements of Sections I1.C, Ill.A and IV.A of Appendix I, 10CFR Part 50. The Control are the guides set forth in Section I1.C of Appendix I. The ACTION statements provide the required-operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The calculational methods specified in the Surveillance Requirements implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.

The calculational methodology and parameters for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 1 0CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors" Revision 1, July 1977. These equations also provide for determining the actual doses based upon the annual average atmospheric conditions. The release rate specifications for iodine-131; tritium, and radionuclides in particulate form with half-lives greater than 8 days are dependent upon the existing radionuclide pathways to man in the areas at and beyond the SITE BOUNDARY. The pathways that were examined in the development of these calculations were: (1) individual inhalation of airborne radionuclides, (2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, (3) deposition onto grassy areas where milk animals and meat producing animals graze with Page 79

CY-CL-170-301 Rev*ision 26 September 2022 consumption of the milk and meat by man, and (4) deposition on the ground with subsequent exposure of man.

This requirement applies to the release of radioactive materials in gaseous effluents from one reactor unit on the site.

5.4.4 Gaseous Radwaste Treatment (Off-Gas) System (3/4.4.4)

The FUNCTIONALITY of the WASTE GAS HOLDUP SYSTEM ensures that the system will be available for use whenever gaseous effluents require treatment prior to release to the environment. The requirement that the appropriate portions of the system be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as reasonably achievable." This requirement implements the requirements of 10CFR Part 50.36a, General Design Criterion 60 of Appendix A to 1 0CFR Part 50 and the design objectives given in Section I1.D of Appendix I to 1 0CFR Part 50. The specified limits governing the use of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in Section I1.B and I1.C of Appendix I, 1 0CFR Part 50, for gaseous effluents.

This requirement applies to the release of radioactive materials in gaseous effluents from the one reactor unit on the site.

5.4.5 Ventilation Exhaust Treatment System (3/4.4.5)

The FUNCTIONALITY of the VENTILATION EXHAUST TREATMENT SYSTEM ensures that the system will be available for use whenever gaseous effluents require treatment prior to release to the environment. The requirement that the appropriate portions of the system be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as reasonably achievable."

This requirement implements the requirements of 1 0CFR Part 50.36a, General Design Criterion 60 of Appendix A to 1 0CFR Part 50 and the design objectives given in Section I1.D of Appendix I to 10CFR Part 50. The specified limits governing the use of appropriate portions of the systems'were specified as a suitable fraction of the dose design objectives set forth in Section I1.B and I1.C of Appendix I, 10CFR Part 50, for gaseous effluents.

This requirement applies to the release of radioactive materials in gaseous effluents from the one reactor unit on the site.

5.5 TOTAL DOSE (3/4.5)

This requirement is provided to meet the dose limitations of 40CFR Part 190 that have been incorporated into 1 0CFR20.1301, as well as the dose limitations specfic to Independent Spent Fuel Storage Installation {ISFSI) operations in accordance with 10CFR72.104. Over the long term, as more storage modules containing dry shielded canisters of spent fuel are placed on the ISFSI pad, it is expected that ISFSI operations will become the prominent contributor to dose limits in this section. ISFSI dose Page 80

CY-CL-170-301 Revision 26 September 2022 contribution is in the form of direct radiation as no liquid or gas releases are expected to occur from the ISFSI canisters. The CPS 1 0CFR72.212 Report prepared in accordance with 1 0CFR72 requirements assumes a certain array of storage modules exists on the pad. The dose contribution from this array of casks combination with historical uranium fuel cycle operations prior to ISFSI operations was analyzed to be within 40CFR190 and 10CFR72.104 limits, and is documented in Holtec Report No. Hl-2135750, Site Boundary Dose Rate Calculations for HI-STORM FW System for Clinton Power Station.

The requirement that dose limits of 10CFR72.104 apply to "any real individual" is controlled for ISFSI activities in the ISFSI 72.212 report. Therefore, for the purposes of analyzing dose from the ISFSI, the member of the public as defined in 40CFR190 is the same as the "real individual" identified in the 72.212 report Dose monitoring requirements of 40CFR190 and 10CFR72.104 may be met through direct measurement (i.e., field dosimeters), determined from survey measurements, or calculated from shielding codes. CPS determines the 40CFR190 dose by the use of field dosimeters maintained and reported on as part of the Radiological Environmental Monitoring Program (REMP). The requirement requires the preparation and submittal of a Special Report whenever the calculated doses from plant generated radioactive effluents and direct radiation exceed 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem. For sites containing up to 4 reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40CFR Part 190 if the individual reactors remain within twice the dose design objectives of Appendix I, and if direct radiation doses from the reactor units and outside storage tanks are kept small. The Special Report will describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40CFR Part 190 or 10CFR72.104 limits. For the purposes of the Special Report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycles sources is negligible, with the exception that dose contributions from other nuclear fuel cycle facilities at the same site or within a radius of 8 km must be considered. If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40CFR Part 190 or 10CFR72.104, the Special Report with a request for a variance (provided the release conditions resulting in violation of 40CFR Part 190 or 10CFR72.104 have not already been corrected), in accordance with the provisions of 40CFR Part 190.11, 10CFR72.104 and 1 0CFR Part 20.2203, is considered to be a timely request and fulfills the requirements of 40CFR Part 190 or 10CFR72.104 until NRC staff action is completed. The variance only relates to the limits of 40CFR Part 190 or 10CFR72.104, and does not apply in any way to the other requirements for dose limitation of 1 0CFR Part 20, as addressed in 3.3.1 and 3.4.1. An individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel cycle.

5.6 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM (3/4.6)

The radiological environmental monitoring program required by this requirement provides representative measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBERS OF THE PUBLIC resulting from the station operation.

Page 81

CY-CL-170-301 Revision 26 September 2022 This monitoring program implementsSection IV.B.2 of Appendix I to 1 0CFR Part 50 and thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and the modeling of the environmental exposure pathways. Guidance for this monitoring program is provided by the Radiological Assessment Branch Technical Position on Environmental Monitoring, Revision 1, November 1979. The initially specified monitoring program will be effective for at least the first three years of commercial operation. Following this period, program changes may be initiated based on operational experience.

The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs required by TABLE 4.6-3 are considered optimum for routine environmental measurements in industrial laboratories.

It should be recognized that the LLD is defined as an~ priori (before the fact) limit representing the capability of a measurement system and not as an ~ posteriori (after the fact) limit for a particular measurement.

Detailed discussion of the LLD, and other detection limits, can be found in Currie, L.A.,

"Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300.

5.7 LAND USE CENSUS (3/4.7)

This requirement is provided to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identified and that modifications to the radiological environmental monitoring program are made if required by the results of this census.

The land use census shall be performed using the best information available (e.g., a door-to-door survey, from aerial surveys, questionnaire, or from consulting with local agricultural authorities). This census satisfies the requirements of Section IV.8.3 of

Appendix I to 1 0CFR Part 50. Restricting the census to gardens of greater than 50 m2 provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this size is the minimum required to produce the quantity (26 kg/year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following assumptions were made: (1) 20% of the garden was used for growing broad leaf vegetation (i.e., similar to lettuce and cabbage) and (2) a vegetation yield of 2 kg/m2.

5.8 INTERLABORATORY COMPARISON PROGRAM (3/4.8)

The requirement for participation in an lnterlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are valid for the purposes of Section IV.8.2 of Appendix I to 1 0CFR Part 50.

5.9 METEOROLOGICAL MONITORING PROGRAM (3/4.9 NOT USED)

Page 82

6.0 REPORTING REQUIREMENTS CY-CL-170-301 Revision 26 September 2022 6.1 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT 6.1.1 Routine Radiological Environmental Operating Reports covering the operation of the unit during the previous calendar year shall be submitted by May 1 of each year pursuant to Technical Specification 5.6.2.

6.1.2 The Annual Radiological Environmental Operating Reports shall include the following information:

6.1.2.1 Summaries, interpretations, and an analysis of trends of the results of the radiological environmental surveillance activities for the report period, including a comparison with preoperational studies, with operational controls as appropriate, and with previous environmental surveillance reports, and an assessment of the observed impacts of the plant operation on the environment.

6.1.2.2 The results of land use censuses required by 3.7.

6.1.2.3 Results of analysis of all radiological environmental samples and of all environmental radiation measurements taken during the period pursuant to the locations specified in the Tables and Figures in this manual, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Assessment Branch Technical Position, Revision 1, November 1979. In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results. The missing data shall be submitted as soon as possible in a supplementary report.

6.1.2.4 A summary description of the radiological environmental monitoring program.

6.1.2.5 At least two legible maps covering all sample locations keyed to a table giving distances and directions from the HVAC stack. One map shall cover stations near the SITE BOUNDARY and a second map shall include the more distant stations.

6.1.2.6 The results of licensee participation in the lnterlaboratory Comparison Program, required by 3.8.

6.1.2.7 Discussion of all deviations from the sampling schedule of Table 4.6-1.

6.1.2.8 Discussion of all analysis in which the LLD required by TABLE 4.6-3 was not achievable.

6.2 RADIOACTIVE EFFLUENT RELEASE REPORT 6.2.1 Routine Radioactive Effluent Release Reports covering the operations of the unit during the previous calendar year of operation shall be submitted by May 1 of each year pursuant to Technical Specification 5.6.3.

Page 83

CY-CL-170-301 Revision 26 September 2022 6.2.2 The Radioactive Effluent Release Report shall include the following information:

6.2.2.1 A summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the unit as outlined in Regulatory Guide 1.21, "Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants, Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof. For solid wastes, the format for Table 3 in Appendix B shall be supplemented with 3 additional categories: class of solid wastes (as defined by 1 0CFR Part 61 ), type of container (e.g., LSA, Type A, Type B, Large Quantity), and SOLIDIFICATION agent or absorbent (e.g., cement, urea formaldehyde).

6.2.2.2 The following information for each class of solid waste (as defined by 1 0CFR Part 61) shipped offsite during the report period:

a.

Total container volume,

b.

Total curie quantity (specify whether determined by measurement or estimate),

c.

Principal radionuclides (specify whether determined by measurement or estimate),

d.

Source of waste and processing employed (e.g., dewatered spent resin, compacted dry waste, evaporator bottoms).

6.2.2.3 A list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive materials in gaseous and liquid effluents made during the reporting period.

6.2.2.4 A listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to 3.7.

6.2.2.5 Changes to the ODCM pursuant to Technical Specification 5.5.1.

6.2.2.6 Major changes to radioactive liquid, gaseous, and solid waste treatment systems.

Licensees may choose to submit the information called for in this requirement as part of its annual USAR update. Changes described by this requirement shall become effective upon review by the Plant Operations Review Committee (PORC). The discussion of each change shall contain.

a.

A summary of the evaluation that led to the determination that the change could be made in accordance with 1 0CFR Part 50.59.

b.

Sufficient detailed information to totally support the reason for the change without benefit of additional or supplemental information;

c.

A detailed description of the equipment, components and processes involved and the interfaces with other plant systems; Page 84

CY-CL-170-301 Revision 26 September 2022

d.

An evaluation of the change, which shows the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste that differ from those previously predicted in the license application and amendments thereto;

e.

An evaluation of the change, which shows the expected minimum exposures to a MEMBER OF THE PUBLIC in the UNRESTRICTED AREA and to the general population that differ from those previously estimated in the license application and amendments thereto;

f.

A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents and in solid waste, to the actual releases for the period prior to when the changes are to be made;

g.

An estimate of the exposure to plant operating personnel as a result of the change; and

h.

Documentation of the fact that the change was reviewed and found acceptable by the PORC.

6.2.2.7 An annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction, atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, and atmospheric stability.

6.2.2.8 An assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from the unit or station during the previous calendar year. Beta and gamma air dose due to the release of noble gas in gaseous effluents is calculated at the CPS site boundary in each of the 16 geographical directions surrounding CPS. Dose due to the release of radioactive iodines and particulates in gaseous effluents is calculated at the critical receptor location in each of the 16 geographical sectors surrounding CPS to a distance of 5 miles. Dose summaries based on these calculations are provided in the Radioactive Effluent Release Report.

6.2.2.9 An assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY (FIGURE 1-1) during the report period.

Page 85

CY-CL-170-301 Revision 26 September 2022 NOTE:

All assumptions used i11 making the following assessments, i.e., specific activity, exposure time and location, shall be included in these reports.

Annual average meteorological conditions or meteorological conditions concurrent with the time of release of radioactive materials in gaseous effluents, as determined by sampling frequency and measurements, may be used for determining the gaseous pathway doses. The assessment of radiation doses shall be performed in accordance with the methodology and parameters in this manual.

6.2.2.10 An assessment of radiation doses to the likely most exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources, including doses from primary effluent pathways and direct radiation, for the previous calendar year to show conformance with 40CFR Part 190, Environmental Radiation Protection Standards for Nuclear Power Operation and 10CFR72.104, Criteria for radioactive materials in effluents and direct radiation from an ISFSI or MPS.

Acceptable methods for calculating the dose contribution from liquid and gaseous effluents are given in Regulatory Guide 1.109, Rev. 1, October 1977.

Page 86

CY-CL-170-301 Revision 26 September 2022 PART II - METHODOLOGY AND PARAMETERS OFFSITE DOSE CALCULATION MANUAL CLINTON POWER STATION Page 87

1.0 1.1 GENERAL INFORMATION INTRODUCTION CY-CL-170-301 Revision 26 September 2022 The Clinton Power Station OFFSITE DOSE CALCULATION MANUAL (CPS-ODCM) provides the methodologies and parameters to be used by Clinton Power Station to assure compliance with the radioactive effluent dose limitations stated in 1 0CFR20, 1 0CFR50 Appendix A (General Design Criteria 60 and 64), 1 0CFR50 Appendix I, 40CFR190, and 10CFR72.

The CPS-ODCM was prepared based on guidance provided in NUREG-0133, Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants (October 1978), and NUREG-0473, Radiological Effluent Technical Specifications for Boiling Water Reactors (Draft 7, to Revision 3). This manual along with station procedures will be used by CPS personnel to demonstrate compliance with the above referenced Federal Regulations.

Changes to the CPS-ODCM shall be provided in the Radioactive Effluent Release Report.

1.2 MCR ARPR LAN The MCR ARPR LAN is the means whereby data is transmitted from the ARPR monitors to the central collection equipment. ARPR monitor instrumentation consists of 0RM34J AR/PR Monitor on 1CX16J and 0RM32J AR/PR Monitor on 1H13-P864.

The communication requirements for the MCR ARPR LAN will be satisfied if communication is verified at either the 1 CC 16J terminal or the 1 H 13-P864 terminal with either terminal being designated as the Master Terminal.

Page 88

2.0 2.1 CY-CL-170-301 Revision 26 September 2022 RADIOACTIVE LIQUID SYSTEM EFFLUENT MONITORING SYSTEM LIQUID RADWASTE DISCHARGE PROCESS RADIATION MONITORING (PRM)

INTRUMENTATION This monitoring subsystem measures liquid radwaste effluent radioactivity prior to the effluent joining plant service water and circulating water dilution streams. A high radioactivity signal from this gamma scintillation detector automatically terminates the liquid radwaste effluent release. The liquid radwaste effluent flow, variable from 10-60 GPM or 50-300 GPM, combines with Plant Service Water flow (minimum flow approximately 2000 GPM during plant shutdown periods depending on system loads) and Plant Circulating Water flow (0-567,000 GPM) in the Seal Well prior to entering the 3.4-mile discharge flume to Lake Clinton (see Figure 2-1 ).

2.1.1 Liquid Radwaste Discharge PRM Setpoints To comply with Part I RECS Sections 3.1.1 and 3.3.1, the alarm/trip setpoints for liquid effluent monitors and flow measurement devices are set to assure that the following equation is satisfied:

cf/(F + f) ~ ECL (2-1)

Where:

ECL

=

the Effluent Concentration Limit (Part I RECS Section 3.3.1) implementing 10 times the effluent concentration limit of 1 0CFR20, Appendix B, Table 2, Column 2 and corresponding to the specific mix of radionuclides in the effluent stream being considered, in µCi/ml. For dissolved or entrained noble gases, the concentration is limited to 2.00E-04 µCi/ml.

c

=

the setpoint, in µCi/ml, of the radioactivity monitor measuring the radioactivity concentration in the effluent line prior to dilution and subsequent release; the setpoint is inversely proportional to the volumetric flow of the effluent line and proportional to the volumetric flow of the dilution stream(s) plus the effluent stream.

F

=

the dilution water flow setpoints as determined at the Seal Well, in volume per unit time f

=

the liquid radwaste discharge flow setpoint as determined at the liquid radwaste discharge PRM location, in volume per unit time (same units as F)

The available dilution water flow (F) should be constant for a given release, and the liquid radwaste tank discharge flow (f) and monitor setpoint (c) are set to meet the condition of equation (2-1) for a given effluent concentration (ECL). The method by which this is accomplished is illustrated in sections 2.1.1.1 through 2.1.1.5.

Page 89

2.1.1.1 Liquid Radwaste Tank Isotopic Concentration CY-CL-170-301 Revision 26 September 2022 The isotopic concentration for a liquid radwaste tank to be discharged is obtained from the sum of the measured concentrations as determined by the analyses required in Part I RECS Table 4.3.1-1:

(2-2)

Where:

l:9C9 =

The sum of concentrations C9 of each measured gamma emitter g (including 1-131) observed by gamma spectroscopy of the waste sample, µCi/ml.

EaCa =

The sum of concentrations Ca of alpha emitters (a) in liquid radwaste as measured in the most current QUARTERLY composite discharge tank sample, µCi/ml.

EsCs =

The sum of concentrations Cs of Sr-89/Sr-90 in liquid radwaste as observed in the most current QUARTERLY composite discharge tank sample, µCi/ml.

CT

=

The measured concentration of H-3 in liquid radwaste as determined from an~lysis of the most current QUARTERLY composite discharge tank sample, µCi/ml.

CFe

=

The measured concentration of Fe-55 in liquid radwaste as observed in the most current QUARTERLY composite discharge tank sample, µCi/ml.

2.1.1.2 Dilution Factor Calculation The measured radionuclide concentrations are used to calculate a DILUTION FACTOR (OF) which is equivalent to the ratio of total dilution flow rate to liquid radwaste tank effluent flow rate required to assure that the limiting concentrations specified in Part I RECS Section 3.3.1 are met at the point of discharge to the unrestricted area.

Dreq = Dreq,g + Dreq,ng (2-3)

Where:

Dreq,g =

Required dilution factor for gamma emitters Dreq,ng =

Required dilution factor for non-gamma emitters Page 90

CY-CL-170-301 Revision 26 September 2022 EGL =

Effluent concentration limit of nuclide i in µCi/ml equal to 10 times the values in 1 0CFR20 Appendix B, Table 2, Column 2 for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the f

=

Rmax =

Ci

=

SF

=

concentration is limited to 2.00E-04 µCi/ml.

Release point safety factor.

The maximum EGL ratio from the release point setpoint definition.

The,concentration of nuclide i in µCi/ml.

The conservative SAFETY FACTOR, if used, normally applied to compensate for statistical fluctuations and measurement errors, dimensionless.

2.1.1.3 Effluent Flow Rate The maximum permissible liquid radwaste tank effluent flow rate, Rcwmax, is calculated by the following equation:

F. +(+

F

)

R

=

avail j a/foe waste volume/time cwmax D

(2-4)

Where:

Rcwmax =

Favail =

falloc =

Fwaste =

Dreq =

req Maximum waste flow rate Minimum expected dilution water flow rate (Circulating and/or Service Water systems), volume/time 0.9 = Flow rate correction factor to provide a 10% margin for variations in flow rates, dimensionless Maximum expected liquid radwaste tank effluent flow rate, volume/time The DILUTION FACTOR calculated by equation (2-3),

dimensionless Equation (2-4) is valid only for DF~1; for DF<1, the liquid radwaste tank effluent concentration meets the limits of Part I RECS Section 3.3.1 without dilution and therefore Rcwmax may assume any value not to exceed discharge pump capacity.

2.1.1.4 Liquid Radwaste Discharge PRM Setpoint The liquid radwaste discharge PRM setpoint may now be specified based on the values of ~iCi (Eq. 2-2) and Rcwmax (Eq. 2-4) which were determined to provide compliance with the concentration limits of Part I RECS Section 3.3.1. The monitor response is primarily a gamma response and the actual setpoint is therefore based on ~9C9 (Eq. 2-2). The monitor setpoint, in counts per minute (cpm), which corresponds to the particular setpoint concentration, Smax, is determined based on monitor calibration data or operational data which correlates monitor response to sample analyses associated with the actual liquid radwaste discharged. The use of Page 91

CY-CL-170-301 Revision 26 September 2022 operational data is considered valid only if the integrity of the laboratory methods of determination are proven more accurate than the monitor data.

The set point concentration, Smax, is obtained by the following equations:

S

_ Rcwmax d' -

ay Fwaste (2-5)

Smax = Sadj

LgCg (2-6)

Where:

Fwaste =

The actual liquid radwaste effluent flow rate, volume/time Rcwmax and Fwaste are defined in section 2.1.1.3.

If Sadj ~1. the value obtained for Smax is used to determine the monitor setpoint above background, cpm, from either of the two methods described above. In the case where Sadi <1, no release may be made using.the existing discharge parameter values (Rcwmax, Fwaste).

The setpoint concentration is conservative, even if Rcwmax is attainable, since the calculated flow rate contains the SAFETY FACTOR, dilution flow rate and liquid radwaste tank effluent flow rate margins.

2.1.1.5 Spurious Alarm Prevention To prevent spurious alarms, revise the Plant Service Water Effluent PRM setpoint to coincide with the setpoint concentration, Smax, calculated by equation (2-6). This setpoint is valid only during periods of actual liquid radwaste discharges.

2.2 PLANT SERVICE WATER EFFLUENT PRM 2.2.1 Plant Service Water Effluent PRM Setpoints Plant service water effluent continuously releases to the Seal Well where it mixes with circulating water effluent (if present) prior to entering Lake Clinton via the 3.4-mile discharge flume. Anytime water is flowing through the Plant Service Water System, then radioactive effluent monitoring is required. To ensure that Plant Service Water intersystem leakage has not occurred, quarterly Service Water effluent grab samples will be obtained anytime water is flowing through the Plant Service Water System and analyzed to determine the identity and quantity of principal gamma-emitting radionuclides and tritium. In addition, a quarterly composite of positive grab samples will be analyzed to determine the quantity of Sr-89, Sr-90, Fe-55 and gross alpha species released. The analytical Lower Limit of Detection (LLD) for these analyses are specified in Part I RECS Table 4.3-1.

Page 92

CY-CL-170-301 Revision 26 September 2022 If the quarterly grab sample analysis indicates the presence of contamination above background, PRM setpoints will be established following section 2.1 methodology as follows:

2.2.1.1 Perform section 2.1.1.2, solving equation (2-3) for OF using the appropriate values in the concentration term from the grab sample analysis.

2.2.1.2 A modified dilution factor, DFm, must be determined so that available dilution flows may be apportioned among simultaneous discharge pathways. The modified dilution factor is defined as:

Where:

FA Where:

n (2-7)

=

Is an administrative allocation factor which may be assigned any value between O and 1 under the condition that (2-8)

=

The number of liquid discharge pathways for which OF ~1 and which are planned for simultaneous release. For simplicity, FA may be assigned the value 1/n. Calculate Rcwmax in equation (2-4) by substituting the value of DFm for Dreq and perform the calculation specified in section 2.1.1.4 to determine flow rate and PRM setpoints.

2.3 SHUTDOWN SERVICE WATER (SX) EFFLUENT PRM 2.3.1 Shutdown Service Water (SX) Effluent RPM Setpoints Shutdown Service Water, when initiated, is a potential continuous radioactive discharge pathway to the Ultimate Heat Sink (UHS) (see Figure 2-2). SX effluent sampling, analysis and setpoint establishment will be performed as discussed for the Plant Service Water system in Section 2.2.

2.4 FUEL POOL HEAT EXCHANGER SERVICE WATER EFFLUENT PRM 2.4.1 Fuel Pool Heat Exchanger Service Water Effluent PRM Setpoints The Fuel Pool Heat Exchanger Service Water is normally supplied by the Component Cooling Water (CCW) system (a closed loop system). The Component Cooling Water system rejects heat loads to the Plant Service Water system where radiation from intersystem leakage would be detected as described in section 2.2.

Fuel Pool Heat Exchanger Service Water cooling may also be provided from the Safe Shutdown Service Water System (SX), which is not a closed system. Effluent from the SX system is considered a potential radioactive discharge pathway when Page 93

CY-CL-170-301 Revision 26 September 2022 SX replaces Component Cooling Water as the heat sink for the Fuel Pool heat exchangers. Samples are collected from the Component Cooling Water system on a quarterly basis and analyzed as discussed in section 2.2. This sample allows Component Cooling Water to be analyzed prior to placing the Fuel Pool Heat Exchanger in the SX Cooling mode. This will account for a potential radioactive release to the Ultimate Heat Sink via SX. Discharge monitoring will be performed any time a Fuel Pool Cooling heat exchanger is in service (FC water is flowing through the heat exchanger) AND the heat sink for the FC heat exchanger is being provided by SX. The analysis results may then be used to establish Fuel Pool Heat Exchanger Service Water PRM and flow rate setpoints following Section 2.2.1.1 and 2.2.1.2 methodology.

Any releases of radioactivity to the environment from the Plant Service Water (except during liquid radwaste discharges), Shutdown Service Water or Fuel Pool Heat Exchanger Service Water Systems are considered abnormal events. Such events will be accounted for as unplanned releases in the Radioactive Effluent Release Report.

2.5 COMPONENT COOLING WATER PRM 2.5.1 Component Cooling Water PRM Setpoints The Component Cooling water system is a potential continuous radioactive discharge pathway to the Service Water system due to the Component Cooling water system generally operating at a higher pressure and the potential for heat exchanger tube leaks. Component Cooling provides cooling to components and heat exchangers that carry radioactive fluids or are in areas that could result in radioactive contamination if the components are damaged. Except for the sampling requirement described in 2.4, sampling on this system is done on an as needed basis. The PRM setpoints are established using the methodology in Section 2.22.

Page 94

FIGURE 2-1 UNRESTRICTED AREA BOUNDARY FOR LIQUID EFFLUENTS CPS RESTRICTED AREA NOTE 1 HWY. 54 HWY. 4B NOTES CY-CL-170-301 Revision 26 September 2022 LEGEND 17"7.,,.-.,,,.-,,.. -,.., SITE BOUNDARY VZTfl?J UNRESTRICTED AREA l;f;!,;,l:;,s,:! SPECIAL UNRESTRICTED AREA(See Note 1)

AREA WITHIN SITE BOUNDARY NOT OWNED BY IPC

1.

The Area in the Lake Between the Buoys and the Exclusion Area Boundary Is Unrestricted at this Time. But Will Be Controlled if Plant Effluent Conditions Warrant Closure.

2.

Land Parcel Not Owned by Clinton Power Station, Includes Residences.

3.

Land Parcel Not Owned by Clinton Power Station, Oil Company Pipeline Pumping Station.

4.

Land Parcel Not Owned by Clinton Power Station, Agricultural Use.

5.

The Lake Shoreline Is Approximately 690 ft. Msl Elevation Line.

Page 95

FIGURE 2-2 CY-CL-170-301 Revision 26 September 2022 LIQUID RADWASTE TREATMENT SYSTEM

--l><J---r------*

OWEOJDA

~--,---*-..i---~

OWEOIDB

--IXI-------,--~*

RWCTlUl'.CTlON SYSTEl'vl TO DISOIARGE FLUME RWCOllEClION SYSIEM

IRIX-PR036

Monitors required by Part I RECS Section 3.1.1 1WF01S Floor Drain 0WZ01 P Chem. Wst.

2WF04T Floor Drain Evaporator Evap. Tank Pump Evaporator Tank 2WF01S Floor Drain DWE01 FA,B, and C 0WZ01T Chem. Waste Evaporator Waste Filters Evaporator Tank 0WZ01 S Chemical 0WE01DA,B, and C 1WF04P Fir. Orn. Evap.

Waste Evaporator Waste Demins Tank Pump 1WF04T Floor Drain 0WE02TA,B, and C 2WF04P Fir. Orn. Evap.

Evaporator Tank Waste Sample Tks.

Tank Pump Page 96 OWEOlTA OWEOllB RWCOlLECllON SYSIEM CYTANK 0WE02PA,B, and C Waste Samp. Tk Pumps 0WE01TA and B Excess Water Tanks 0WE01 PA and B Excess Water Tank Pumps 1 PR036 Service Water PRM 0PR040 Liquid RW Discharge PRM

CY-CL-170-301 Revision 26 September 2022 SHUTDOWN SERVICE WATER LOOP 11A" SHUTDOWN SERVICE WATER LOOP "B" FIGURE 2-3 SHUTDOWN AND FUEL POOL HEAT EXCHANGER SERVICE WATER EFFLUENT MONITORS RHR HEAT EXCHANGER "A" A

SHUTDOWN OTHER SYSTEM SERVICE WATER LOADS EFFLUENT "A" 1RIX-PR038*

SHUTDOWN SERVICE WATER ULTIMATE HEAT SINK 1 COMPONENT COOLING WATER 1RIX-PR037 OTHER SYSTEM LOADS SHUTDOWN SERVICE WATER EFFLUENT "B" 1RIX-PR039*

RHR HEAT EXCHANGER "B" iY ULTIMATE HEAT SINK T

SHUTDOWN SERVICE WATER SHUTDOWN SERVICE WATER FUEL POOL HEAT 1 EXCHANGER SERVICE WATER PRM 1RIX-PR004*

FUEL POOL COOLING HEAT EXCHANGER "A" FUEL POOL COOLING HEAT EXCHANGER "B" 11 11 FUEL POOL HEAT EXCHANGER SERVICE T WATER PRM 1RIX-PR005*

SHUTDOWN SERVICE WATER NORMAL COOLING SUPPLY - COMPONENT COOLING WATER EMERGENCY COOLING SUPPLY - SHUTDOWN SERVICE WATER

Monitors required by Part I RECS Section 3.1.1 1 RIX-PR038 Shutdown Service Water Effluent "A" 1 RIX-PR039 Shutdown Service Water Effluent "B" 1 RIX-PR037 Component Cooling Water 1 RIX-PR005 Fuel Pool Heat Exchanger Service Water PRM "B" 1 RIX-PR004 Fuel Pool Heat Exchanger Service Water PRM "A" Page 97 COMPONENT COOLING WATER

WASTE DEMINERALIZER FLOOR DRAIN EVAPORATOR BOTTOMS CHEMICAL WASTE EVAPORATOR BOTTOMS SPENT RESIN TANK PHASE SEPARATOR FP/FD SLUDGE TANK W'ASTE SLUDGE TANK CONCENTRATE

[WASTE TANK FIGURE 2-4 SOLi D RADWASTE SYSTEM SIMPLIFIED FLOW DIAGRAM OFFSITE BURIAL DRY RADIOACTIVE SORTING WASTE Page 98 f

VOLUME REDUCTION I

PRE-SHIPMENT MONITORING I

STORAGE VENDOR SOLIDIFCATION SERVICES CY-CL-170-301 Revision 26 September 2022 PRE-SHIPMENT MONITORING STORAGE

3.0 3.1 RADIOACTIVE GASEOUS EFFLUENT MONITORING SYSTEM CY-CL-170-301 Revision 26 September 2022 HVAC STACK PROCESS RADIATION MONITORING (PRM) INSTRUMENTATION The HVAC Stack inputs are monitored for radioactivity prior to discharge to the environment by the HVAC Stack PRM. The PRM detector configuration provides effluent monitoring using nine (9) channels as follows:

a.

Beta scintillator for particulates

b.

Alpha surface barrier detector to account for the radon/thoron contribution to the beta particulate measurement

c.

Gamma scintillator for iodine

d.

Iodine background subtraction

e.

Beta scintillator for low range noble gas

f.

Energy-compensated Geiger-Mueller (G-M) detector for high range noble gas

g.

Energy-compensated G-M detector for gamma area subtraction

h.

Sample pressure indication at the HVAC PRM

i.

Sample flow rate indication at the HVAC PRM This monitor has one control function. Upon detection of activity that exceeds the high alarm setpoint on any channel, a failure of any channel (low or high), loss of AC power to the monitor, or flow failure the HVAC Accident Range PRM (0RIX-PR012) automatically transfers from a "STANDBY" condition to in service. Also, an annunciator alarms in the Main Control Room where proper response actions will be initiated in accordance with CPS procedures.

3.2 SGTS STACK PROCESS RADIATION MONITORING (PRM) INSTRUMENTATION As is discussed in Part II ODCM Section 5.1, the SGTS is used to reduce post-accident concentrations of radioactivity in the primary and secondary containment via filter trains. The SGTS Stack PRM monitors the gaseous effluent of the filter trains at the SGTS Stack prior to release to the environment. The PRM detector configuration utilizes nine (9) channels as follows:

a.

Beta scintillator for particulates

b.

Gamma scintillator for iodine Page 99

c.

Iodine background subtraction

d.

Beta scintillator for low range noble gas CY-CL-170-301 Revision 26 September 2022

e.

Energy-compensated G-M detector for intermediate range noble gas

f.

Energy-compensated G-M detector for gamma area subtraction

g.

Alpha surface barrier detector to account for the radon/thoron contribution to the beta particulate measurement

h.

Sample pressure indication at the SGTS PRM

i.

Sample flow-rate indication at the SGTS PRM This monitor has no control function but annunciates in the Main Control Room where proper response actions will be initiated in accordance with CPS procedures.

3.3 MAIN CONDENSER OFF-GAS MONITORING INSTRUMENTATION.

3.3.1 Pre-Treatment Air Ejector Off-Gas Process Radiation Monitor (PRM)

The Pre-Treatment Off-Gas PRM monitors hydrogen recombiner effluent for gross noble gas radioactivity. This effluent is then routed to the charcoal adsorbers for eventual release to the environment via the station HVAC Stack (see Figure 3-1).

The PRM detector configuration consists of a single energy-compensated G-M detector mounted in a gas volume.

The monitor has no control function but annunciates in the Main Control Room where proper response actions will be initiated in accordance with CPS procedures.

3.3.2 Post-Treatment Air Ejector Off-Gas Process Radiation Monitor (PRM)

The Post-Treatment Off-Gas PRM monitors the gaseous radioactivity at upstream, intermediate or downstream sections of the charcoal adsorber beds prior to the effluent entering the station HVAC Stack for release to the environment (see Figure 3-1). The PRM detector configuration is as described for the HVAC Stack PRM System (3.1).

The monitor has two control functions. Upon detection of noble gas activity in excess of the ALERT setpoint, the charcoal adsorber bypass valves shut (if in the charcoal bypass mode) and the off-gas is routed through the adsorbers.

Should noble gas activity exceed the HIGH setpoint, or upon PRM failure, the off-gas system is automatically isolated from the HVAC Stack and a reactor scram may occur if loss of condenser vacuum occurs.

Page 100

CY-CL-170-301 Revision 26 September 2022 The Main Condenser Off-Gas Treatment System is shown in Figure 3-1.

3.4 GASEOUS EFFLUENT MONITOR SETPOINT CALCULATIONS Gaseous effluent Process Radiation Monitor (PRM) alarm setpoints shall be calculated to ensure that the instantaneous dose rate in unrestricted areas due to noble gases released do not exceed 500 mrem/year to the total body and 3000 mrem/year to the skin. The initial setpoints were calculated using the BWR/GALE code radionuclide mix obtained for CPS; when the actual radionuclide mix can be determined, it will be used for setpoint calculations. The PRM setpoints are based on the instantaneous noble gas dose rates and are applied at the point of which the effluent enters an unrestricted area.

Due to PRM limitations, non-noble gas setpoints will not be implemented to demonstrate compliance with Part I RECS Section 3.4.1 (b). Compliance with the organ dose rate limitation is demonstrated during performance of sampling and analysis activities required by Part I RECS Table 4.4.1-1.

Both total body and skin dose setpoints will be calculated and the more restrictive limit applied to the respective PRM. The actual setpoint used may be lower than the restrictive limit since the two release points will be partitioned such that their sum does not exceed 100 percent of the restrictive limit. The percentages used to partition the release points could vary at plant discretion to accommodate plant operational conditions. In no case will the combined releases due to variations in the PRM setpoints result in effluent limits being exceeded.

3.4.1 Total Body Dose Rate Setpoint The fraction of the total gaseous radioactivity in each gaseous effluent release path j for each noble gas radionuclide i shall be determined using the following relationship:

Where:

Cii (3-1)

=

The measured concentration of identified noble gas radionuclide i in gaseous effluent release path j, µCi/cc The maximum acceptable release rate of all noble gases in release path j to comply with Part I RECS Section 3.4.1 is calculated by using the equation:

500-F.

QTJ = [(XI Q) 1

. L; 1

(K;/iJ )], µCi/sec (3-2)

Where:

Ori

=

The maximum acceptable release rate of all noble gases in release path j, µCi/sec Page 101

Fi

=

500 =

(XI Q) 1 =

Ki

=

CY-CL-170-301 Revision 26 September 2022 Total dose rate allocation factor assigned to release path j (varying between 0.0 and 1.0), dimensionless Total body dose rate limit specified in Part I RECS Section 3.4.1.1 (a), mrem/year The highest calculated average relative concentration of release path j at the site boundary The total body dose factor due to gamma emissions of noble gas radionuclide i as listed in Table 8-1 of Regulatory Guide 1.109 and Part II ODCM Table 5-1 of this manual, mrem/yr per µCi/m3 fii

=

The fraction as defined by equation (3-1 ), dimensionless The total maximum acceptable concentration setpoint of noble gas radionuclides in release path j is calculated using the following equation:

(3-3)

Where:

Cri

=

The total maximum acceptable concentration setpoint of all noble gases in release path j, µCi/cc Ori

=

The maximum acceptable release rate of all noble gases in release path j determined from equation (3 - 4), µCi/sec Ri

=

The effluent release rate of release point j, cc/sec 3.4.2 Skin Dose Rate Setpoint To ensure compliance with the Part I RECS Section 3.4.1 (a) skin dose rate limit, PRM setpoints shall be calculated using the methodology presented in Section 3.4.1 and by substituting the following equation for equation (3-1 ):

(3-4)

Where:

Osi

=

The maximum accepfable release rate of all noble gases in release path j, µCi/sec Fi

=

Total dose rate allocation factor assigned to release path j (varying between 0.0 and 1.0), dimensionless 3000 =

Skin dose rate limit specified in Part I RECS Section 3.4.1.1 (a), mrem/year (X/Q) J =

The highest calculated average relative concentration of release path j at the site boundary Li

=

The skin dose factor due to gamma emissions for each Page 102

CY-CL-170-301 Revision 26 September 2022 identified noble gas radionuclide i, mrem/yr per µCi/m3, as listed in Part II ODCM Table 5-1 of this manual.

1.1

=

An air dose to skin dose equivalent conversion factor, mrem/mrad Mi

=

The air dose factor due to gamma emissions for each identified noble gas radionuclide i, mrad/yr per µCi/m3, as listed in Part II ODCM Table 5-1 of this manual fii

=

The fraction defined by equation (3-1)

The calculated total body and skin maximum acceptable concentration setpoints are compared and the more restrictive setpoint used. A safety factor may also be applied to the concentration setpoint calculated by equation (3-2) to compensate for statistical fluctuations and measurement errors.

Page 103

IRIX-PR034 ICA0IAA ICD0IA MAIN CONDENSER FIGURE 3-1 CY-CL-170-301 Revision 26 September 2022 MAIN CONDENSER OFF-GAS TREATMENT SYSTEM PR1MARY/SECONDARY CONTAINMENT EXHAUST IN66Z003A IN66Z0038 0CA0IPB

0RIX-PR003 SGTS EXHAUST STACK IN66D0l2

!N66D0l3 HVAC STACK

ORIX-PROO I

Monitors required by Part I RECS Sections 3.2.1 and 3.2.2 1CD01A Main DCA01TA CV 1 N66B01 OB Cooler 1N66D013 Charcoal 1 RIX-PR035 Off-Gas Condenser Separator Tank A Condenser 8 Adsorber Post Treatment PRM 1CA01M Steam 0CA01TB CV 1N66Z003A 1N66D016 HEPA 1 RIX-PR041 Off-Gas Jet Air Ejector A Separator Tank B Dessicant Dryer A Filter Post Treatment PRM 1CA01AB Steam 1N66D005A 1N66Z0038 0RIX-PR001 HVAC 0RIX-PR003 Standby Jet Air Ejector B Recombiner A Dessicant Dryer B Stack PRM #1 Gas Treatment PRM 0CA01PA Condenser 1N66O0058 1 N668011 Gas 0RIX-PR002 HVAC 0RIX-PR004 Standby Vacuum (CV)

Recombiner 8 Cooler Stack PRM #2 Gas Treatment PRM Pump A 0CA01PB CV 1N668010A Cooler 1N66D012 1 RIX-PR034 Off-Gas PumpB Condenser A Charcoal Adsorber Pretreatment PRM Page 104

4.0 4.1 LIQUID EFFLUENTS INTRODUCTION CY-CL-170-301 Revision 26 September 2022 Liquid radwaste effluent released from CPS will meet ten times the 1 0CFR20 concentration limits at the point of discharge to the unrestricted area shown in FIGURE 4-1. This design and operation objective will be achieved at all times.

Actual discharges of liquid radwaste effluent will normally occur on a batch basis and the average concentration at the point of discharge will be only a small percentage of the allowed limits. Refer to Clinton USAR Section 11.5 for a description of radiation monitoring, sampling and effluent control systems.

Cumulative quarterly dose contributions due to radioactive effluents released to the unrestricted area will be determined once every 31 days using NUREG-0133 and Regulatory Guide 1.109 methodology and parameters during periods when liquid effluent activity exceeds the Lower Limit of Detection (LLD) values.

4.2 10CFR20 RELEASE CONCENTRATION LIMITS The Operation and Surveillance Requirements pertaining to discharge of liquid radwaste effluent to the unrestricted area are specified in RECS 3/4.3.1.

4.3 1 0CFR50, APPENDIX I DOSE LIMITS The Operation and Surveillance Requirements concerning 1 0CFR50, Appendix I Release Limits are specified in section RECS 3/4.3.2.

This section is based upon the aquatic food and potable water exposure pathways only. Other exposure pathways, namely shoreline deposits and irrigated crops, may arise at Clinton Power Station and will be included in the section 4.3 dose contribution if they are likely to provide a significant contribution to the total dose. A pathway is considered significant if a conservative evaluation yields an additional dose increment greater than or equal to 10 percent of the total from all other existing pathways. Methods for calculating doses from other poten.tially significant liquid effluent pathways are presented in Appendix A to Regulatory Guide 1.109.

When the land use census or environmental monitoring information determine that other significant liquid effluent pathways are present, the Regulatory Guide 1.109 Appendix A equations and parameters will be used in lieu of site-specific data to determine a pathway's significance.

Page 105

CY-CL-170-301 Revision 26 September 2022 The dose contribution to the maximum exposed individual from all radionuclides identified in liquid effluents released to the unrestricted area is calculated as follows:

DJ =AijI,t.,.t,*C;,*Fsr, mrem (4-1) s,i Where:

o* J

=

The cumulative calendar quarter or yearly dose to any organ j from liquid effluent for the total release period, mrem Ats

=

The length of time, s, over which Cis and Fsr are averaged for liquid releases, hours

=

Liquid Radwaste Tank Volume/Liquid Radwaste Discharge Flow Rate Cis

=

The average concentration of nuclide i for time period s in undiluted liquid effluent during release period Ats for any liquid release, µCi/ml Fsr

=

The near field average dilution factor for receptor r during any liquid effluent release, dimensionless. Defined as the ratio of the average undiluted liquid radwaste flow during the release, to the product of the average flow from the discharge structure (during the reporting period, i.e.,

quarter or year) to the unrestricted receiving water and Z

=

Average Undiluted Liguid Waste Flow (Average Discharge Structure Flow) z

=

The applicable dilution factor for Lake Clinton, dimensionless

=

1.0 Aij

=

The composite ingestion dose commitment factor for the total body or critical organ j of an ADULT for radionuclide i, mrem/hr per µCi/ml

=

Ko[(Uw/Dw) + (UfBFi)]DFi (4-1)

Where:

Ko

=

A units conversion factor, 1.14E+05 pCi-ml-yr/µCi-liter-hr

=

(1.00E+06 pCi/µCi)(1.00E+03 ml/liter)/8760 hr/yr Uw

=

Annual water consumption by the maximum adult, liter/yr Dw

=

Dilution factor from the near field area to the nearest potable water intake, 1.0 Uf

=

Adult fish consumption rate, 21 kg/yr (Table E-5 of Regulatory Guide 1.109)

BFi

=

Bioaccumulation factor for radionuclide i in fish, pCi/kg per pCi/liter (TABLE 4-2 taken from Table A-1 of Regulatory Guide 1.109)

DFi =

Adult ingestion dose conversion factor for radionuclide i, Page 106

CY-CL-170-301 Revision 26 September 2022 total body or critical organ, mrem/pCi (TABLE 4-3 taken from Table E-11 of Regulatory Guide 1.109)

TABLE 4-1 contains values for Aij as calculated by equation (4-1 ).

4.4 LIQUID EFFLUENT DOSE PROJECTION CALCULATIONS The 31 day projected dose shall be calculated using the following equation:

Dpi = (Di* p) + Dai (4-2)

Where:

Dpi

=

Dj

=

p

=

The 31 day projected dose by organ j.

Total dose (mrem) for all valid release points for the release period (usually quarter) by organ j.

The projection factor which is the results of 31 divided by the number of days from the start of the quarter to the end of the release.

Dai

=

Additional anticipated dose for gaseous release by organ j and quarter of release.

4.5 TEMPORARY LIQUID RADWASTE HOLD-UP TANKS The use of temporary liquid radwaste hold-up tanks may occur at CPS. To comply with Operational Requirements Manual (ORM) 2.4.4, the curie limit for liquid radwaste stored in such tanks may be calculated using the methodology presented in Appendix B of NUREG-0133 (BWR-RATAFR code), but limited to less than or equal to 10 curies, excluding tritium and dissolved or entrained noble gases.

Page 107

i=IGURE 4-1 UNRESTRICTED AREA BOUNDARY FOR LIQUID EFFLUENTS CPS RESTRICTED AREA NOTE 1 HWY. 48 NOTES CY-CL-170-301 Revision 26 September 2022 LEGEND

,..,......::: SITE BOUNDARY WIZ?J UNRESTRICTED AREA 1:,::::4:i*;:I SPECIAL UNRESTRICTED AREA(See Note 1)

AREA WITHIN SITE BOUNDARY NOT OWNED BY IPC

1.

The Area in the Lake Between the Buoys and the Exclusion Area Boundary Is Unrestricted at this Time. But Will Be Controlled if Plant Effluent Conditions Warrant Closure.

2.

Land Parcel Not Owned by Clinton Power Station, Includes Residences.

3.

Land Parcel Not Owned by Clinton Power Station, Oil Company Pipeline Pumping Station.

4.

Land Parcel Not Owned by Clinton Power Station, Agricultural Use.

Page 108

5.

The Lake Shoreline Is Approximately 690 ft. Msl Elevation Line.

Page 109 CY-CL-170-301 Revision 26 September 2022

CY-CL-170-301 Revision 26 September 2022 TABLE 4-1 ADULT INGESTION DOSE COMMITMENT FACTORS - Aii (mrem/hr per µCi/ml)

Page 1 of 2 ISOTOPE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU H-3 NO DATA 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-01 C-14 3.12E+04 6.24E+03 6.24E+03 6.24E+03 6.24E+03 6.24E+03 6.24E+03 NA-24 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06E+02 4.06E+02 P-32 1.39E+06 8.62E+04 5.36E+04 NO DATA NO DATA NO DATA 1.56E+05 CR-51 NO DATA NO DATA 1.27E+00 7.60E-01 2.B0E-01 1.68E+00 3.20E+02 MN-54 NO DATA 4.37E+03 8.34E+02 NO DATA.

1.30E+03 NO DATA 1.34E+04 MN-56 NO DATA 1.10E+02 1.95E+01 NO DATA 1.40E+02 NO DATA 3.51E+03 FE-55 6.57E+02 4.54E+02 1.06E+02 NO DATA NO DATA 2.53E+02 2.60E+02 FE-59 1.04E+03 2.44E+03 9.34E+02 NO DATA NO DATA 6.81 E+02 8.13E+03 CO-58 NO DATA 8.90E+01 2.00E+02 NO DATA NO DATA NO DATA 1.80E+03 CO-60 NO DATA 2.56E+02 5.64E+02 NO DATA NO DATA NO DATA 4.80E+03 Nl-63 3.11E+04 2.15E+03 1.04E+03 NO DATA NO DATA NO DATA 4.49E+02 Nl-65 1.26E+02 1.64E+01 7.48E+00 NO DATA NO DATA NO DATA 4.16E+02 CU-64 NO DATA 9.97E+O0 4.67E+O0 NO DATA 2.51E+01 NO DATA 8.48E+02 ZN-65 2.31E+04 7.36E+04 3.33E+04 NO DATA 4.92E+04 NO DATA 4.64E+04 ZN-69 4.92E+01 9.42E+01 6.55E+00 NO DATA 6.12E+01 NO DATA 1.41E+01 BR-83 NO DATA NO DATA 4.03E+01 NO DATA NO DATA NO DATA 5.81E+01 BR-84 NO DATA NO DATA 5.23E+01 NO DATA NO DATA NO DATA 4.10E-04 BR-85 NO DATA NO DATA 2.15E+00 NO DATA NO DATA NO DATA LT1E-15*

RB-86 NO DATA 1.01E+05 4.70E+04 NO DATA NO DATA NO DATA 1.99E+04 RB-88 NO DATA 2.89E+02 1.53E+02 NO DATA NO DATA NO DATA 4.00E-09 RB-89 NO DATA 1.92E+02 1.35E+02 NO DATA NO DATA NO DATA 1.11E-11 SR-89 2.21E+04 NO DATA 6.34E+02 NO DATA NO DATA NO DATA 3.54E+03 SR-90 5.43E+05 NO DATA 1.33E+05 NO DATA NO DATA NO DATA 1.57E+04 SR-91 4.06E+02 NO DATA 1.64E+01 NO DATA NO DATA NO DATA 1.94E+03 SR-92 1.54E+02 NO DATA 6.67E+00 NO DATA NO DATA NO DATA 3.05E+03 Y-90 5.75E-01 NO DATA 1.54E-02 NO DATA NO DATA NO DATA 6.10E+03 Y-91m 5.43E-03 NO DATA 2.10E-04 NO DATA

NO DATA NO DATA 1.60E-02 Y-91 8.42E+00 NO DATA 2.25E-01 NO DATA NO DATA NO DATA 4.64E+03 Y-92 5.05E-02 NO DATA 1.48E-03 NO DATA NO DATA NO DATA 8.84E+02 Y-93 1.60E-01 NO DATA 4.42E-03 NO DATA NO DATA NO DATA 5.08E+03 ZR-95 2.40E-01 7.69E-02 5.20E-02 NO DATA 1.21 E-01 NO DATA 2.44E+02 ZR-97 1.32E-02 2.67E-03 1.22E-03 NO DATA 4.04E-03 NO DATA 8.28E+02 NB-95 4.46E+02 2.48E+02 1.33E+02 NO DATA 2.45E+02 NO DATA 1.51E+06 MO-99 NO DATA 1.03E+02 1.96E+01 NO DATA 2.33E+02 NO DATA 2.39E+02 TC-99m 8.86E-03 2.S0E-02 3.19E-01 NO DATA 3.S0E-01 1.23E-02 1.48E+01 TC-101 9.11E-03 1.31 E-02 1.29E-01 NO DATA 2.36E-01 6.70E-03 3.94E-14 RU-103 4.42E+00 NO DATA 1.90E+00 NO DATA 1.69E+01 NO DATA 5.16E+02 RU-105 3.68E-01 NO DATA 1.45E-01 NO DATA 4.76E+00 NO DATA 2.25E+02 RU-106 6.57E+01 NO DATA 8.32E+0O NO DATA 1.27E+02 NO DATA 4.25E+03 AG-110m NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA TE-125m 2.57E+03 9.28E+02 3.43E+02 7.70E+02 1.04E+04 NO DATA 1.02E+04 TE-127m 6.47E+03 2.31E+03 7.89E+02 1.65E+03 2.63E+04 NO DATA 2.17E+04 TE-127 1.05E+02 3.77E+01 2.28E+01 7.79E+01 4.28E+02 NO DATA 8.30E+03 TE-129m 1.10E+04 4.10E+03 1.74E+03 3.78E+03 4.59E+04 NO DATA 5.54E+04 TE-129 3.00E+01 1.13E+01 7.31 E+00 2.30E+01 1.26E+02 NO DATA 2.26E+01 TE-131m 1.65E+03 8.09E+02 6.74E+02 1.28E+03 8.19E+03 NO DATA 8.03E+04 TE-131 1.88E+01 7.87E+00 5.95E+OO 1.55E+01 8.25E+01 NO DATA 2.67E+00 Page 110

CY-CL-170-301 Revision 26 September 2022 TABLE 4-1 ADULT INGESTION DOSE COMMITMENT FACTORS - Aii (mrem/hr per µCi/ml)

Page 2 of 2 ISOTOPE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI TE-132 2.41E+03 1.56E+03 1.46E+03 1.72E+03 1.50E+04 NO DATA 7.37E+04 1-130 2.71E+01 7.99E+01 3.15E+01 6.78E+03 1.25E+02 NO DATA 6.88E+01 1-131 1.49E+02 2.13E+02 1.22E+02 6.99E+04 3.66E+02 NO DATA 5.63E+01 1-132 7.28E+00 1.95E+01 6.81 E+00 6.81 E+02 3.10E+01 NO DATA 3.66E+00 1-133 5.09E+01 8.85E+01 2.70E+01 1.30E+04 1.54E+02 NO DATA 7.96E+01 1-134 3.80E+00 1.03E+01 3.69E+00 1.79E+02 1.64E+01 NO DATA 9.00E-03 1-135 1.59E+01 4.16E+01 1.53E+01 2.74E+03 6.67E+01 NO DATA 4.70E+01 CS-134 2.97E+05 7.07E+05 5.78E+05 NO DATA 2.29E+05 7.60E+04 1.24E+04 CS-136 3.11E+04 1.23E+05 8.84E+04 NO DATA 6.84E+04 9.37E+03 1.40E+04 CS-137 3.81 E+05 5.21 E+05 3.41E+05 NO DATA 1.77E+05 5.88E+04 1.01E+04 CS-138 2.64E+02 5.21 E+02 2.58E+02 NO DATA 3.83E+02 3.78E+01 2.22E-03 BA-139 9.29E-01 6.60E-04 2.72E-02 NO DATA 6.18E-04 3.75E-04 1.65E+00 BA-140 1.94E+02 2.44E-01 1.27E+01 NO DATA 8.29E-02 1.40E-01 4.00E+02 BA-141 4.50E-01 3.40E-04 1.52E-02 NO DATA 3.16E-04 1.93E-04 2.12E-10 BA-142 2.04E-01 2.09E-04 1.28E-02 NO DATA 1.77E-04 1.18E-04 2.89E-19 LA-140 1.49E-01 7.53E-02 1.99E-02 NO DATA NO DATA NO DATA 5.53E+03 LA-142 7.65E-03 3.48E-03 8.66E-04 NO DATA NO DATA NO DATA 2.54E+01 CE-141 2.24E-02 1.51 E-02 1.72E-03 NO DATA 7.03E-03 NO DATA 5.78E+01 CE-143 3.94E-03 2.92E+00 3.23E-04 NO DATA 1.28E-03 NO DATA 1.09E+02 CE-144 1.17E+00 4.88E-01 6.26E-02 NO DATA 2.89E-01 NO DATA 3.94E+02 PR-143 5.50E-01 2.20E-01 2.72E-02 NO DATA 1.27E-01 NO DATA 2.41E+03 PR-144 1.80E-03 7.47E-04 9.14E-05 NO DATA 4.21 E-04 NO DATA 2.59E-10 ND-147 3.76E-01 4.34E-01 2.60E-02 NO DATA 2.54E-01 NO DATA 2.08E+03 W-187 2.95E+02 2.47E+02 8.63E+01 NO DATA NO DATA NO DATA 8.09E+04 NP-239 2.84E-02 2.80E-03 1.54E-03 NO DATA 8.72E-03 NO DATA 5.74E+02 Less than 1.00E-15 Page 111

TABLE 4-2 BIOACCUMULATION FACTORS - BFi (pCi/kg per pCi/liter)

ELEMENT FRESHWATER FISH H

9.00E-01 C

4.60E+03 Na 1.00E+02 p

1.00E+05 Cr 2.00E+02 Mn 4.00E+02 Fe 1.00E+02 Co 5.00E+01 Ni 1.00E+02 Cu 5.00E+01 Zn 2.00E+03 Br 4.20E+02 Rb 2.00E+03 Sr 3.00E+01 y

2.50E+01 Zr 3.30E+00 Nb 3.00E+04 Mo 1.00E+01 Tc 1.50E+01 Ru 1.00E+01 Rh 1.00E+01 Te 4.00E+02 I

1.50E+01 Cs 2.00E+03 Ba 4.00E+00 La 2.50E+01 Ce 1.00E+00 Pr 2.50E+01 Nd 2.50E+01 w

1.20E+03 Np 1.00E+01 Page 112 CY-CL-170-301 Revision 26 September 2022

CY-CL-170-301 Revision 26 September 2022 TABLE 4-3 ADULT INGESTION DOSE FACTORS -DFi (mrem/pCi ingested)

Page 1 of 2 ISOTOPE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA-24 1.?0E-06 1.?0E-06 1.?0E-06 1.?0E-06 1.?0E-06 1.?0E-06 1.?0E-06 P-32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 CR-51 NO DATA NO DATA 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 MN-54 NO DATA 4.57E-06 8.72E-07 NO DATA 1.36E-06 NO DATA 1.40E-05 MN-56 NO DATA 1.15E-07 2.04E-08 NO DATA 1.46E-07 NO DATA 3.67E-06 FE-55 2.75E-06 1.90E-06 4.43E-07 NO DATA NO DATA 1.06E-06 1.09E-06 FE-59 4.34E-06 1.02E-05 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 CO-58 NO DATA 7.45E-07 1.67E-06 NO DATA NO DATA NO DATA 1.51 E-05 CO-60 NO DATA 2.14E-06 4.72E-06 NO DATA NO DATA NO DATA 4.02E-05 Nl-63 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA 1.88E-06 Nl-65 5.28E-07 6.86E-08 3.13E-08 NO DATA NO DATA NO DATA 1.74E-06 CU-64 NO DATA 8.33E-08 3.91E-08 NO DATA 2.10E-07

NO DATA 7.10E-06 ZN-65 4.84E-06 1.54E-05 6.96E-06 NO DATA 1.03E-05 NO DATA 9.?0E-06 ZN-69 1.03E-08 1.97E-08 1.37E-09 NO DATA 1.28E-08 NO DATA 2.96E-09 BR-83 NO DATA NO DATA 4.02E-08 NO DATA NO DATA NO DATA 5.79E-08 BR-84 NO DATA NO DATA 5.21 E-08 NO DATA NO DATA NO DATA 4.09E-13 BR-85 NO DATA NO DATA 2.14E-09 NO DATA NO DATA NO DATA LT 1E-24*

RB-86 NO DATA 2.11 E-05 9.83E-06 NO DATA NO DATA NO DATA 4.16E-06 RB-88 NO DATA 6.05E-08 3.21E-08 NO DATA NO DATA NO DATA 8.36E-19 RB-89 NO DATA 4.01E-08 2.82E-08 NO DATA NO DATA NO DATA 2.33E-21 SR-89 3.08E-04 NO DATA 8.84E-06 NO DATA NO DATA NO DATA 4.94E-05 SR-90 7.58E-03 NO DATA 1.86E-03 NO DATA NO DATA NO DATA 2.19E-04 SR-91 5.67E-06 NO DATA 2.29E-07 NO DATA NO DATA NO DATA 2.?0E-05 SR-92 2.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05 Y-90 9.62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E-04 Y-91m 9.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10 Y-91 1.41 E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 Y-92 8.45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 Y-93 2.68E-09 NO DATA 7.40E-11 NO DATA NO DATA NO DATA 8.50E-05 ZR-95 3.04E-08 9.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05 ZR-97 1.68E-09 3.39E-10 1.55E-10 NO DATA 5.12E-10 NO DATA 1.05E-04 NB-95 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MO-99 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA 9.99E-06 TC-99m 2.47E-10 6.98E-10 8.89E-09 NO DATA 1.06E-08 3.42E-10 4.13E-07 TC-101 2.54E-10 3.66E-10 3.59E-09 NO DATA 6.59E-09 1.87E-10 1.10E-21 RU-103 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 RU-105 1.54E-08 NO DATA 6.08E-09 NO DATA 1.99E-07 NO DATA 9.42E-06 RU-106 2.75E-06 NO DATA 3.48E-07 NO DATA 5.31 E-06 NO DATA 1.78E-04 AG-110m 1.60E-07 1.48E-07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E-05 TE-125m 2.68E-06 9.71 E-07 3.59E-07 8.06E-07 1.09E-05 NO DATA 1.0?E-05 TE-127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 NO DATA 2.27E-05 TE-127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 NO DATA 8.68E-06 TE-129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 NO DATA 5.79E-05 TE-129 3.14E-08 1.18E-08 7.65E-09 2.41 E-08 1.32E-07 NO DATA 2.37E-08 TE-131m 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 NO DATA 8.40E-05 TE-131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 NO DATA 2.79E-09 Page 113

CY-CL-170-301 Revision 26 September 2022 TABLE 4-3 ADULT INGESTION DOSE FACTORS - DFi (mrem/pCi ingested)

Page 2 of 2 ISOTOPE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU TE-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 NO DATA 7.71E-05 1-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 NO DATA 1.92E-06 1-131 4.16E-06 5.95E-06 3.41 E-06 1.95E-03 1.02E-05 NO DATA 1.57E-06 1-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 1-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31 E-06 NO DATA 2.22E-06 1-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 NO DATA 2.51E-10 1-135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 NO DATA 1.31 E-06 CS-134 6.22E-05 1.48E-04 1.21 E-04 NO DATA 4.79E-05 1.59E-05 2.59E-06 CS-136 6.51E-06 2.57E-05 1.85E-05 NO DATA 1.43E-05 1.96E-06 2.92E-06 CS-137 7.97E-05 1.09E-04 7.14E-05 NO DATA 3.?0E-05 1.23E-05 2.11 E-06 CS-138 5.52E-08 1.09E-07 5.40E-08 NO DATA 8.01E-08 7.91E-09 4.65E-13 BA-139 9.?0E-08 6.91 E-11 2.84E-09 NO DATA 6.46E-11 3.92E-11 1.72E-07 BA-140 2.03E-05 2.55E-08 1.33E-06 NO DATA 8.67E-09 1.46E-08 4.18E-05 BA-141 4.71E-08 3.56E-11 1.59E-09 NO DATA 3.31E-11 2.02E-11 2.22E-17 BA-142 2.13E-08 2.19E-11 1.34E-09 NO DATA 1.85E-11 1.24E-11 3.00E-26 LA-140 2.50E-09 1.26E-09 3.33E-10 NO DATA NO DATA NO DATA' 9.25E-05 LA-142 1.28E-10 5.82E-11 1.45E-11 NO DATA NO DATA NO DATA 4.25E-07 CE-141 9.36E-09 6.33E-09 7.18E-10 NO DATA 2.94E-09 NO DATA 2.42E-05 CE-143 1.65E-09 1.22E-06 1.35E-10 NO DATA 5.37E-10 NO DATA 4.56E-05 CE-144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1.65E-04 PR-143 9.20E-09 3.69E-09 4.56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 PR-144 3.01E-11 1.25E-11 1.53E-12 NO DATA 7.05E-12 NO DATA 4.33E-18 ND-147 6.29E-09 7.27E-09 4.35E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 W-187 1.03E-07 8.61E-08 3.01E-08 NO DATA NO DATA NO DATA 2.82E-05 NP-239 1.19E-09 1.17E-10 6.45E-11 NO DATA 3.65E-10, NO DATA 2.40E-05 Less than 1.00E-24 Page 114

5.0 RADIOACTIVE GASEOUS EFFLUENTS 5.1

. INTRODUCTION CY-CL-170-301 Revision 26 September 2022 Gaseous effluents from CPS are released on both a batch and continuous basis.

Gaseous effluents are normally discharged on a long-term basis. High volume Continuous Containment Purge and mechanical vacuum pump discharge may be considered short-term releases.

There are two gaseous effluent release points to the environment: the Common Station HVAC Stack and the Standby Gas Treatment System (SGTS) Stack. The height of these stacks is such that all gaseous effluents are treated as mixed-mode releases. The SGTS is an Engineered Safety Feature filter system utilized following an accident to reduce iodine and particulate activity in gases leaking from the primary containment and which are potentially present in the secondary containment. The Common Station HVAC Stack ("HVAC Stack") receives process and ventilation exhaust from the following inputs:

a.

Continuous Containment Purge (CCP)

b.

Containment Building Ventilation

c.

Turbine Building Ventilation

d.

Radwaste Building Ventilation

e.

Auxiliary Building Ventilation

f.

Fuel Building Ventilation

g.

Auxiliary Building Refrigerant Purge

h.

Laboratory Ventilation System

i.

Counting/Equipment Decon Rooms Ventilation

j.

Steam Packing Exhauster

k.

Mechanical Vacuum Pump I.

Drywell Purge The effluent exiting the SGTS stack is monitored at the SGTS stack and the combined inputs to the HVAC stack are monitored at the HVAC stack. All inputs to the HVAC Stack, with the exception of input numbers g through j, can be monitored prior to entering the stack.

Page 115

CY-CL-170-301 Revision 26 September 2022 FIGURE 5-1 delineates the CPS site boundary for implementation of gaseous effluent 1 0CFR20 and 1 0CFRS0, Appendix I Release Rate Limits.

Page 116

CY-CL-170-301 Revision 26 September 2022 5.2 TECHNICAL SPECIFICATION RELEASE RATE LIMITS The Operation and Surveillance Requirements concerning Technical Specification Release Rate Limits are specified in Part I RECS Section 3/4.4.1. Dose Rate calculations for ensuring compliance with these limits are discussed in Sections 5.3 and 5.4, below.

5.3 DOSE RATE DUE TO NOBLE GASES In order to comply with Part I RECS Section 3.4.1.1.(a), the dose rate at or beyond the site boundary due to noble gases shall be calculated as follows:

Dt

=

LiKi

shf

Lv[(X/O)vr*Oiv]

(5-1)

=

total body dose rate at time of release, mrem/year Ds

=

Li shf * (Li + 1.1 Mi)* Lv [(X/O)vr*Oiv]

(5-2)

=

skin dose rate at time of release, mrem/year The terms in the above equations are defined in section 5.4.

5.4 DOSE RATE DUE TO RADIOIODINES, PARTICULATES AND TRITIUM In order to comply with Part I RECS Section 3.4.1.1 (b), organ dose rates due to radioiodines (1-131, 1-133), particulates with half-lives> 8 days and tritium shall be calculated as follows:

Dj

=

L[Pij

Oivm * (X/O)v]

(5-3)

=

organ dose rate at time of release, mrem/yr The terms used in equations (5-1) through (5-3) are defined as follows:

Ki

=

The total body dose factor due to gamma emissions for each identified noble gas radionuclide i, mrem/yr per µCi/m3 from TABLE 5-1 Li

=

The skin dose factor due to beta emissions for each identified noble gas radionuclide i, mrem/yr per µCi/m3 from TABLE 5-1 Mi

=

The air dose factor due to gamma emissions for each identified noble gas radionuclide i, mrad/yr per µCi/m3 (1.1 mrem/mrad converts air dose to skin dose) from TABLE 5-1 Shf

=

Noble gas shielding factor, which is set to 1 Pij

=

The dose factor for non-noble gas radionuclide i and organ j which includes pathway transport parameters, receptor usage factors and the dosimetry of the exposure. The dose factors for the inhalation, mrem/yr per µCi/m3, pathway are listed in TABLE 5-2 (CHILD).

Page 117

CY-CL-170-301 Revision 26 September 2022

Dose factors are based on NUREG-0133, Section 5.2.1.1 assumptions unless otherwise stated.

Oiv

=

The release rate of noble gas radionuclide i in gaseous effluent from mixed-mode release points, µCi/sec Oivm =

The release rate of non-noble gas radionuclide i in gaseous effluent from mixed-mode release points, µCi/sec (X/Q)vr =

The highest value of the annual atmospheric dispersion factor from release point vat the site boundary, for all sectors, (sec/m3).

(X/Q)v =

The highest calculated average relative concentration (X/Q) for any area at or beyond the site boundary from mixed-mode release point 3

v, sec/m.

Dj is calculated for each of six organs and the total body; the maximum Dj value is then used to determine compliance with Part I RECS Section 3.4.1.1 (b).

The factors Ki, Li, and Mi relate the radionuclide airborne concentrations to various dose rates assuming a semi-infinite cloud. These factors are listed in TABLE 5-1 and were obtained from Table B-1 of Regulatory Guide 1.109 after multiplying the values by the conversion 106 pCi/µCi.

10CFR20 organ dose rate calculations are limited to the inhalation pathway only.

Part I RECS Section 3.4.1.1 (a) is applicable to the unrestricted area location characterized by the (X/O)v value that results in the maximum total body or skin dose commitment. Should the total body and skin locations differ, the selected location shall be that which minimizes allowable release rates.

There are unrestricted areas within the CPS site boundary that are utilized by members of the public for residences, farming, recreation and camping. These areas are identified in TABLE 5-3. TABLE 5-3 will be revised to remain consistent with the most recent land use census.

Page 118

TABLE 5-1 DOSE FACTORS FOR NOBLE GASES AND DAUGHTERS*

Radionuclide Total Body Dose Factor, Skin Dose Factor, Li Gamma Air Dose Factor, Ki Mi (mrem/yr per µCitm3)

(mrem/yr per µCitm3)

(mrad/yr per µCitm3)

Kr-85m 1.17E+03 1.46E+03 1.23E+03 Kr-85 1.61 E+01 1.34E+03 1.72E+01 Kr-87 5.92E+03 9.73E+03 6.17E+03 Kr-88 1.47E+04 2.37E+03 1.52E+04 Kr-89 1.66E+04 1.01E+04 1.73E+04 Kr-90 1.56E+04 7.29E+03 1.63E+04 Xe-131 m 9.15E+01 4.76E+02 1.56E+02 Xe-133m 2.51E+02 9.94E+02 3.27E+02 Xe-133 2.94E+02 3.06E+02 3.53E+02 Xe-135m 3.12E+03 7.11 E+02 3.36E+03 Xe-135 1.81E+03 1.86E+03 1.92E+03 Xe-137 1.42E+03 1.22E+04 1.51E+03 Xe-138 8.83E+03 4.13E+03 9.21E+03 Ar-41 8.84E+03 2.69E+03 9.30E+03 The listed dose factors are for radionuclides that may be detected in gaseous effluents.

Page 119 CY-CL-170-301 Revision 26 September 2022 Beta Air Dose Factor, Ni (mrad/yr per µCitm3) 1.97E+03 1.95E+03 1.03E+04 2.93E+03 1.06E+04 7.83E+03 1.11E+03 1.48E+03 1.05E+03 7.39E+02 2.46E+03 1.27E+04 4.75E+03 3.28E+03

ORGAN ISOTOPE H-3 P-32 CR-51 MN-54 FE-55 FE-59 CO-58 CO-60 Nl-63 ZN-65 RB-86 SR-89 SR-90 Y-90 Y-91 ZR-95 NB-95 MO-99 TC-99m RU-103 RU-106 AG-110m TE-125m TE-127m TE-129m 1-130 1-131 1-132 1-133 1-134 1-135 CS-134 CS-136 CS-137 BA-140 CE-141 CE-144 PR-143 ND-147 C-14 TABLE 5-2 CY-CL-170-301 Revision 26 September 2022 INHALATION PATHWAY DOSE RATE FACTORS (CHILD) - Pu (mrem/yr per µCi/m3)

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU NO DATA 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 2.60E+06 1.14E+05 9.88E+04 NO DATA NO DATA NO DATA 4.22E+04 NO DATA NO DATA 1.54E+02 8.55E+01 2.43+01 1.70E+04 1.08E+03 NO DATA 4.29E+04 9.51E+03 NO DATA 1.00E+04 1.58E+06 2.29E+04 4.74E+04 2.52E+04 7.77E+03 NO DATA NO DATA 1.11E+05 2.87E+03 2.07E+04 3.34E+04 1.67E+04 NO DATA NO DATA 1.27E+06 7.07E+04 NO DATA 1.77E+03 3.16E+03 NO DATA NO DATA 1.11E+06 3.44E+04 NO DATA 1.31E+04 2.26E+04 NO DATA NO DATA 7.07E+06 9.62E+04 8.21E+05 4.63E+04 2.80E+04 NO DATA NO DATA 2.75E+05 6.33E+03 4.26E+04 1.13E+05 7.03E+04 NO DATA 7.14E+04 9.95E+05 1.63E+04 NO DATA 1.98E+05

. 1.14E+05 NO DATA NO DATA NO DATA 7.99E+03 5.99E+05 NO DATA 1.72E+04 NO DATA NO DATA 2.16E+06 1.67E+05 1.01E+08 NO DATA 6.49E+06 NO DATA NO DATA 1.48E+07 3.43E+05 4.11 E+03 NO DATA 1.11E+02 NODATA NO DATA 2.62E+05 2.68E+05 9.14E+05 NO DATA 2.44E+04 NO DATA NO DATA 2.63+06 1.84E+05 1.90E+05 4.18E+04 3.70E+04 NO DATA 5.96E+04 2.23E+06 6.11E+04 2.35E+04 9.18E+03 6.55E+03 NO DATA 8.62E+03 6.14E+05 3.70E+04 NO DATA 1.72E+02 4.26E+01 NO DATA 3.92E+02 1.35E+05 1.27E+05 1.78E-03 3.48E-03 5.77E-02 NO DATA 5.07E-02 9.51E+02 4.81E+03 2.79E+03 NO DATA 1.07E+03 NO DATA 7.03E+03 6.62E+05 4.48E+04 1.36E+05 NO DATA 1.69E+04 NO DATA 1.84E+05 1.43E+07 4.29E+05 1.69E+04 1.14E+04 9.14E+03 NO DATA 2.12E+04 5.48E+06 1.00E+05 6.73E+04 2.33E+03 9.14E+02 1.92E+03 NO DATA 4.77E+05 3.38E+04 2.49E+04 8.56E+03 3.03E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+04 NO DATA 5.11E+03 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 NO DATA 2.84E+03 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+03 NO DATA 3.20E+03 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 NO DATA 5.48E+03 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 NO DATA 9.55E+02 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 NO DATA 4.44E+03 6.51E+05 1.01E+06 2.25E+05 NO DATA 3.30E+05 1.21E+05 3.84E+03 6.51E+04 1.71E+05 1.16E+05 NO DATA 9.55E+04 1.45E+04 4.18E+03 9.07E+05 8.25E+05 1.28E+05 NO DATA 2.82E+05 1.04E+05 3.62E+03 7.40E+04 6.48E+01 4.33E+03 NO DATA 2.11 E+01 1.74E+06 1.02E+05 3.92E+04 1.95E+04 2.90E+03 NO DATA 8.55E+03 5.44E+05 5.66E+04 6.77E+06 2.12E+06 3.62E+05 NO DATA 1.17E+06 1.20E+07 3.89E+05 1.85E+04 5.55E+03 9.14E+02 NO DATA 3.00E+03 4.33E+05 9.73E+04 1.08E+04 8.73E+03 6.81E+02 NO DATA 4.81E+03 3.28E+05 8.21E+04 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 Page 120

TABLE 5-3 CY-CL-170-301 Revision 26 September 2022 LOCATION OF MEMBERS OF THE PUBLIC WITHIN THE CPS SITE BOUNDARY AND THEIR ASSOCIATED OCCUPANCY FACTORS*

Location Distance (mile/meter)

Road 0.3/495 Agricultural Acreage(2>

0.9/1372 Clinton Lake 0.2/335 Department of Conservation Recreation 0.8/1287 Area Residence 0.8/1219 Residence 1.5/2414 Residence 1.7/2736 (1) Assumes travel on road for forty minutes per day.

(2) Maximum farm acreage (276) within site boundary.

(3) Assumes 3.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months in field per acre farmed.

Sector Occupancy (hrs/yr)

SE 243(1)

SSW 955(3)

NW 2208(4)

ESE 2208(5)

SW 8760 WSW 8760 SSE 8760 (4) Assumes continuous occupation on Clinton Lake for the months of June, July, and August.

(5) Assumes continuous occupation on Department of Conservation camping areas for the months of June, July, and August.

Doses for such MEMBERS OF THE PUBLIC are provided in the Radioactive Effluent Release Report as given in Part I RECS Section 5.4.

Page 121

5.5 1 0CFR50, APPENDIX I RELEASE RATE LIMITS CY-CL-170-301 Revision 26 September 2022 The Operation and Surveillance Requirements concerning 1 0CFR50 (Appendix I)

Release Rate Limits are specified in Part I RECS Section 3/4.4.2 and 3/4.4.3. Dose calculations for ensuring compliance with these limits are discussed in Sections 5.5.1 and 5.5.2 below.

5.5.1 Noble Gas Air Dose Equations The air dose at or beyond the site boundary (see Figure 5-1) due to noble gases released in gaseous effluent will be determined using the following equations.

During any calendar quarter or calendar year, for gamma radiation:

Dy= 3.1 ?E-08

Li[ Mi* (X/O)v

Oiv] (5-4)

During any calendar quarter or calendar year, for beta radiation:

D!3 = 3.1 ?E-08

Lj[Ni * (X/Q)v

Oiv] (5-5)

Where:

Mi

=

The gamma air dose factor for each identified noble gas radionuclide i, mrad/year per µCi/m3 (Mi values are listed in TABLE 5-1).

Ni

=

The beta air dose factor for each identified noble gas radionuclide i, mrad/year per µCi/m3 (Ni values are listed in TABLE 5-1).

(X/Q)v =

The highest calculated average relative concentration from mixed-mode release points for areas at or beyond the site boundary, sec/m3.

Oiv

=

The total release of noble gas radionuclide i for long-term releases from mixed-mode release points, µCi. Releases shall be cumulative over the calendar quarter or year, as appropriate.

3.1 ?E-08 =

The inverse of the number of seconds in a year.

Part I RECS Section 3.4.2 noble gas dose calculations are evaluated at the site boundary location where maximum air doses prevail. Should the beta and gamma locations differ, the selected location shall be that which minimizes allowable release rates due to the gamma component.

Page 122

5.5.2 Radioiodines, Particulates and Tritium Dose Equations CY-CL-170-301 Revision 26 September 2022 The dose to an individual at or beyond the site boundary due to radioiodines (1-131, 1-133), tritium and particulates with half-lives> 8 days, will be determined using the following equation:

For any calendar quarter or calendar year, Dj = 3.1 ?E-08

fo

Li[RPija

Wpv

Oiv]

(5-6)

Where:

Oiv

=

The releases of radionuclide i (1-131, 1-133, tritium and particulates with half-lives greater than 8 days) for releases from vent v for mixed-mode releases, µCi. Releases shall be cumulative over the calendar quarter or year, as appropriate.

Wpv

=

The annual average dispersion parameter for estimating the dose to an individual as appropriate to pathway p and release point v, at a controlling location, for mixed-mode releases.

=

(X/O)m, sec/m3, for the inhalation pathway at the location of the critical receptor.

=

(D/O}m, m-2, for the food and ground plane pathways at the location of the critical receptor.

3.17E-08 =

The inverse of the number of seconds in a year.

RPiia

=

The dose factor for each identified radionuclide i, pathway (p), organ G), and age group (a), m2-mrem/year per µCi/sec or mrem/year per µCi/m3*

fo

=

Occupancy factor which is set to 1 Part I RECS Section 3.4.3 is applicable to the location at or beyond the site boundary where the combination of existing pathways and receptor age groups indicates the maximum potential exposure. The inhalation and ground plane exposure pathways exist at all locations; other pathways exist as determined by the most current land use census.

The dose to an individual at or beyond the site boundary due to Carbon-14 is calculated in accordance with the instructions of CY-AA-170-2300, "Determination Of Carbon-14 In Gaseous Effluents".

5.5.2.1 Dose* Factor For Radionuclide i (RPija)

The RPiia values used to calculate Dj in equation (5-6) are determined separately for each of the potential exposure pathways, namely:

Page 123

a.

Inhalation (I)

CY-CL-170-301 Revision 26 September 2022

b.

Ground Plane Contamination (G)

c.

Grass-Cow/Goat-Milk (C)

d.

Grass-Cow-Meat (M)

e.

Vegetation (V)

The RPiia parameter is independent of the duration of gaseous releases and is calculated using the methodology discussed in the remainder of this section.

(a)Calculation of the Inhalation Pathway Factor, R1ua R1ija = K'(BR)8(DFAii)a, mrem/year per µCi/m3 (5-7)

Where:

K'

=

(BR)a =

=

A units conversion constant, 106 pCi/µCi The breathing rate of the receptor age group (a), m3/year 1400 (infant) 3700 (child) 8000 (teen and adult)

Values for (BR)a are obtained from NUREG-0133, pg. 32 (DFAii)a

=

The organ inhalation dose factor for receptor of age group (a) for radionuclide i, and organ j, mrem/pCi. Values for (DFAij)a were obtained from Tables E-7 through E-10 of Regulatory Guide 1.109 and are presented in TABLE 5-4 through TABLE 5-7 of this manual.

(b)Calculation of the Ground Plane Pathway Factor, RGllii R8 iia =K'K (SF)(DFGij)[(1-e*"i1)/J\j], m2-mrem/year per µCi/sec (5-8)

Where:

K'.

K" SF DFGii

=

A units conversion constant, 106 pCi/µCi A units conversion constant, 8760 hour/year The shielding factor, dimensionless 0.7 as suggested in Table E-15 of Regulatory Guide 1.109 The ground plane dose conversion factor for radionuclide i, mrem/hour per pCi/m2* Values for DFGij were obtained from Table E-6 of Regulatory Guide 1.109 and are presented in TABLE 5-8 of this manual.

Page 124

Ai

=

The decay constant for radionuclide i, sec-1 t

=

The exposure time, sec

=

6.31 E+0B sec (20 years)

CY-CL-170-301 Revision 26 September 2022 (c)Calculation of the Grass-Cow/Goat-Milk Pathway Factor, Rei.@

Where:

K'

=

QF

=

Uap

=

VP

=

Ys

=

Fmi

=

r

=

Ai

=

Aw

=

tf

=

th

=

fp

=

fs

=

(5-9)

A units conversion constant, 106 pCi/µCi The cow/goat feed consumption rate, kg(wet)/day The receptor's milk consumption rate for age group (a),

liters/year The agricultural productivity by unit area of pasture feed grass, kg/m2 The agricultural productivity by unit area of stored feed, kg/m2 The stable element transfer coefficient for nuclide i in milk, days/liter. These values are from Tables E-1 and E-2 of Regulatory Guide 1.109.

Fraction of deposited activity retained on feed grass, dimensionless The organ ingestion dose factor for radionuclide i and the receptor in age group (a), mrem/pCi. Values for (DFLij)a were obtained from Tables E-11 through E-14 of Regulatory Guide 1.109 and are presented in TABLE 5-9 through TABLE 5-12 of this manual.

The decay constant for radionuclide i, sec01 The decay constant for removal of activity on leaf and plant surfaces by weathering, sec-1 5.73E-07 sec-1 (corresponding to a 14-day half-life)

The transport time from pasture to animal, to milk, to receptor, sec The transport time from pasture to harvest, to animal, sec Fraction of the year that the cow/goat is on pasture, dimension less Fraction of the cow/goat feed that is pasture grass while the cow/goat is on pasture, dimensionless Page 125

CY-CL-170-301 Revision 26 September 2022 The input parameters for calculating Rciia are listed in TABLE 5-13.

Tritium The concentration of tritium in milk is based on its airborne concentration rather than the deposition.

(5-10)

Where:

K"

=

A units conversion constant, 103 gm/kg H

=

The absolute atmospheric humidity

=

8 gm/m3 (NUREG-0133, p. 34) 0.75

=

The fraction of total feed that is water, dimensionless 0.5

=

The ratio of the specific activity of the feed grass water to the atmospheric water, dimensionless The other parameters are as defined in the calculation of Rciia Carbon-14 The concentration of carbon-14 in milk is based on its airborne concentration rather than the deposition.

RC c-14 = K' K" p Fm QF (DFLijt [0.11/0.16] I mrem/yr per µCi/m3 (5-11)

Where:

p

=

0.11

=

0.16

=

The fractional equilibrium ration (4400 hrs/8760 hrs). The ratio of the total annual release time for (C-14) atmospheric releases to the total annual time during photosynthesis occurs (taken to be 4400 hrs), under the condition that the value of p should never exceed unity. For continuous C-14 releases, p is taken to be unity.

The fraction of total plant mass that is natural carbon, dimensionless.

The concentration of natural carbon in the atmosphere,

[gm/m3].

The other parameters are as defined in the calculation of Rcija.

Page 126

CY-CL-170-301 Revision 26 September 2022 (d)Calculation of the Grass-Cow-Meat Pathway Factor, RMli§.

RM ija = [K'Qr(Uap)]Fr(r)(DFLijt. [fpfs + (l-fpf,)(e-J.;th) l. e(-,l;t,)' m2-mrem/yr per ~Ci/sec (A; + Aw)

Yp Ys J

Where:

K'

=

Uap

=

Ft

=

ts

=

th

=

(DFLii)a =

(5-12)

A units conversion constant, 106 pCi/µCi The receptor's meat consumption rate for age group (a),

kg/year The stable element transfer coefficient, days/kg The transport time from pasture to animal to slaughter of meat animal to receptor, seconds The transport time from crop field to harvest to animal, seconds The organ ingestion dose factor for radionuclide i and the receptor in age group (a), mrem per pCi. Values are tabulated in TABLE 5-9 through TABLE 5-12 of this manual.

The input parameters necessary for calculating RMiia are listed in TABLE 5-14. All other terms are as defined for equations (5-9) and (5-10).

Tritium The concentration of tritium in meat is based on its airborne concentration rather than the deposition.

RMr = K'K"FtOFUap(DFLij)a*[0.75(0.5/H)], mrem/yr per µCi/m3 The terms in equation (5-13) are as defined in equations (5-10) and (5-11 ).

Carbon-14 (5-13)

The concentration of carbon-14 in meat is based on its airborne concentration rather than the deposition.

RM c-14 = K' K" p Fm QF (DFLij) a [0.11/0.16]' mrem/yr per µCi/m3 (5-14)

The terms in equation (5-14) are as defined in equation (5-10), and (5-11 ).

Page 127

CY-CL-170-301 Revision 26 September 2022 (e)Calculation of the Vegetation Pathway Factor, Rvioi Rvipj =K'[.

(r)

]*(DFL;j)a *[ULa/1,(e-"11')+U 8a/g(e~A;i,,)], m2 -mrem/yrperµCi/sec (Yv(/4; + /4w))

Where:

K'

=

Ula

=

U5a =

fL

=

fg

=

tL

=

th

=

Yv

=

(DFLij)a =

(5-15)

A unit.s conversion constant, 106 pCi/µCi The consumption rate of fresh leafy vegetation by the receptor in age group (a), kg/year The consumption rate of stored vegetation by the receptor in age group (a), kg/yr The fraction of the annual intake of fresh leafy vegetation grown locally, dimensionless The fraction of the annual intake of stored vegetation grown locally, dimensionless The average time between harvest of leafy vegetation and its consumption, seconds The average time between harvest of stored vegetation and its consumption, seconds the vegetation area density, kg/m2 The organ ingestion dose factor for organ j, radionuclide I, and the receptor in age group (a}, mrem per pCi. Values are tabulated in TABLE 5-9 through TABLE 5-12 of this manual.

The input parameters necessary for calculating Rvipj are listed in TABLE 5-15. All other terms are as defined for equations (5-9) and (5-11).

Tritium The concentration of tritium in vegetation is based on its airborne concentration rather than the deposition.

RVT = K'K"(UL afL + U 8 af9)(DFLij)a [0. 75(0.5/H)], mrem/yr per µCi/m3 (5-16)

The terms in equation (5-16) are as defined in equations (5-10) and (5-11}.

Page 128

Carbon-14 CY-CL-170-301 Revision 26 September 2022 The concentration of carbon-14 in vegetation is based on its airborne concentration rather than the deposition.

Rv c-14 = K' K" p F,n QF (DFLii L [0.11/0.16], mrem/yr per uCi/m3 (5-17)

The terms in equation (5-17) are as defined in equations (5-10) and (5-11 ).

The pathway dose rate factors by age group are listed in TABLE 5-16 through TABLE 5-34.

5.6 GASEOUS EFFLUENT DOSE PROJECTION CALCULATIONS The 31 day projected dose shall be calculated using the following equation Dpi = (Di

p) + Dai (5-18)

Where:

Dpi

=

Di

=

p

=

the 31 day projected dose by organ j.

sum of dose for all valid release points for the release period (usually quarter) by organ j.

the projection factor which is the results of 31 divided by the number of days from the start of the quarter to the end of the release.

Dai

=

additional anticipated dose for gaseous release by organ j and quarter of release.

Page 129

FIGURE 5-1 CPS SITE BOUNDARY FOR GASEOUS EFFLUENTS CPS RESTRICTED AREA NOTE 1 HWY. 54 HWY. 48 NOTES CY-CL-170-301 Revision 26 September 2022 LEGEND

,..,...,..::: SITE BOUNDARY V22?ZJ UNRESTRICTED AREA j:::/:!:j:;:;:/:j SPECIAL UNRESTRICTED AREA(See Note 1)

AREA WITHIN SITE BOUNDARY NOT OWNED BY IPC

1.

The area in the lake between the buoys and the exclusion area boundary is unrestricted at this time. But will be controlled if plant effluent conditions warrant closure.

2.

Land parcel not owned by Clinton Power Station, includes residences.

3.

Land parcel not owned by Clinton Power Station, oil company pipeline pumping station.

4.

Land parcel not owned by Clinton Power Station, agricultural use.

5.

The lake shoreline is approximately 690 ft. MSL elevation line.

Page 130

CY-CL-170-301 Revision 26 September 2022 TABLE 5-4 INHALATION DOSE FACTORS FOR INFANT - (DFAi)a (mrem per pCi inhaled)

NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 C-14 1.89E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 P-32 1.45E-03 8.03E-05 5.53E-05 NO DATA NO DATA NO DATA 1.15E-05 CR-51 NO DATA NO DATA 6.39E-08 4.11 E-08 9.45E-09 9.17E-06 2.55E-07 MN-54 NO DATA 1.81E-05 3.56E-06 NO DATA 3.56E-06 7.14E-04 5.04E-06 FE-55 1.41 E-05 8.39E-06 2.38E-06 NO DATA NO DATA 6.21E-05 7.82E-07 FE-59 9.69E-06 1.68E-05 6.77E-06 NO DATA NO DATA 7.25E-04 1.77E-05 CO-58 NO DATA 8.71 E-07 1.30E-06 NO DATA NO DATA 5.55E-04 7.95E-06 CO-60 NO DATA 5.73E-06 8.41E-06 NO DATA NO DATA 3.22E-03 2.28E-05 Nl-63 2.42E-04 1.46E-05 8.29E-06 NO DATA NO DATA 1.49E-04 1.73E-06 ZN-65 1.38E-05 4.47E-05 2.22E-05 NO DATA 2.32E-05 4.62E-04 3.67E-05 RB-86 NO DATA 1.36E-04 6.30E-05 NO DATA NO DATA NO DATA 2.17E-06 SR-89 2.84E-04 NO DATA 8.15E-06 NO DATA NO DATA 1.45E-03 4.57E-05 SR-90 2.92E-02 NO DATA 1.85E-03 NO DATA NO DATA 8.03E-03 9.36E-05 Y-90 2.35E-06 NO DATA 6.30E-08 NO DATA NO DATA 1.92E-04 7.43E-05 Y-91 4.20E-04 NO DATA 1.12E-05 NO DATA NO DATA 1.75E-03 5.02E-05 ZR-95 8.24E-05 1.99E-05 1.45E-05 NO DATA 2.22E-05 1.25E-03 1.55E-05 NB-95 1.12E-05 4.59E-06 2.?0E-06 NO DATA 3.37E-06 3.42E-04 9.05E-06 MO-99 NO DATA 1.18E-07 2.31E-08 NO DATA 1.89E-07 9.63E-05 3.48E-05 TC-99m 9.98E-13 2.06E-12 2.66E-11 NO DATA 2.22E-11 5.79E-07 1.45E-06 RU-103 1.44E-06 NO DATA 4.85E-07 NO DATA 3.03E-06 3.94E-04 1.15E-05 RU-106 6.20E-05 NO DATA 7.?0E-06 NO DATA 7.61E-05 8.26E-03 1.17E-04 AG-110m 7.13E-06 5.16E-06 3.57E-06 NO DATA 7.B0E-06 2.62E-03 2.36E-05 TE-125m 3.40E-06 1.42E-06 4.?0E-07 1.16E-06 NO DATA 3.19E-04 9.22E-06 TE-127m 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 TE-129m 1.01E-05 4.35E-06 1.59E-06 3.91E-06 2.27E-05 1.20E-03 4.93E-05 1-130 4.54E-06 9.91E-06 3.98E-06 1.14E-03 1.09E-05 NO DATA 1.42E-06 1-131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.?0E-05 NO DATA 7.56E-07 1-132 1.21 E-06 2.53E-06 8.99E-07 1.21 E-04 2.82E-06 NO DATA 1.36E-06 1-133 9.46E-06 1.37E-05 4.00E-06 2.54E-03 1.60E-05 NO DATA 1.54E-06 1-134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 NO DATA 9.21E-07 1-135 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 NO DATA 1.31 E-06 CS-134 2.83E-04 5.02E-04 5.32E-05 NO DATA 1.36E-04 5.69E-05 9.53E-07 CS-136 3.45E-05 9.61E-05 3.78E-05 NO DATA 4.03E-05 8.40E-06 1.02E-06 CS-137 3.92E-04 4.37E-04 3.25E-05 NO DATA 1.23E-04 5.09E-05 9.53E-07 BA-140 4.00E-05 4.00E-08 2.0?E-06 NO DATA 9.59E-09 1.14E-03 2.74E-05 CE-141 1.98E-05 1.19E-05 1.42E-06 NO DATA 3.75E-06 3.69E-04 1.54E-05 CE-144 2.28E-03 8.65E-04 1.26E-04 NO DATA 3.84E-04 7.03E-03 1.06E-04 PR-143 1.00E-05 3.74E-06 4.99E-07 NO DATA 1.41E-06 3.09E-04 2.66E-05 ND-147 5.67E-06 5.81E-06 3.57E-07 NO DATA 2.25E-06 2.30E-04 2.23E-05 Page 131

CY -CL-170-301 Revision 26 September 2022 TABLE 5-5 INHALATION DOSE FACTORS FOR CHILD - (DFAi)a (mrem per pCi inhaled)

NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C-14 9.?E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 P-32 7.04E-04 3.09E-05 2.67E-05 NO DATA NO DATA NO DATA 1.14E-05 CR-51 NO DATA NO DATA 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07 MN-54 NO DATA 1.16E-05 2.57E-06 NO DATA 2.71E-06 4.26E-04 6.19E-06 FE-55 1.28E-05 6.80E-06 2.10E-06 NO DATA NO DATA 3.00E-05 7.75E-07 FE-59 5.59E-06 9.04E-06 4.51E-06 NO DATA NO DATA 3.43E-04 1.91 E-05 CO-58 NO DATA 4.79E-07 8.SSE-07 NO DATA NO DATA 2.99E-04 9.29E-06 CO-60 NO DATA 3.SSE-06 6.12E-06 NO DATA NO DATA 1.91E-03 2.60E-05 Nl-63 2.22E-04 1.25E-05 7.56E-06 NO DATA NO DATA 7.43E-05 1.71E-06 ZN-65 1.15E-05 3.06E-05 1.90E-05 NO DATA 1.93E-05 2.69E-04 4.41E-06 RB-86 NO DATA 5.36E-05 3.09E-05 NO DATA NO DATA NO DATA 2.16E-06 SR-89 1.62E-04 NO DATA 4.66E-06 NO DATA NO DATA 5.83E-04 4.52E-05 SR-90 2.73E-02 NO DATA 1.74E-03 NO DATA NO DATA 3.99E-03 9.28E-05 Y-90 1.11E-06 NO DATA 2.99E-08 NO DATA NO DATA 7.0?E-05 7.24E-05 Y-91 2.47E-04 NO DATA 6.59E-06 NO DATA NO DATA 7.10E-04 4.97E-05 ZR-95 5.13E-05 1.13E-05 1.00E-05 NO DATA 1.61E-05 6.03E-04 1.65E-05 NB-95 6.35E-06 2.48E-06 1.77E-06 NO DATA 2.33E-06 1.66E-04 1.00E-05 MO-99 NO DATA 4.66E-08 1.15E-08 NO DATA 1.06E-07 3.66E-05 3.42E-05 TC-99rn 4.81E-13 9.41 E-13 1.56E-11 NO DATA 1.37E-11 2.57E-07 1.30E-06 RU-103 7.SSE-07 NO DATA 2.90E-07 NO DATA 1.90E-06 1.79E-04 1.21 E-05 RU-106 3.68E-05 NO DATA 4.57E-06 NO DATA 4.97E-05 3.87E-03 1.16E-04 AG-110rn 4.56E-06 3.0BE-06 2.47E-06 NO DATA 5.74E-06 1.48E-03 2.71E-05 TE-125rn 1.82E-06 6.29E-07 2.47E-07 5.20E-07 NO DATA 1.29E-04 9.13E-06 TE-127rn 6.72E-06 2.31E-06 8.18E-07 1.64E-06 1.72E-05 4.00E-04 1.93E-05 TE-129rn 5.19E-06 1.85E-06 8.22E-07 1.71E-06 1.36E-05 4.76E-04 4.91E-05 1-130 2.21E-06 4.43E-06 2.28E-06 4.99E-04 6.61E-06 NO DATA 1.38E-06 1-131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 NO DATA 7.68E-07 1-132 5.72E-07 1.10E-06 5.0?E-07 5.23E-05 1.69E-06 NO DATA 8.65E-07 1-133 4.48E-06 5.49E-06 2.0SE-06 1.04E-03 9.13E-06 NO DATA 1.48E-06 1-134 3.17E-07 5.84E-07 2.69E-07 1.37E-05 8.92E-07 NO DATA 2.58E-07 1-135 1.33E-06 2.36E-06 1.12E-06 2.14E-04 3.62E-06 NO DATA 1.20E-06 CS-134 1.76E-04 2.74E-04 6.0?E-05 NO DATA 8.93E-05 3.27E-05 1.04E-06 CS-136 1.76E-05 4.62E-05 3.14E-05 NO DATA 2.58E-05 3.93E-06 1.13E-06 CS-137 2.45E-04 2.23E-04 3.47E-05 NO DATA 7.63E-05 2.81E-05 9.78E-07 BA-140 2.00E-05 1.75E-08 1.17E-06 NO DATA 5.71E-09 4.71E-04 2.75E-05 CE-141 1.06E-05 5.28E-06 7.83E-07 NO DATA 2.31 E-06 1.47E-04 1.53E-05 CE-144 1.83E-03 5.72E-04 9.77E-05 NO DATA 3.17E-04 3.23E-03 1.05E-04 PR-143 4.99E-06 1.S0E-06 2.47E-07 NO DATA 8.11E-07

1. 17E-04 2.63E-05 ND-147 2.92E-06 2.36E-06 1.84E-07 NO DATA 1.30E-06 8.87E-05 2.22E-05 Page 132

CY-CL-170-301 Revision 26 September 2022 TABLE 5-6 INHALATION DOSE FACTORS FOR TEEN - (DFAi)a (mrem per pCi inhaled)

NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 C-14 3.25E-06 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 P-32 2.36E-04 1.37E-05 8.95E-06 NO DATA NO DATA NO DATA 1.16E-05 CR-51 NO DATA NO DATA 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 MN-54 NO DATA 6.39E-06 1.05E-06 NO DATA 1.59E-06 2.48E-04 8.35E-06 FE-55 4.18E-06 2.98E-06 6.93E-07 NO DATA NO DATA 1.55E-05 7.99E-07 FE-59 1.99E-06 4.62E-06 1.79E-06 NO DATA NO DATA 1.91 E-04 2.23E-05 CO-58 NO DATA 2.59E-07 3.47E-07 NO DATA NO DATA 1.68E-04 1.19E-05 CO-60 NO DATA 1.89E-06 2.48E-06 NO DATA NO DATA 1.09E-03 3.24E-05 Nl-63 7.25E-05 5.43E-06 2.47E-06 NO DATA NO DATA 3.84E-05 1.77E-06 ZN-65 4.82E-06 1.67E-05 7.80E-06 NO DATA 1.08E-05 1.55E-04 5.83E-06 RB-86 NO DATA 2:38E-05 1.05E-05 NO DATA NO DATA NO DATA 2.21E-06 SR-89 5.43E-05 NO DATA 1.56E-06 NO DATA NO DATA 3.02E-04 4.64E-05 SR-90 1.35E-02 NO DATA 8.35E-04 NO DATA NO DATA 2.06E-03 9.56E-05 Y-90 3.73E-07 NO DATA 1.00E-08 NO DATA NO DATA 3.66E-05 6.99E-05 Y-91 8.26E-05 NO DATA 2.21E-06 NO DATA NO DATA 3.67E-04 5.11 E-05 ZR-95 1.82E-05 5.73E-06 3.94E-06 NO DATA 8.42E-06 3.36E-04 1.86E-05 NB-95 2.32E-06 1.29E-06 7.08E-07 NO DATA 1.25E-06 9.39E-05 1.21E-05 MO-99 NO DATA 2.11 E-08 4.03E-09 NO DATA 5.14E-08 1.92E-05 3.36E-05 TC-99m 1.73E-13 4.83E-13 6.24E-12 NO DATA 7.20E-12 1.44E-07 7.66E-07 RU-103 2.63E-07 NO DATA 1.12E-07 NO DATA 9.29E-07 9.79E-05 1.36E-05 RU-106 1.23E-05 NO DATA 1.55E-06 NO DATA 2.38E-05 2.01E-03 1.20E-04 AG-110m 1.73E-06 1.64E-06 9.99E-07 NO DATA 3.13E-06 8.44E-04 3.41 E-05 TE-125m 6.10E-07 2.80E-07 8.34E-08 1.75E-07 NO DATA 6.?0E-05 9.38E-06 TE-127m 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.0?E-04 1.99E-05 TE-129m 1.74E-06 8.23E-07 2.81E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05 1-130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 NO DATA 1.14E-06 1-131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 NO DATA 8.11 E-07 1-132 1.99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E-07 NO DATA 1.59E-07 1-133 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 NO DATA 1.29E-06 1-134 1.11 E-07 2.90E-07 1.05E-07 4.94E-06 4.58E-07 NO DATA 2.55E-09 1-135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 NO DATA 8.69E-07 CS-134 6.28E-05 1.41 E-04 6.86E-05 NO DATA 4.69E-05 1.83E-05 1.22E-06 CS-136 6.44E-06 2.42E-05 1.71 E-05 NO DATA 1.38E-05 2.22E-06 1.36E-06 CS-137 8.38E-05 1.06E-04 3.89E-05 NO DATA 3.80E-05 1.51 E-05 1.06E-06 BA-140 6.84E-06 8.38E-09 4.40E-07 NO DATA 2.85E-09 2.54E-04 2.86E-05 CE-141 3.55E-06 2.37E-06 2.71E-07 NO DATA 1.11 E-06 7.67E-05 1.58E-05 CE-144 6.11 E-04 2.53E-04 3.28E-05 NO DATA 1.51 E-04 1.67E-03 1.08E-04 PR-143 1.67E-06 6.64E-07 8.28E-08 NO DATA 3.86E-07 6.04E-05 2.67E-05 ND-147 9.83E-07 1.0?E-06 6.41 E-08 NO DATA 6.28E-07 4.65E-05 2.28E-05 Page 133

CY-CL-170-301 Revision 26 September 2022 TABLE 5-7 INHALATION DOSE FACTORS FOR ADULT - (DFAi)a (mrem per pCi inhaled)

NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 C-14 2.27E-06 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 P-32 1.65E-04 9.64E-06 6.26E-06 NO DATA NO DATA NO DATA 1.0SE-05 CR-51 NO DATA NO DATA 1.25E-08 7.44E-09 2.85E-09 1.B0E-06 4.15E-07 MN-54 NO DATA 4.95E-06 7.87E-07 NO DATA 1.23E-06 1.75E-04 9.67E-06 FE-55 3.07E-06 2.12E-06 4.93E-07 NO DATA NO DATA 9.01E-06 7.54E-07 FE-59 1.47E-06 3.47E-06 1.32E-06 NO DATA NO DATA 1.27E-04 2.35E-05 CO-58 NO DATA 1.98E-07 2.59E-07 NO DATA NO DATA 1.16E-04 1.33E-05 CO-60 NO DATA 1.44E-06 1.85E-06 NO DATA NO DATA 7.46E-04 3.56E-05 Nl-63 5.40E-05 3.93E-06 1.81E-06 NO DATA NO DATA 2.23E-05 1.67E-06 ZN-65 4.05E-06 1.29E-05 5.82E-06 NO DATA 8.62E-06 1.0SE-04 6.68E-06 RB-86 NO DATA 1.69E-05 7.37E-06 NO DATA NO DATA NO DATA 2.0BE-06 SR-89 3.B0E-05 NO DATA 1.09E-06 NO DATA NO DATA 1.75E-04 4.37E-05 SR-90 1.24E-02 NO DATA 7.62E-04 NO DATA NO DATA 1.20E-03 9.02E-05 Y-90 2.61E-07 NO DATA 7.01 E-09 NO DATA NO DATA 2.12E-05 6.32E-05 Y-91 5.78E-05 NO DATA 1.55E-06 NO DATA NO DATA 2.13E-04 4.81E-05 ZR-95 1.34E-05 4.30E-06 2.91E-06 NO DATA 6.77E-06 2.21E-04 1.88E-05 NB-95 1.76E-06 9.77E-07 5.26E-07 NO DATA 9.67E-07 6.31E-05 1.30E-05 MO-99 NO DATA 1.51E-08 2.87E-09 NO DATA 3.64E-08 1.14E-05 3.10E-05 TC-99m 1.29E-13 3.64E-13 4.63E-12 NO DATA 5.52E-12 9.55E-08 5.20E-07 RU-103 1.91E-07 NO DATA 8.23E-08 NO DATA 7.29E-07 6.31 E-05 1.38E-05 RU-106 8.64E-06 NO DATA 1.09E-06 NO DATA 1.67E-05 1.17E-03 1.14E-04 AG-110m 1.35E-06 1.25E-06 7.43E-07 NO DATA 2.46E-06 5.79E-04 3.78E-05 TE-125m 4.27E-07 1.98E-07 5.84E-08 1.31E-07 1.55E-06 3.92E-05 8.83E-06 TE-127m 1.58E-06 7.21E-07 1.96E-07 4.11E-07 5.72E-06 1.20E-04 1.87E-05 TE-129m 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05 1-130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61E-06 NO DATA 9.61E-07 1-131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.66E-06 NO DATA 7.85E-07 1-132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E-07 NO DATA 5.0BE-08 1-133 1.0SE-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 NO DATA 1.11E-06 1-134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3.44E-07 NO DATA 1.26E-10 1-135 3.35E-07 8.73E-07 3.21E-07 5.60E-05 1.39E-06 NO DATA 6.56E-07 CS-134 4.66E-05 1.06E-04 9.10E-05 NO DATA 3.59E-05 1.22E-05 1.30E-06 CS-136 4.88E-06 1.83E-05 1.38E-05 NO DATA 1.07E-05 1.50E-06 1.46E-06 CS-137 5.98E-05 7.76E-05 5.35E-05 NO DATA 2.78E-05 9.40E-06 1.05E-06 BA-140 4.BBE-06 6.13E-09 3.21E-07 NO DATA 2.09E-09 1.59E-04 2.73E-05 CE-141 2.49E-06 1.69E-06 1.91E-07 NO DATA 7.83E-07 4.52E-05 1.50E-05 CE-144 4.29E-04 1.79E-04 2.30E-05 NO DATA 1.06E-04 9.72E-04 1.02E-04 PR-143 1.17E-06 4.69E-07 5.B0E-08 NO DATA 2.70E-07 3.51E-05 2.50E-05 ND-147 6.59E-07 7.62E-07 4.56E-08 NO DATA 4.45E-07 2.76E-05 2.16E-05 Page 134

TABLE 5-8 GROUND PLANE DOSE FACTORS - DFGi (mrem/hr per µCi/m2)

ELEMENT TOTAL BODY SKIN H-3 0.0 0.0 C-14 0.0 0.0 P-32 0.0 0.0 Cr-51 2.20E-10 2.60E-10 Mn-54 5.80E-09 6.80E-09 Fe-55 0.0 0.0 Fe-59 8.00E-09 9.40E-09 Co-58 7.00E-09 8.20E-09 Co-60 1.70E-08 2.00E-08 Ni-63 0.0 0.0 Zn-65 4.00E-09 4.60E-09 Rb-86 6.30E-10 7.20E-10 Sr-89 5.60E-13 6.50E-13 Y-90 2.20E-12 2.60E-12 Y-91 2.40E-11 2.70E-11 Zr-95 5.00E-09 5.80E-09 Nb-95 5.10E-09 6.00E-09 Mo-99 1.90E-09 2.20E-09 Tc-99m 9.60E-10 1.10E-09 Ru-103 3.60E-09 4.20E-09 Ru-106 1.50E-09 1.80E-09 Ag-110m 1.80E-08 2.10E-08 Te-125m 3.50E-11 4.80E-11 Te-127m 1.10E-12 1.30E-12 Te-129m 7.70E-10 9.00E-10 1-130 1.40E-08 1.70E-08 1-131 2.80E-09 3.40E-09 1-132 1.70E-08 2.00E-08 1-133 3.70E-09 4.50E-09 1-134 1.60E-08 1.90E-08 1-135 1.20E-08 1.40E-08 Cs-134 1.20E-08 1.40E-08 Cs-136 1.50E-08 1.70E-08 Cs-137 4.20E-09 4.90E-09 Ba-140 2.1 0E-09 2.40E-09 Ce-141 5.50E-1 0 6.20E-10 Ce-144 3.20E-10 3.70E-10 Pr-143 0.0 0.0 Nd-147 1.00E-09 1.20E-09 C-14 0.0 0.0 Page 135 CY-CL-170-301 Revision 26 September 2022

CY-CL-170-301 Revision 26 September 2022 TABLE 5-9 INGESTION DOSE FACTORS FOR INFANT - (DFLi)a (mrem per pCi ingested)

NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU H-3 NO DATA 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 C-14 2.37E-05 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 P-32 1.?0E-03 1.00E-04 6.59E-05 NO DATA NO DATA NO DATA 2.30E-05 CR-51 NO DATA NO DATA 1.41 E-08 9.20E-09 2.01E-09 1.79E-08 4.11E-07 MN-54 NO DATA 1.99E-05 4.51E-06 NO DATA 4.41E-06 NO DATA 7.31 E-06 FE-55 1.39E-05 8.98E-06 2.40E-06 NO DATA NO DATA 4.39E-06 1.14E-06 FE-59 3.0SE-05 5.38E-05 2.12E-05 NO DATA NO DATA 1.59E-05 2.57E-05 CO-58 NO DATA 3.60E-06 8.98E-06 NO DATA NO DATA NO DATA 8.97E-06 CO-60 NO DATA 1.0BE-05 2.55E-05 NO DATA NO DATA NO DATA 2.57E-05 Nl-63 6.34E-04 3.92E-05 2.20E-05 NO DATA NO DATA NO DATA 1.95E-06 ZN-65 1.84E-05 6.31E-05 2.91E-05 NO DATA 3.06E-05 NO DATA 5.33E-05 RB-86 NO DATA 1.?0E-04 8.40E-05 NO DATA NO DATA NO DATA 4.34E-06 SR-89 2.51 E-03 NO DATA 7.20E-05 NO DATA NO DATA NO DATA 5.16E-05 SR-90 1.85E-02 NO DATA 4.71E-03 NO DATA NO DATA NO DATA 2.31E-04 Y-90 8.69E-08 NO DATA 2.33E-09 NO DATA NO DATA NO DATA 1.20E-04 Y-91 1.13E-06 NO DATA 3.01E-08 NO DATA NO DATA NO DATA 8.10E-05 ZR-95 2.06E-07 5.02E-08 3.56E-08 NO DATA 5.41E-08 NO DATA 2.50E-05 NB-95 4.20E-08 1.73E-08 1.00E-08 NO DATA 1.24E-08 NO DATA 1.46E-05 MO-99 NO DATA 3.40E-05 6.63E-06 NO DATA 5.0SE-05 NO DATA 1.12E-05 TC-99m 1.92E-09 3.96E-09 5.10E-08 NO DATA 4.26E-08 2.0?E-09 1.15E-06 RU-103 1.48E-06 NO DATA 4.95E-07 NO DATA 3.0SE-06 NO DATA 1.B0E-05 RU-106 2.41E-05 NO DATA 3.01E-06 NO DATA 2.85E-05 NO DATA 1.83E-04 AG-110m 9.96E-07 7.27E-07 4.81E-07 NO DATA 1.04E-06 NO DATA 3.77E-05 TE-125m 2.33E-05 7.79E-06 3.15E-06 7.84E-06 NO DATA NO DATA 1.11 E-05 TE-127m 5.85E-05 1.94E-05 7.0BE-06 1.69E-05 1.44E-04 NO DATA 2.36E-05 TE-129m 1.00E-04 3.43E-05 1.54E-05 3.84E-05 2.S0E-04 NO DATA 5.97E-05 1-130 6.00E-06 1.32E-05 5.30E-06 1.48E-03 1.45E-05 NO DATA 2.83E-06 1-131 3.59E-05 4.23E-05 1.86E-05 1.39E-02 4.94E-05 NO DATA 1.51E-06 1-132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-06 NO DATA 2.73E-06 1-133 1.25E-05 1.82E-05 5.33E-06 3.31E-03 2.14E-05 NO DATA 3.0BE-06 1-134 8.69E-07 1.78E-06 6.33E-07 4.15E-05 1.99E-06 NO DATA 1.84E-06 1-135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.0?E-06 NO DATA 2.62E-06 CS-134 3.77E-04 7.03E-04 7.10E-05 NO DATA 1.81E-04 7.42E-05 1.91E-06 CS-136 4.59E-05 1.35E-04 5.04E-05 NO DATA 5.38E-05 1.10E-05 2.05E-06 CS-137 5.22E-04 6.11E-04 4.33E-05 NO DATA 1.64E-04 6.64E-05 1.91E-06 BA-140 1.71E-04

1. 71 E-07 8.81E-06 NO DATA 4.06E-08 1.05E-07 4.20E-05 CE-141 7.87E-08 4.B0E-08 5.65E-09 NO DATA 1.48E-08 NO DATA 2.48E-05 CE-144 2.98E-06 1.22E-06 1.67E-07 NO DATA 4.93E-07 NO DATA 1.71E-04 PR-143 8.13E-08 3.04E-08 4.03E-09 NO DATA 1.13E-08 NO DATA 4.29E-05 ND-147 5.53E-08 5.68E-08 3.48E-09 NO DATA 2.19E-08 NO DATA 3.60E-05 Page 136

CY-CL-170-301 Revision 26 September 2022 TABLE 5-10 INGESTION DOSE FACTORS FOR CHILD - (DFLi)a (mrem per pCi ingested)

NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI H-3 NO DATA 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 C-14 1.21E-05 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 P-32 8.25E-04 3.86E-05 3.18E-05 NO DATA NO DATA NO DATA 2.28E-05 CR-51 NO DATA NO DATA 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07 MN-54 NO DATA 1.0?E-05 2.85E-06 NO DATA 3.00E-06 NO DATA 8.98E-06 FE-55 1.15E-05 6.10E-06 1.89E-06 NO DATA NO DATA 3.45E-06 1.13E-06 FE-59 1.65E-05 2.67E-05 1.33E-05 NO DATA NO DATA 7.74E-06 2.78E-05 CO-58 NO DATA 1.B0E-06 5.51E-06 NO DATA NO DATA NO DATA 1.05E-05 CO-60 NO DATA 5.29E-06 1.56E-05 NO DATA NO DATA NO DATA 2.93E-05 Nl-63 5.38E-04 2.88E-05 1.83E-05 NO DATA NO DATA NO DATA 1.94E-06 ZN-65 1.37E-05 3.65E-05 2.27E-05 NO DATA 2.30E-05 NO DATA 6.41E-06 RB-86 NO DATA 6.?0E-05 4.12E-05 NO DATA NO DATA NO DATA 4.31E-06 SR-89 1.32E-03 NO DATA 3.77E-05 NO DATA NO DATA NO DATA 5.11E-05 SR-90 1.?0E-02 NO DATA 4.31E-03 NO DATA NO DATA NO DATA 2.29E-04 Y-90 4.11E-08 NO DATA 1.10E-09 NO DATA NO DATA NO DATA 1.17E-04 Y-91 6.02E-07 NO DATA 1.61E-08 NO DATA NO DATA NO DATA 8.02E-05 ZR-95 1.16E-07 2.55E-08 2.27E-08 NO DATA 3.65E-08 NO DATA 2.66E-05 NB-95 2.25E-08 8.76E-09 6.26E-09 NO DATA 8.23E-09 NO DATA 1.62E-05 MO-99 NO DATA 1.33E-05 3.29E-06 NO DATA 2.84E-05 NO DATA 1.10E-05 TC-99m 9.23E-10 1.81 E-09 3.00E-08 NO DATA 2.63E-08 9.19E-10 1.03E-06 RU-103 7.31E-07 NO DATA 2.81E-07 NO DATA 1.84E-06 NO DATA 1.89E-05 RU-106 1.17E-05 NO DATA 1.46E-06 NO DATA 1.58E-05 NO DATA 1.82E-04 AG-110m 5.39E-07 3.64E-07 2.91E-07 NO DATA 6.78E-07 NO DATA 4.33E-05 TE-125m 1.14E-05 3.09E-06 1.52E-06 3.20E-06 NO DATA NO DATA 1.10E-05 TE-127m 2.89E-05 7.78E-06 3.43E-06 6.91 E-06 8.24E-05 NO DATA 2.34E-05 TE-129m 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 NO DATA 5.94E-05 1-130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 NO DATA 2.76E-06 1-131 1.72E-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 NO DATA 1.54E-06 1-132 8.00E-07 1.47E-06 6.76E-07 6.82E-05 2.25E-06 NO DATA 1.73E-06 1-133 5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 NO DATA 2.95E-06 1-134 4.19E-07 7.78E-07 3.58E-07 1.79E-05 1.19E-06 NO DATA 5.16E-07 1-135 1.75E-06 3.15E-06 1.49E-06 2.79E-04 4.83E-06 NO DATA 2.40E-06 CS-134 2.34E-04 3.84E-04 8.10E-05 NO DATA 1.19E-04 4.27E-05 2.0?E-06 CS-136 2.35E-05 6.46E-05 4.18E-05 NO DATA 3.44E-05 5.13E-06 2.27E-06 CS-137 3.27E-04 3.13E-04 4.62E-05 NO DATA 1.02E-04 3.67E-05 1.96E-06 BA-140 8.31E-05 7.28E-08 4.85E-06 NO DATA 2.37E-08 4.34E-08 4.21 E-05 CE-141 8.97E-08 1.98E-08 2.94E-09 NO DATA 8.68E-09 NO DATA 2.47E-05 CE-144 2.0BE-06 6.52E-07 1.11 E-07 NO DATA 3.61E-07 NO DATA 1.?0E-04 PR-143 3.93E-08 1.18E-08 1.95E-09 NO DATA 6.39E-09 NO DATA 4.24E-05 ND-147 2.79E-08 2.26E-08 1.75E-09 NO DATA 1.24E-08 NO DATA 3.58E-05 Page 137

CY-CL-170-301 Revision 26 September 2022 TABLE 5-11 INGESTION DOSE FACTORS FOR TEEN - (DFLi)a (mrem per pCi ingested)

NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU H-3 NO DATA 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 C-14 4.06E-06 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 P-32 2.76E-04 1.71E-05 1.0?E-05 NO DATA NO DATA NO DATA 2.32E-05 CR-51 NO DATA NO DATA 3.60E-09 2.00E-09 7.89E-10 5.14E-09 6.05E-07 MN-54 NO DATA 5.90E-06 1.17E-06 NO DATA 1.76E-06 NO DATA 1.21 E-05 FE-55 3.78E-06 2.68E-06 6.25E-07 NO DATA NO DATA 1.?0E-06 1.16E-06 FE-59 5.87E-06 1.37E-05 5.29E-06 NO DATA NO DATA 4.32E-06 3.24E-05 CO-58 NO DATA 9.72E-07 2.24E-06 NO DATA NO DATA NO DATA 1.34E-05 CO-60 NO DATA 2.81E-06 6.33E-06 NO DATA NO DATA NO DATA 3.66E-05 Nl-63 1.77E-04 1.25E-05 6.00E-06.

NO DATA NO DATA NO DATA 1.99E-06 ZN-65 5.76E-06 2.00E-05 9.33E-06 NO DATA 1.28E-05 NO DATA 8.47E-06 RB-86 NO DATA 2.98E-05 1.40E-05 NO DATA NO DATA NO DATA 4.41E-06 SR-89 4.40E-04 NO DATA 1.26E-05 NO DATA NO DATA NO DATA 5.24E-05 SR-90 8.30E-03 NO DATA 2.05E-03 NO DATA NO DATA NO DATA 2.33E-04 Y-90 1.37E-08 NO DATA 3.69E-10 NO DATA NO DATA NO DATA 1.13E-04 Y-91 2.01E-07 NO DATA 5.39E-09 NO DATA NO DATA NO DATA 8.24E-05 ZR-95 4.12E-08 1.30E-08 8.94E-09 NO DATA 1.91E-08 NO DATA 3.00E-05 NB-95 8.22E-09 4.56E-09 2.51E-09 NO DATA 4.42E-09 NO DATA 1.95E-05 MO-99 NO DATA 6.03E-06 1.15E-06 NO DATA 1.38E-05 NO DATA 1.0BE-05 TC-99m 3.32E-10 9.26E-10 1.20E-08 NO DATA 1.38E-08 5.14E-10 6.0BE-07 RU-103 2.55E-07 NO DATA 1.09E-07 NO DATA 8.99E-07 NO DATA 2.13E-05 RU-106 3.92E-06 NO DATA 4.94E-07 NO DATA 7.56E-06 NO DATA 1.88E-04 AG-110m 2.05E-07 1.94E-07 1.18E-07 NO DATA 3.?0E-07 NO DATA 5.45E-05 TE-125m 3.83E-06 1.38E-06 5.12E-07 1.07E-06 NO DATA NO DATA 1.13E-05 TE-127m 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 NO DATA 2.41E-05 TE-129m 1.63E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 NO DATA 6.12E-05 1-130 1.03E-06 2.98E-06 1.19E-06 2.43E-04 4.59E-06 NO DATA 2.29E-06 1-131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41E-05 NO DATA 1.62E-06 1-132 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 NO DATA 3.18E-07 1-133 2.01E-06 3.41E-06 1.04E-06 4.76E-04 5.98E-06 NO DATA 2.58E-06 1-134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.10E-07 NO DATA 5.10E-09 1-135 6.10E-07 1.57E-06 5.82E-07 1.01E-04 2.48E-06 NO DATA 1.74E-06 CS-134 8.37E-05 1.97E-04 9.14E-05 NO DATA 6.26E-05 2.39E-05 2.45E-06 CS-136 8.59E-06 3.38E-05 2.27E-05 NO DATA 1.84E-05 2.90E-06 2.72E-06 CS-137 1.12E-04 1.49E-04 5.19E-05 NO DATA 5.07E-05 1.97E-05 2.12E-06 BA-140 2.84E-05 3.48E-08 1.83E-06 NO DATA 1.18E-08 2.34E-08 4.38E-05 CE-141 1.33E-08 8.88E-09 1.02E-09 NO DATA 4.18E-09 NO DATA 2.54E-05 CE-144 6.96E-07 2.88E-07 3.74E-08 NO DATA 1.72E-07 NO DATA 1.75E-04 PR-143 1.31E-08 5.23E-09 6.52E-10 NO DATA 3.04E-09 NO DATA 4.31E-05 ND-147 9.38E-09 1.02E-08 6.11E-10 NO DATA 5.99E-09 NO DATA 3.68E-05 Page 138

CY-CL-170-301 Revision 26 September 2022 TABLE 5-12 INGESTION DOSE FACTORS FOR ADULT - (DFLi)a (mrem per pCi ingested)

NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU H-3 NO DATA 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 P-32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 CR-51 NO DATA NO DATA 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 MN-54 NO DATA 4.57E-06 8.72E-07 NO DATA 1.36E-06 NO DATA 1.40E-05 FE-55 2.75E-06 1.90E-06 4.43E-07 NO DATA NO DATA 1.06E-06 1.09E-06 FE-59 4.34E-06 1.02E-05 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 CO-58 NO DATA 7.45E-07 1.67E-06 NO DATA NO DATA NO DATA 1.51 E-05 CO-60 NO DATA 2.14E-06 4.72E-06 NO DATA NO DATA NO DATA 4.02E-05 Nl-63 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA 1.88E-06 ZN-65 4.84E-06 1.54E-05 6.96E-06 NO DATA 1.03E-05 NO DATA 9.?0E-06 RB-86 NO DATA 2.11 E-05 9.83E-06 NO DATA NO DATA NO DATA 4.16E-06 SR-89 3.08E-04 NO DATA 8.84E-06 NO DATA NO DATA NO DATA 4.94E-05 SR-90 7.58E-03 NO DATA 1.86E-03 NO DATA NO DATA NO DATA 2.19E-04 Y-90 9.62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E-04 Y-91 1.41E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 ZR-95 3.04E-08 9.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05 NB-95 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MO-99 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA 9.99E-06 TC-99m 2.47E-10 6.98E-10 8.89E-09 NO DATA 1.06E-08 3.42E-10 4.13E-07 RU-103 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 RU-106 2.75E-06 NO DATA 3.48E-07 NO DATA 5.31E-06 NO DATA 1.78E-04 AG-110m 1.60E-07 1.48E-07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E-05 TE-125m 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 NO DATA 1.0?E-05 TE-127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 NO DATA 2.27E-05 TE-129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 NO DATA 5.79E-05 1-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 NO DATA 1.92E-06 1-131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 NO DATA 1.57E-06 1-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 1-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31 E-06 NO DATA 2.22E-06 1-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 NO DATA 2.51E-10 1-135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 NO DATA 1.31 E-06 CS-134 6.22E-05 1.48E-04 1.21E-04 NO DATA 4.79E-05 1.59E-05 2.59E-06 CS-136 6.51E-06 2.57E-05 1.85E-05 NO DATA 1.43E-05 1.96E-06 2.92E-06 CS-137 7.97E-05 1.09E-04 7.14E-05 NO DATA 3.?0E-05 1.23E-05 2.11 E-06 BA-140 2.03E-05 2.55E-08 1.33E-06 NO DATA 8.67E-09 1.46E-08 4.18E-05 CE-141 9.36E-09 6.33E-09 7.18E-10 NO DATA 2.94E-09 NO DATA 2.42E-05 CE-144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1.65E-04 PR-143 9.20E-09 3.69E-09 4.56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 ND-147 6.29E-09 7.27E-09 4.35E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 Page 139

TABLE 5-13 CY -CL-170-301 Revision 26 September 2022 INPUT PARAMETERS FOR CALCULATING Rcaii Parameter Value Table*

Qf(kg/day) 50 for cow E-3 6 for goat Uap(liters/yr) - Infant 330 E-5

- Child 330 E-5

-Teen 400 E-5

-Adult 310 E-5

vp(kgtm2) 0.7 E-15 Ys(kgtm2) 2.0 E-15 Fm( days/liter)

Each stable element for cow E-1 Each stable element for goat E-2 r( dimensionless) 1.0 for radioiodine E-15 0.2 for particulates E-15 tf(seconds) 1.73E+05(2 days)

E-15 th(seconds) 7.78E+06(90 days)

E-15 fs(dimensionless) 1.0 for COW NUREG-0133 1.0 for goat Section 5.3.1.3 fp(dimensionless) 1.0 for cow NUREG-0133 1.0 for goat Section 5.3.1.3 of Regulatory Guide 1.109 unless otherwise stated Page 140

TABLE 5-14 INPUT PARAMETERS FOR CALCULATING RMaii Parameter Value Table*

Uap(liters/yr) - Infant 0

E-5

- Child 41 E-5

-Teen 65 E-5

-Adult 110 E-5 Ff(days/kg)

Each stable element E-1 ts(seconds) 1.73E+06 (20 days)

E-15 th(seconds) 7.78E+06 (90 days)

E-15 Yp(kgtm2) 0.7 E-15 Ys(kg/m2) 2.0 E-15 r(dimensionless) 1.0 for radioiodine E-15 0.2 for particulates E-15 Qf(kg/day) 50 E-3

of Regulatory Guide 1.109 Page 141 CY-CL-170-301 Revision 26 September 2022

TABLE 5-15 INPUT PARAMETERS FOR CALCULATING Rvau Parameter Value Table*

Ula (kg/yr) - Infant 0

E-5 26 E-5

-Child 42 E-5

-Teen 64 E-5

-Adult u8 a (kg/yr) - Infant 0

E-5 520 E-5

-Child 630 E-5

-Teen 520 E-5

-Adult fL (dimensionless) 1.0 E-15 fg (dimensionless) 0.76 E-15 tL (seconds) 8.60E+04 (1 day)

E-15 th (seconds) 5.18E+06 (60 days)

E-15 Yv (kgtm2) 2.0 E-15 of Regulatory Guide 1.109 Page 142 CY-CL-170-301 Revision 26 September 2022

CY-CL-170-301 Revision 26 September 2022 TABLE 5-16 INHALATION PATHWAY FACTORS - RIaii (INFANT)

(mrem/yr per µCi/m3)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 6.47E+02 C-14 2.65E+04 5.31 E+03 5.31 E+03 5.31 E+03 5.31 E+03 5.31 E+03 5.31 E+03 P-32 2.03E+06 1.12E+05 7.74E+04 NO DATA NO DATA NO DATA 1.61E+04 CR-51 NO DATA NO DATA 8.95E+01 5.75E+01 1.32E+01 1.28E+04 3.57E+02 MN-54 NO DATA 2.53E+04 4.98E+03 NO DATA 4.98E+03 1.00E+06 7.06E+03 FE-55 1.97E+04 1.17E+04 3.33E+03 NO DATA NO DATA 8.69E+04 1.09E+03 FE-59 1.36E+04 2.35E+04 9.48E+03 NO DATA NO DATA 1.02E+06 2.48E+04 CO-58 NO DATA 1.22E+03 1.82E+03 NO DATA NO DATA 7.77E+05 1.11E+04 CO-60 NO DATA 8.02E+03 1.18E+04 NO DATA NO DATA 4.51E+06 3.19E+04 Nl-63 3.39E+05 2.04E+04 1.16E+04 NO DATA NO DATA 2.09E+05 2.42E+03 ZN-65 1.93E+04 6.26E+04 3.11E+04 NO DATA 3.25E+04 6.47E+05 5.14E+04 RB-86 NO DATA 1.90E+05 8.82E+04 NO DATA NO DATA NO DATA 3.04E+03 SR-89 3.98E+05 NO DATA 1.14E+04 NO DATA NO DATA 2.03E+06 6.40E+04 SR-90 4.09E+07 NO DATA 2.59E+06 NO DATA NO DATA 1.12E+07 1.31E+05 Y-90 3.29E+03 NO DATA 8.82E+01 NO DATA NO DATA 2.69E+05 1.04E+05 Y-91 5.88E+05 NO DATA 1.57E+04 NO DATA NO DATA 2.45E+06 7.03E+04 ZR-95 1.15E+05 2.79E+04 2.03E+04 NO DATA 3.11E+04 1.75E+06 2.17E+04 NB-95 1.57E+04 6.43E+03 3.78E+03 NO DATA 4.72E+03 4.79E+05 1.27E+04 MO-99 NO DATA 1.65E+02 3.23E+01 NO DATA 2.65E+02 1.35E+05 4.87E+04 TC-99m 1.40E-03 2.88E-03 3.72E-02 NO DATA 3.11 E-02 8.11 E+02 2.03E+03 RU-103 2.02E+03 NO DATA 6.79E+02 NO DATA 4.24E+03 5.52E+05 1.61 E+04 RU-106 8.68E+04 NO DATA 1.09E+04 NO DATA 1.07E+05 1.16E+07 1.64E+05 AG-110m 9.98E+03 7.22E+03 5.00E+03 NO DATA 1.09E+04 3.67E+06 3.30E+04 TE-125m 4.76E+03 1.99E+03 6.58E+02 1.62E+03 NO DATA 4.47E+05 1.29E+04 TE-127m 1.67E+04 6.90E+03 2.07E+03 4.87E+03 3.75E+04 1.31E+06 2.73E+04 TE-129m 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 1-130 6.39E+03 1.39E+04 5.57E+03 1.60E+06 1.53E+04 NO DATA 1.99E+03 1-131 3.79E+04 4.44E+04 1.96E+04 1.48E+07 5.18E+04 NO DATA 1.06E+03 1-132 1.69E+03 3.54E+03 1.26E+03 1.69E+05 3.95E+03 NO DATA 1.90E+03 1-133 1.32E+04 1.92E+04 5.60E+03 3.56E+06 2.24E+04 NO DATA 2.16E+03 1-134 9.21 E+02 1.88E+03 6.65E+02 4.45E+04 2.09E+03 NO DATA 1.29E+03 1-135 3.86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 NO DATA 1.83E+03 CS-134 3.96E+05 7.03E+05 7.45E+04 NO DATA 1.90E+05 7.97E+04 1.33E+03 CS-136 4.83E+04 1.35E+05 5.29E+04 NO DATA 5.64E+04 1.18E+04 1.43E+03 CS-137 5.49E+05 6.12E+05 4.55E+04 NO DATA 1.72E+05 7.13E+04 1.33E+03 BA-140 5.60E+04 5.60E+01 2.90E+03 NO DATA 1.34E+01 1.60E+06 3.84E+04 CE-141 2.77E+04 1.67E+04 1.99E+03 NO DATA 5.25E+03 5.17E+05 2.16E+04 CE-144 3.19E+06 1.21E+06 1.76E+05 NO DATA 5.38E+05 9.84E+06 1.48E+05 PR-143 1.40E+04 5.24E+03 6.99E+02 NO DATA 1.97E+03 4.33E+05 3.72E+04 ND-147 7.94E+03 8.13E+03 5.00E+02 NO DATA 3.15E+03 3.22E+05 3.12E+04 Page 143

CY-CL-170-301 Revision 26 September 2022 TABLE 5-17 INHALATION PATHWAY FACTORS - R 1

aij (CHILD)

(mrem/yr per µCi/m3)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 C-14 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 P-32 2.60E+06 1.14E+05 9.87E+04 NO DATA NO DATA NO DATA 4.21E+04 CR-51 NO DATA NO DATA 1.54E+02 8.54E+01 2.43E+01 1.70E+04 1.08E+03 MN-54 NO DATA 4.29E+04 9.51E+03 NO DATA 1.00E+04 1.58E+06 2.29E+04 FE-55 4.74E+04 2.52E+04 7.77E+03 NO DATA NO DATA 1.11E+05 2.87E+03 FE-59 2.07E+04 3.34E+04 1.67E+04 NO DATA NO DATA 1.27E+06 7.07E+04 CO-58 NO DATA 1.77E+03 3.16E+03 NO DATA NO DATA 1.11E+06 3.44E+04 CO-60 NO DATA 1.31E+04 2.26E+04 NO DATA NO DATA 7.07E+06 9.62E+04 Nl-63 8.21 E+05 4.63E+04 2.80E+04 NO DATA NO DATA 2.75E+05 6.33E+03 ZN-65 4.26E+04 1.13E+05 7.03E+04 NO DATA 7.14E+04 9.95E+05 1.63E+04 RB-86 NO DATA 1.98E+05 1.14E+05 NO DATA NO DATA NO DATA 7.99E+03 SR-89 5.99E+05 NO DATA 1.72E+04 NO DATA NO DATA 2.16E+06 1.67E+05 SR-90 1.01E+08 NO DATA 6.44E+06 NO DATA NO DATA 1.48E+07 3.43E+05 Y-90 4.11E+03 NO DATA 1.11E+02 NO DATA NO DATA 2.62E+05 2.66E+05 Y-91 9.14E+05 NO DATA 2.44E+04 NO DATA NO DATA 2.63E+06 1.84E+05 ZR-95 1.90E+05 4.18E+04 3.70E+04 NO DATA 5.96E+04 2.23E+06 6.11 E+04 NB-95 2.35E+04 9.18E+03 6.55E+03 NO DATA 8.62E+03 6.14E+05 3.70E+04 MO-99 NO DATA 1.72E+02 4.26E+01 NO DATA 3.92E+02 1.35E+05 1.27E+05 TC-99m 1.78E-03 3.48E-03 5.77E-02 NO DATA 5.07E-02 9.51E+02 4.81E+03 RU-103 2.79E+03 NO DATA 1.07E+03 NO DATA 7.03E+03 6.62E+05 4.48E+04 RU-106 1.36E+05 NO DATA 1.69E+04 NO DATA 1.84E+05 1.43E+07 4.29E+05 AG-110m 1.69E+04 1.14E+04 9.14E+03 NO DATA 2.12E+04 5.48E+06 1.00E+05 TE-125m 6.73E+03 2.33E+03 9.14E+02 1.92E+03 NO DATA 4.77E+05 3.38E+04 TE-127m 2.49E+04 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 TE-129m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 1-130 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+04 NO DATA 5.11E+03 1-131 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 NO DATA 2.84E+03 1-132 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+03 NO DATA 3.20E+03 1-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 NO DATA 5.48E+03 1-134 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 NO DATA 9.54E+02 1-135 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 NO DATA 4.44E+03 CS-134 6.51E+05 1.01E+06 2.25E+05 NO DATA 3.30E+05 1.21E+05 3.85E+03 CS-136 6.51E+04 1.71E+05 1.16E+05 NO DATA 9.55E+04 1.45E+04 4.18E+03 CS-137 9.70E+05 8.25E+05 1.28E+05 NO DATA 2.82E+05 1.04E+05 3.62E+03 BA-140 7.40E+04 6.48E+01 4.33E+03 NO DATA 2.11E+01 1.74E+06 1.02E+05 CE-141 3.92E+04 1.95E+05 2.90E+03 NO DATA 8.55E+03 5.44E+05 5.66E+04 CE-144 6.77E+06 2.12E+06 3.61E+05 NO DATA 1.17E+06 1.20E+07 3.89E+05 PR-143 1.85E+04 5.55E+03 9.14E+02 NO DATA 3.00E+03 4.33E+05 9.73E+04 ND-147 1.08E+04 8.73E+03 6.81E+02 NO DATA 4.81E+03 3.28E+05 8.21E+04 Page 144 J

CY-CL-170-301 Revision 26 September 2022 TABLE 5-18 INHALATION PATHWAY FACTORS - RIaij (TEEN)

(mrem/yr per µCi/m3)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU ISOTOPE H-3 NO DATA 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 C-14 2.60E+04 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 P-32 1.89E+06 1.10E+05 7.16E+04 NO DATA NO DATA NO DATA 9.28E+04 CR-51 NO DATA NO DATA 1.35E+02 7.50E+01 3.07E+01 2.10E+04 3.00E+03 MN-54 NO DATA 5.11E+04 8.40E+03 NO DATA 1.27E+04 1.98E+06 6.68E+04 FE-55 3.34E+04 2.38E+04 5.54E+03 NO DATA NO DATA 1.24E+05 6.39E+03 FE-59 1.59E+04 3.70E+04 1.43E+04 NO DATA NO DATA 1.53E+06 1.78E+05 CO-58 NO DATA 2.07E+03 2.78E+03 NO DATA NO DATA 1.34E+06 9.52E+04 CO-60 NO DATA 1.51E+04 1.98E+04 NO DATA NO DATA 8.72E+06 2.59E+05 Nl-63 5.80E+05 4.34E+04 1.98E+04 NO DATA NO DATA 3.07E+05 1.42E+04 ZN-65 3.86E+04 1.34E+05 6.24E+04 NO DATA 8.64E+04 1.24E+06 4.66E+04 RB-86 NO DATA 1.90E+05 8.40E+04 NO DATA NO DATA NO DATA 1.77E+04 SR-89 4.34E+05 NO DATA 1.25E+04 NO DATA NO DATA 2.42E+06 3.71E+05 SR-90 1.08E+08 NO DATA 6.68E+06 NO DATA NO DATA 1.65E+07 7.65E+05 Y-90 2.98E+03 NO DATA 8.00E+01 NO DATA NO DATA 2.93E+05 5.59E+05 Y-91 6.61 E+05 NO DATA 1.77E+04 NO DATA NO DATA 2.94E+06 4.09E+05 ZR-95 1.46E+05 4.58E+04 3.15E+04 NO DATA 6.74E+04 2.69E+06 1.49E+05 NB-95 1.86E+04 1.03E+04 5.66E+03 NO DATA 1.00E+04 7.51 E+05 9.68E+04 MO-99 NO DATA 1.69E+02 3.22E+01 NO DATA 4.11E+02 1.54E+05 2.69E+05 TC-99m 1.38E-03 3.86E-03 4.99E-02 NO DATA 5.76E-02 1.15E+03 6.13E+03 RU-103 2.10E+03 NO DATA 8.96E+02 NO DATA 7.43E+03 7.83E+05 1.09E+05 RU-106 9.84E+04 NO DATA 1.24E+04 NO DATA 1.90E+05 1.61E+07 9.60E+05 AG-110m 1.38E+04 1.31E+04 7.99E+03 NO DATA 2.50E+04 6.75E+06 2.73E+05 TE-125m 4.88E+03 2.24E+03 6.67E+02 1.40E+03 NO DATA 5.36E+05 7.50E+04 TE-127m 1.80E+04 8.16E+03 2.18E+03 4.38E+03 6.54E+04 1.66E+06 1.59E+05 TE-129m 1.39E+04 6.58E+03 2.25E+03 4.58E+03 5.19E+04 1.98E+06 4.05E+05 1-130 6.24E+03 1.78E+04 7.17E+03 1.49E+06 2.75E+04 NO DATA 9.12E+03 1-131 3.54E+04 4.91 E+04 2.64E+04 1.46E+07 8.40E+04 NO DATA 6.49E+03 1-132 1.59E+03 4.38E+03 1.58E+03 1.51E+05 6.92E+03 NO DATA 1.27E+03 1-133 1.22E+04 2.05E+04 6.22E+03 2.92E+06 3.59E+04 NO DATA 1.03E+04 1-134 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 NO DATA 2.04E+01 1-135 3.70E+03 9.44E+03 3.49E+03 6.21 E+05 1.49E+04 NO DATA 6.95E+03 CS-134 5.02E+05 1.12E+06 5.49E+05 NO DATA 3.75E+05 1.46E+05 9.76E+03 CS-136 5.15E+04 1.94E+05 1.37E+05 NO DATA 1.10E+05 1.78E+04 1.09E+04 CS-137 6.70E+05 8.48E+05 3.11E+05 NO DATA 3.04E+05 1.21 E+05 8.48E+03 BA-140 5.47E+04 6.70E+01 3.52E+03 NO DATA 2.28E+01 2.03E+06 2.29E+05 CE-141 2.84E+04 1.90E+04 2.17E+03 NO DATA 8.88E+03 6.14E+05 1.26E+05 CE-144 4.89E+06 2.02E+06 2.62E+05 NO DATA 1.21E+06 1.34E+07 8.64E+05 PR-143 1.34E+04 5.31 E+03 6.62E+02 NO DATA*

3.09E+03 4.83E+05 2.14E+05 ND-147 7.86E+03 8.56E+03 5.13E+02 NO DATA 5.02E+03 3.72E+05 1.82E+05 Page 145

CY-CL-170-301 Revision 26 September 2022 TABLE 5-19 INHALATION PATHWAY FACTORS - R 1aii (AOUL T)

(mrem/yr per µCi/m3)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU ISOTOPE H-3 NO DATA 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 C-14 1.82E+04 3.41E+03 3.41E+03 3.41E+D3 3.41E+D3 3.41E+03 3.41E+03 P-32 1.32E+06 7.71E+04 5.01E+04 NO DATA NO DATA NO DATA 8.64E+04 CR-51 NO DATA NO DATA 1.00E+D2 5.95E+01 2.28E+01 1.44E+04 3.32E+03 MN-54 NO DATA 3.96E+04 6.30E+03 NO DATA 9.84E+03 1.40E+06 7.74E+04 FE-55 2.46E+04 1.7DE+04 3.94E+03 NO DATA NO DATA 7.21E+04 6.03E+03 FE-59 1.18E+04 2.78E+04 1.06E+04 NO DATA NO DATA 1.02E+06 1.88E+05 CO-58 NO DATA 1.58E+03 2.07E+03 NO DATA NO DATA 9.28E+05 1.06E+05 CO-60 NO DATA 1.15E+04 1.48E+04 NO DATA NO DATA 5.97E+06 2.85E+05 Nl-63 4.32E+05 3.14E+04 1.45E+04 NO DATA NO DATA 1.78E+D5 1.34E+D4 ZN-65 3.24E+04 1.03E+05 4.66E+D4 NO DATA 6.9DE+D4 8.64E+05 5.34E+D4 RB-86 NO DATA 1.35E+05 5.9DE+04 NO DATA NO DATA NO DATA 1.66E+04 SR-89 3.04E+05 NO DATA 8.72E+03 NO DATA NO DATA 1.40E+06 3.50E+05 SR-90 9.92E+07 NO DATA 6.10E+06 NO DATA NO DATA 9.60E+06 7.22E+05 Y-90 2.09E+03 NO DATA 5.61E+01 NO DATA NO DATA 1.70E+05 5.06E+05 Y-91 4.62E+05 NO DATA 1.24E+04 NO DATA NO DATA 1.70E+06 3.85E+05 ZR-95 1.07E+05 3.44E+04 2.33E+04 NO DATA 5.42E+04 1.77E+06 1.50E+05 NB-95 1.41E+04 7.82E+03 4.21E+03 NO DATA 7.74E+03 5.05E+05 1.04E+05 MO-99 NO DATA 1.21E+02 2.30E+01 NO DATA 2.91E+02 9.12E+04 2.48E+05 TC-99m 1.03E-03 2.91E-03 3.?0E-02 NO DATA 4.42E-02 7.64E+02 4.16E+03 RU-103 1.53E+03 NO DATA 6.58E+02 NO DATA 5.83E+03 5.05E+05 1.10E+05 RU-106 6.91E+04 NO DATA 8.72E+03 NO DATA 1.34E+05 9.36E+06 9.12E+05 AG-110m 1.08E+04 1.00E+04 5.94E+03 NO DATA 1.97E+04 4.63E+06 3.02E+05 TE-125m 3.42E+03 1.58E+03 4.67E+02 1.05E+03 1.24E+04 3.14E+05 7.06E+04 TE-127m 1.26E+04 5.77E+03 1.57E+03 3.29E+03 4.58E+04 9.60E+05 1.50E+05 TE-129m 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04 1.16E+06 3.83E+05 1-130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09E+04 NO DATA 7.69E+03 1-131 2.52E+04 3.58E+04 2.05E+04 1.19E+07 6.13E+04 NO DATA 6.28E+03 1-132 1.16E+03 3.26E+03 1.16E+03 1.14E+05 5.18E+03 NO DATA 4.06E+02 1-133 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58E+04 NO DATA 8.88E+03 1-134 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 NO DATA 1.01E+00 1-135 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.11E+04 NO DATA 5.25E+03 CS-134 3.73E+05 8.48E+05 7.28E+05 NO DATA 2.87E+05 9.76E+04 1.04E+04 CS-136 3.90E+04 1.46E+05 1.10E+05 NO DATA 8.56E+04 1.20E+04 1.17E+04 CS-137 4.78E+05 6.21E+05 4.28E+05 NO DATA 2.22E+05 7.52E+04 8.40E+03 BA-140 3.90E+04 4.90E+01 2.57E+03 NO DATA 1.67E+01 1.27E+06 2.18E+05 CE-141 1.99E+04 1.35E+04 1.53E+03 NO DATA 6.26E+03 3.62E+05 1.20E+05 CE-144 3.43E+06 1.43E+06 1.84E+05 NO DATA 8.48E+05 7.78E+06 8.16E+05 PR-143 9.36E+03 3.75E+03 4.64E+02 NO DATA 2.16E+03 2.81E+05 2.00E+05 ND-147 5.27E+03 6.10E+03 3.65E+02 NO DATA 3.56E+03 2.21E+05 1.73E+05 Page 146

CY-CL-170-301 Revision 26 September 2022 TABLE 5-20 COW MILK PATHWAY FACTORS - Rcaii (INFANT)

(m2rem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 2.38E+03*

2.38E+03*

C-14 3.23E+06 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E+05 P-32 1.60E+11 9.41E+09 6.20E+09 NO DATA NO DATA NO DATA 2.16E+09 CR-51 NO DATA NO DATA 1.61E+05 1.05E+05 2.29E+04 2.04E+05 4.69E+06 MN-54 NO DATA 3.90E+07 8.84E+06 NO DATA 8.64E+06 NO DATA 1.43E+07 FE-55 1.35E+08 8.72E+07 2.33E+07 NO DATA NO DATA 4.26E+07 1.11 E+07 FE-59 2.25E+08 3.92E+08 1.55E+08 NO DATA NO DATA 1.16E+08 1.87E+08 CO-58 NO DATA 2.43E+07 6.06E+07 NO DATA NO DATA NO DATA 6.05E+07 CO-60 NO DATA 8.82E+07 2.08E+08 NO DATA NO DATA NO DATA 2.10E+08 Nl-63 3.50E+10 2.16E+09 1.21E+09 NO DATA NO DATA NO DATA 1.08E+08 ZN-65 5.55E+09 1.91E+10 8.78E+09 NO DATA 9.23E+09 NO DATA 1.61E+10 RB-86 NO DATA 2.23E+10 1.10E+10 NO DATA NO DATA NO DATA 5.70E+08 SR-89 1.26E+10 NO DATA 3.61E+08 NO DATA NO DATA NO DATA 2.59E+08 SR-90 1.22E+11 NO DATA 3.10E+10 NO DATA NO DATA NO DATA 1.52E+09 Y-90 6.83E+02 NO DATA 1.83E+01 NO DATA NO DATA NO DATA 9.43E+05 Y-91 7.33E+04 NO DATA 1.95E+03 NO DATA NO DATA NO DATA 5.26E+06 ZR-95 6.82E+03 1.66E+03 1.18E+03 NO DATA 1.79E+03 NO DATA 8.28E+05 NB-95 5.93E+05 2.44E+05 1.41E+05 NO DATA 1.75E+05 NO DATA 2.06E+08 MO-99 NO DATA 2.07E+08 4.04E+07 NO DATA 3.10E+08 NO DATA 6.83E+07 TC-99m 2.75E+01 5.66E+01 7.29E+02 NO DATA 6.09E+02 2.96E+01 1.64E+04 RU-103 8.67E+03 NO DATA 2.92E+03 NO DATA 1.81 E+04 NO DATA 1.06E+05 RU-106 1.91 E+05 NO DATA 2.38E+04 NO DATA 2.26E+05 NO DATA 1.45E+06 AG-110m 3.85E+08 2.81 E+08 1.86E+08 NO DATA 4.02E+08 NO DATA 1.46E+10 TE-125m 1.51E+08 5.05E+07 2.04E+07 5.08E+07 NO DATA NO DATA 7.19E+07 TE-127m 4.22E+08 1.40E+08 5.10E+07 1.22E+08 1.04E+09 NO DATA 1.70E+08 TE-129m 5.56E+08 1.91E+08 8.56E+07 2.14E+08 1.39E+09 NO DATA 3.32E+08 1-130 3.53E+06 7.76E+06 3.12E+06 8.70E+08 8.53E+06 NO DATA 1.66E+06 1-131 2.71E+09 3.19E+09 1.40E+09 1.05E+12 3.73E+09 NO DATA 1.14E+08 1-132 1.43E+00 2.90E+00 1.03E+00 1.36E+02 3.24E+00 NO DATA 2.35E+00 1-133 3.63E+07 5.28E+07 1.55E+07 9.60E+09 6.21E+07 NO DATA 8.93E+06 1-134 1.64E-11 3.36E-11 1.20E-11 7.86E-10 3.76E-11 NO DATA 3.48E-11 1-135 1.13E+05 2.24E+05 8.18E+04 2.01E+07 2.50E+05 NO DATA 8.12E+04 CS-134 3.65E+10 6.81E+10 6.88E+09 NO DATA 1.75E+10 7.19E+09 1.85E+08 CS-136 1.97E+09 5.81E+09 2.17E+09 NO DATA 2.31 E+09 4.73E+08 8.82E+07 CS-137 5.15E+10 6.03E+10 4.27E+09 NO DATA 1.62E+10 6.44E+09 1.89E+08 BA-140 2.45E+08 2.45E+05 1.26E+07 NO DATA 5.72E+04 1.50E+05 5.92E+07 CE-141 4.34E+04 2.65E+04 3.12E+03 NO DATA 8.17E+03 NO DATA 1.37E+07 CE-144 2.34E+06 9.56E+05 1.31E+05 NO DATA 3.87E+05 NO DATA 1.34E+08 PR-143 1.49E+03 5.56E+02 7.37E+01 NO DATA 2.07E+02 NO DATA 7.85E+05 ND-147 8.79E+02 9.03E+02 5.53E+01 NO DATA 3.48E+02 NO DATA 5.72E+05

mrem/yr per µCi/m 3 Page 147

CY-CL-170-301 Revision 26 September 2022 TABLE 5-21 COW MILK PATHWAY FACTORS - Rcaij (CHILD)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU ISOTOPE H-3 NO DATA 1.57E+03*

1.57E+03*

C-14 1.65E+06 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 P-32 7.79E+10 3.64E+09 3.00E+09 NO DATA NO DATA NO DATA 2.15E+09 CR-51 NO DATA NO DATA 1.01E+05 5.63E+04 1.54E+04 1.03E+05 5.38E+06 MN-54 NO DATA 2.10E+07 5.59E+06 NO DATA 5.88E+06 NO DATA 1.76E+07 FE-55 1.12E+08 5.94E+07 1.84E+07 NO DATA NO DATA 3.36E+07 1.10E+07 FE-59 1.20E+08 1.95E+08 9.71E+07 NO DATA NO DATA 5.65E+07 2.03E+08 CO-58 NO DATA 1.21E+07 3.71E+07 NO DATA NO DATA NO DATA 7.08E+07 CO-60 NO DATA 4.32E+07 1.27E+08 NO DATA NO DATA NO DATA 2.39E+08 Nl-63 2.97E+10 1.59E+09 1.01E+09 NO DATA NO DATA NO DATA 1.07E+08 ZN-65 4.13E+09 1.10E+10 6.83E+09 NO DATA 6.92E+09 NO DATA 1.93E+09 RB-86 NO DATA 8.78E+09 5.40E+09 NO DATA NO DATA NO DATA 5.65E+08 SR-89 6.63E+09 NO DATA 1.89E+08 NO DATA NO DATA NO DATA 2.57E+08 SR-90 1.12E+11 NO DATA 2.84E+10 NO DATA NO DATA NO DATA 1.51E+09 Y-90 3.23E+02 NO DATA 8.65E+00 NO DATA NO DATA NO DATA 9.20E+05 Y-91 3.90E+04 Nb DATA 1.04E+03 NO DATA NO DATA NO DATA 5.20E+06 ZR-95 3.84E+03 8.44E+02 7.51E+02 NO DATA 1.21E+03 NO DATA 8.80E+05 NB-95 3.18E+05 1.24E+05 8.84E+04 NO DATA 1.16E+05 NO DATA 2.29E+08 MO-99 NO DATA 8.15E+07 2.02E+07 NO DATA 1.74E+08 NO DATA 6.74E+07 TC-99m 1.32E+01 2.58E+01 4.28E+02 NO DATA 3.75E+02 1.31E+01 1.47E+04 RU-103 4.29E+03 NO DATA 1.65E+03 NO DATA 1.08E+04 NO DATA 1.11E+05 RU-106 9.25E+04 NO DATA 1.15E+04 NO DATA 1.25E+05 NO DATA 1.44E+06 AG-110m 2.09E+08 1.41E+08 1.13E+08 NO DATA 2.63E+08 NO DATA 1.68E+10 TE-125m 7.39E+07 2.00E+07 9.85E+07

2.07E+07 NO DATA NO DATA 7.13E+07 TE-127m 2.08E+08 5.61E+07 2.47E+07 4.98E+07 5.94E+08 NO DATA 1.69E+08 TE-129m 2.71E+08 7.58E+07 4.21E+07 8.74E+07 7.97E+08 NO DATA 3.31E+08 1-130 1.72E+06 3.47E+06 1.79E+06 3.82E+08 5.19E+06 NO DATA 1.62E+06 1-131 1.30E+09 1.31E+09 7.44E+08 4.33E+11 2.15E+09 NO DATA 1.17E+08 1-132 6.91E-01 1.27E+OO 5.84E-01 5.89E+01 1.94E+00 NO DATA 1.49E+00 1-133 1.72E+07 2.12E+07 8.03E+06 3.94E+09 3.54E+07 NO DATA 8.56E+06 1-134 7.92E-12 1.47E-11 6.77E-12 3.38E-10 2.25E-11 NO DATA 9.75E-12 1-135 5.43E+04 9.77E+04 4.62E+04 8.56E+06 1.50E+05 NO DATA 7.44E+04 CS-134 2.27E+10 3.72E+10 7.85E+09 NO DATA 1.15E+10 4.14E+09 2.01E+08 CS-136 1.01E+09 2.78E+09 1.80E+09 NO DATA 1.48E+09 2.21E+08 9.76E+07 CS-137 3.23E+10 3.09E+10 4.56E+09 NO DATA 1.01E+10 3.63E+09 1.94E+08 BA-140 1.18E+08 1.03E+05 6.84E+06 NO DATA 3.37E+04 6.12E+04 5.94E+07 CE-141 2.19E+04 1.09E+04 1.62E+03 NO DATA 4.78E+03 NO DATA 1.36E+07 CE-144 1.63E+06 5.10E+05 8.68E+04 NO DATA 2.82E+05 NO DATA 1.33E+08 PR-143 7.19E+02 2.16E+02 3.57E+01 NO DATA 1.17E+02 NO DATA 7.76E+05 ND-147 4.44E+02 3.59E+02 2.78E+01 NO DATA 1.97E+02 NO DATA 5.69E+05

mrem/yr per µCi/m 3 Page 148

CY-CL-170-301 Revision 26 September 2022 TABLE 5-22 COW MILK PATHWAY FACTORS - Rcaii (TEEN)

(m2mrem/yr per µCi)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU ISOTOPE H-3 NO DATA 9.92E+02*

9.92E+02*

C-14 6.70E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 P-32 3.15E+10 1.95E+09 1.22E+09 NO DATA NO DATA NO DATA 2.64E+09 CR-51 NO DATA NO DATA 5.00E+04 2.78E+04 1.10E+04 7.14E+04 8.41E+06 MN-54 NO DATA 1.40E+07 2.78E+06 NO DATA 4.19E+06 NO DATA 2.88E+07 FE-55 4.46E+07 3.16E+07 7.38E+06 NO DATA NO DATA 2.01 E+O?

1.37E+07 FE-59 5.18E+07 1.21E+08 4.67E+07 NO DATA NO DATA 3.81 E+O?

2.68E+08 C0-58 NO DATA 7.98E+06 1.84E+07 NO DATA NO DATA NO DATA 1.10E+08 C0-60 NO DATA 2.78E+07 6.26E+07 NO DATA NO DATA NO DATA 3.62E+08 Nl-63 1.18E+10 8.34E+08 4.00E+08 NO DATA NO DATA NO DATA 1.33E+08 ZN-65 2.11E+09

. 7.32E+09 3.41E+09 NO DATA 4.68E+09 NO DATA 3.10E+09 RB-86 NO DATA 4.74E+09 2.23E+09 NO DATA NO DATA NO DATA 7.01 E+08 SR-89 2.68E+09 NO DATA 7.67E+07 NO DATA NO DATA NO DATA 3.19E+08 SR-90 6.62E+10 NO DATA 1.64E+10 NO DATA NO DATA NO DATA 1.86E+09 Y-90 1.31E+02 NO DATA 3.53E+OO NO DATA NO DATA NO DATA 1.08E+06 Y-91 1.58E+04 NO DATA 4.24E+02 NO DATA NO DATA NO DATA 6.48E+06 ZR-95 1.65E+03 5.20E+02 3.58E+02 NO DATA 7.65E+02 NO DATA 1.20E+06 NB-95 1.41E+05 7.81 E+04 4.30E+04 NO DATA 7.57E+04 NO DATA 3.34E+08 M0-99 NO DATA 4.46E+07 8.50E+06 NO DATA 1.02E+08 NO DATA 7.98E+07 TC-99m 5.74E+OO 1.60E+01 2.08E+02 NO DATA 2.39E+02 8.89E+OO 1.05E+04 RU-103 1.81 E+03 NO DATA 7.73E+02 NO DATA 6.37E+03 NO DATA 1.51E+05 RU-106 3.75E+04 NO DATA 4.73E+03 NO DATA 7.23E+04 NO DATA 1.80E+06 AG-110m 9.64E+07 9.12E+07 5.55E+07 NO DATA 1.74E+08 NO DATA 2.56E+10 TE-125m 3.01 E+07 1.08E+07 4.02E+06 8.41E+06 NO DATA NO DATA 8.88E+07 TE-127m 8.43E+07 2.99E+07 1.00E+O?

2.01 E+07 3.42E+08 NO DATA 2.10E+08 TE-129m 1.10E+08 4.09E+07 1.74E+07 3.56E+07 4.61 E+08 NO DATA 4.14E+08 1-130 7.33E+05 2.12E+06 8.47E+05 1.73E+08 3.27E+06 NO DATA 1.63E+06 1-131 5.36E+08 7.50E+08 4.03E+08 2.19E+11 1.29E+09 NO DATA 1.48E+08 1-132 2.90E-01 7.59E-01 2.72E-01 2.56E+01 1.20E+OO NO DATA 3.31 E-01 1-133 7.06E+06 1.20E+07 3.65E+06 1.67E+09 2.10E+07 NO DATA 9.06E+06 1-134 3.34E-12 8.86E-12 3.18E-12 1.48E-10 1.40E-11 NO DATA 1.17E-13 1-135 2.29E+04 5.90E+04 2.19E+04 3.80E+06 9.32E+04 NO DATA 6.54E+04 CS-134 9.79E+09 2.30E+10 1.07E+10 NO DATA 7.32E+09 2.80E+09 2.87E+08 CS-136 4.48E+08 1.76E+09 1.18E+09 NO DATA 9.59E+08 1.51E+08 1.42E+08 CS-137 1.33E+10 1.77E+10 6.18E+09 NO DATA 6.03E+09 2.34E+09 2.52E+08 BA-140 4.85E+07 5.95E+04 3.13E+06 NO DATA 2.02E+04 4.00E+04 7.49E+07 CE-141 8.88E+03 5.93E+03 6.81 E+02 NO DATA 2.79E+03 NO DATA 1.70E+07 CE-144 6.61 E+05 2.73E+05 3.55E+04 NO DATA 1.63E+05 NO DATA 1.66E+08 PR-143 2.91E+02 1.16E+02 1.45E+01 NO DATA 6.75E+01 NO DATA 9.57E+05 ND-147 1.81E+02 1.97E+02 1.18E+01 NO DATA 1.16E+02 NO DATA 7.10E+05

mrem/yr per µCi/m 3 Page 149

CY-CL-170-301 Revision 26 September 2022 TABLE 5-23 COW MILK PATHWAY FACTORS - Rcaii (ADULT)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU ISOTOPE H-3 NO DATA 7.62E+02*

7.62E+02*

C-14 3.63E+05 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 P-32 1.71E+10 1.06E+09 6.61E+08 NO DATA NO DATA NO DATA 1.92E+09 CR-51 NO DATA NO DATA 2.85E+04 1.70E+04 6.27E+03 3.78E+04 7.16E+06 MN-54 NO DATA 8.41 E+06 1.60E+06 NO DATA 2.50E+06 NO DATA 2.58E+07 FE-55 2.51E+07 1.73E+07 4.04E+06 NO DATA NO DATA 9.68E+06 9.95E+06 FE-59 2.97E+07 6.99E+07 2.68E+07 NO DATA NO DATA 1.95E+07 2.33E+08 CO-58 NO DATA 4.72E+06 1.06E+07 NO DATA NO DATA NO DATA 9.57E+07 CO-60 NO DATA 1.64E+07 3.62E+07 NO DATA NO DATA NO DATA 3.08E+08 Nl-63 6.73E+09 4.67E+08 2.26E+08 NO DATA NO DATA NO DATA 9.74E+07 ZN-65 1.37E+09 4.37E+09 1.98E+09 NO DATA 2.93E+09 NO DATA 2.75E+09 RB-86 NO DATA 2.60E+09 1.21E+09 NO DATA NO DATA NO DATA 5.12E+08 SR-89 1.45E+09 NO DATA 4.16E+07 NO DATA NO DATA NO DATA 2.33E+08 SR-90 4.68E+10 NO DATA 1.15E+10 NO DATA NO DATA NO DATA 1.35E+09 Y-90 7.10E+01 NO DATA 1.90E+00 NO DATA NO DATA NO DATA 7.53E+05 Y-91 8.60E+03 NO DATA 2.30E+02 NO DATA NO DATA NO DATA 4.73E+06 ZR-95 9.45E+02 3.03E+02 2.05E+02 NO DATA 4.76E+02 NO DATA 9.61E+05 NB-95 8.25E+04 4.59E+04 2.47E+04 NO DATA 4.54E+04 NO DATA 2.79E+08 MO-99 NO DATA 2.48E+07 4.72E+06 NO DATA 5.61E+07 NO DATA 5.74E+07 TC-99m 3.31E+00 9.35E+0O 1.19E+02 NO DATA 1.42E+02 4.58E+00 5.53E+03 RU-103 1.02E+03 NO DATA 4.39E+02 NO DATA 3.89E+03 NO DATA 1.19E+05 RU-106 2.04E+04 NO DATA 2.58E+03 NO DATA 3.94E+04 NO DATA 1.32E+06 AG-110m 5.82E+07 5.39E+07 3.20E+07 NO DATA 1.06E+08 NO DATA 2.20E+10 TE-125m 1.63E+07 5.91E+06 2.19E+06 4.91E+06 6.64E+07 NO DATA 6.52E+07 TE-127m 4.58E+07 1.64E+07 5.58E+06 1.17E+07 1.86E+08 NO DATA 1.53E+08 TE-129m 6.01E+07 2.24E+07 9.52E+06 2.07E+07 2.51E+08 NO DATA 3.03E+08 1-130 4.16E+05 1.23E+06 4.84E+05 1.04E+08 1.91E+06 NO DATA 1.06E+06 1-131 2.97E+08 4.24E+08 2.43E+08 1.39E+11 7.27E+08 NO DATA 1.12E+08 1-132 1.65E-01 4.40E-01 1.54E-01 1.54E+01 7.02E-01 NO DATA 8.27E-02 1-133 3.86E+06 6.72E+06 2.05E+06 9.87E+08 1.17E+07 NO DATA 6.04E+06 1-134 1.89E-12 5.13E-12 1.83E-12 8.88E-11 8.15E-12 NO DATA 4.47E-15 1-135 1.29E+04 3.39E+04 1.25E+04 2.23E+06 5.43E+04 NO DATA 3.83E+04 CS-134 5.67E+09 1.35E+10 1.10E+10 NO DATA 4.37E+09 1.45E+09 2.36E+08 CS-136 2.64E+08 1.04E+09 7.49E+08 NO DATA 5.79E+08 7.94E+07 1.18E+08 CS-137 7.39E+09 1.01E+10 6.62E+09 NO DATA 3.43E+09 1.14E+09 1.96E+08 BA-140 2.72E+07 3.42E+04 1.78E-06 NO DATA 1.16E+04 1.96E+04 5.60E+07 CE-141 4.84E+03 3.27E+03 3.71E+02 NO DATA 1.52E+03 NO DATA 1.25E+07 CE-144 3.58E+05 1.50E+05 1.92E+04 NO DATA 8.87E+04 NO DATA 1.21E+08 PR-143 1.58E+02 6.35E+01 7.84E+00 NO DATA 3.66E+01 NO DATA 6.93E+05 ND-147 9.44E+01 1.09E+02 6.53E+00 NO DATA 6.38E+01 NO DATA 5.24E+05

mrem/yr per µCi/m 3 Page 150

CY-CL-170-301 Revision 26 September 2022 TABLE 5-24 GOAT MILK PATHWAY FACTORS - Reau (INFANT)

(m2rem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 4.86E+03*

4.86E+03*

C-14 3.23E+06 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E+05 6.89E+05 P-32 1.90E+11 1.12E+10 7.46E+09 NO DATA NO DATA NO DATA 2.58E+09 CR-51 NO DATA NO DATA 1.93E+04 1.26E+04 2.75E+03 2.45E+04 5.63E+05 MN-54 NO DATA 4.68E+06 1.06E+06 NO DATA 1.04E+06 NO DATA 1.72E+06 FE-55 1.75E+06 1.13E+06 3.02E+05 NO DATA NO DATA 5.53E+05 1.44E+05 FE-59 2.91 E+06 5.08E+06 2.00E+06 NO DATA NO DATA 1.50E+06 2.43E+06 CO-58 NO DATA 2.90E+06 7.24E+06 NO DATA NO DATA NO DATA 7.23E+06 CO-60 NO DATA 1.06E+07 2.49E+07 NO DATA NO DATA NO DATA 2.51E+07 Nl-63 4.19E+09 2.59E+08 1.45E+08 NO DATA NO DATA NO DATA 1.29E+07 ZN-65 6.64E+08 2.28E+09 1.05E+09 NO DATA 1.10E+09 NO DATA 1.92E+09 RB-86 NO DATA 2.65E+09 1.31E+09 NO DATA NO DATA NO DATA 6.79E+07 SR-89 2.64E+10 NO DATA 7.56E+08 NO DATA NO DATA NO DATA 5.42E+08 SR-90 2.55E+11 NO DATA 6.50E+10 NO DATA NO DATA NO DATA 3.19E+09 Y-90 8.19E+01 NO DATA 2.19E+00 NO DATA NO DATA NO DATA 1.13E+05 Y-91 8.78E+03 NO DATA 2.34E+02 NO DATA NO DATA NO DATA 6.29E+05 ZR-95 8.16E+02 1.99E+02 1.41E+02 NO DATA 2.14E+02 NO DATA 9.90E+04 NB-95 7.12E+04 2.93E+04 1.69E+04 NO DATA 2.10E+04 NO DATA 2.47E+07 MO-99 NO DATA 2.48E+07 4.84E+06 NO DATA 3.71E+07 NO DATA 8.18E+06 TC-99m 3.26E+00 6.73E+00 8.67E+01 NO DATA 7.24E+01 3.52E+00 1.96E+03 RU-103 1.04E+03 NO DATA 3.47E+02 NO DATA 2.16E+03 NO DATA 1.26E+04 RU-106 2.28E+04 NO DATA 2.84E+03 NO DATA 2.69E+04 NO DATA 1.73E+05 AG-110m 4.62E+07 3.37E+07 2.23E+07 NO DATA 4.83E+07 NO DATA 1.75E+09 TE-125m 1.80E+07 6.02E+06 2.43E+06 6.06E+06 NO DATA NO DATA 8.58E+06 TE-127m 5.04E+07 1.67E+07 6.10E+06 1.46E+07 1.24E+08 NO DATA 2.03E+07 TE-129m 6.68E+07 2.29E+07 1.03E+07 2.57E+07 1.67E+08 NO DATA 3.99E+07 1-130 4.22E+06 9.28E+06 3.73E+06 1.04E+09 1.02E+07 NO DATA 1.99E+06 1-131 3.25E+09 3.83E+09 1.69E+09 1.26E+12 4.48E+09 NO DATA 1.37E+08 1-132 1.73E+00 3.50E+00 1.25E+00 1.64E+02 3.91E+00 NO DATA 2.84E+00 1-133 4.34E+07 6.32E+07 1.85E+07 1.15E+10 7.43E+07 NO DATA 1.07E+07 1-134 1.97E-11 4.04E-11 1.44E-11 9.42E-10 4.52E-11 NO DATA 4.18E-11 1-135 1.36E+05 2.70E+05 9.85E+04 2.42E+07 3.01E+05 NO DATA 9.77E+04 CS-134 1.09E+11 2.04E+11 2.06E+10 NO DATA 5.25E+10 2.15E+10 5.54E+08 CS-136 5.92E+09 1.74E+10 6.50E+09 NO DATA 6.94E+09 1.42E+09 2.64E+08 CS-137 1.54E+11 1.80E+11 1.28E+10 NO DATA 4.84E+10 1.96E+10 5.63E+08 BA-140 2.87E+07 2.87E+04 1.48E+06 NO DATA 6.82E+03 1.76E+04 7.06E+06 CE-141 5.20E+03 3.17E+03 3.73E+02 NO DATA 9.78E+02 NO DATA 1.64E+06 CE-144 2.79E+05 1.14E+05 1.56E+04 NO DATA 4.61E+04 NO DATA 1.60E+07 PR-143 1.78E+02 6.66E+01 8.83E+00 NO DATA 2.47E+01 NO DATA 9.40E+04 ND-147 1.06E+02 1.08E+02 6.65E+00 NO DATA 4.18E+01 NO DATA 6.88E+04

mrem/yr per µCi/m 3 Page 151

CY-CL-170-301 Revision 26 September 2022 TABLE 5-25 GOAT MILK PATHWAY FACTORS - Rcaii (CHILD)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 3.20E+03*

3.20E+03*

C-14 1.65E+06 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 3.29E+05 P-32 9.32E+10 4.36E+09 3.59E+09 NO DATA NO DATA NO DATA 2.58E+09 CR-51 NO DATA NO DATA 1.22E+04 6.77E+03 1.85E+03 1.24E+04 6.47E+05 MN-54 NO DATA 2.51E+06 6.70E+05 NO DATA 7.05E+05 NO DATA 2.11E+06 FE-55 1.45E+06 7.65E+05 2.38E+05 NO DATA NO DATA 4.35E+05 1.42E+05 FE-59 1.55E+06 2.52E+06 1.25E+06 NO DATA NO DATA 7.29E+05 2.62E+06 CO-58 NO DATA 1.46E+06 4.46E+06 NO DATA NO DATA NO DATA 8.49E+06 CO-60 NO DATA 5.16E+06 1.52E+07 NO DATA NO DATA NO DATA 2.86E+07 Nl-63 3.55E+09 1.90E+08 1.21E+08 NO DATA NO DATA NO DATA 1.28E+07 ZN-65 4.96E+08 1.32E+09 8.22E+08 NO DATA 8.33E+08 NO DATA 2.32E+08 RB-86 NO DATA 1.05E+09 6.47E+08 NO DATA NO DATA NO DATA 6.77E+07 SR-89 1.39E+10 NO DATA 3.96E+08 NO DATA NO DATA NO DATA 5.37E+08 SR-90 2.35E+11 NO DATA 5.95E+10 NO DATA NO DATA NO DATA 3.16E+09 Y-90 3.86E+01 NO DATA 1.03E+00 NO DATA NO DATA NO DATA 1.10E+05 Y-91 4.67E+03 NO DATA 1.25E+02 NO DATA NO DATA NO DATA 6.22E+05 ZR-95 4.58E+02 1.01E+02 8.97E+01 NO DATA 1.44E+02 NO DATA 1.05E+05 NB-95 3.81E+04 1.48E+04 1.06E+04 NO DATA 1.39E+04 NO DATA 2.75E+07 MO-99 NO DATA 9.74E+06 2.41E+06 NO DATA 2.08E+07 NO DATA 8.05E+06 TC-99m 1.58E+00 3.10E+00 5.13E+01 NO DATA 4.50E+01 1.57E+00 1.76E+03 RU-103 5.10E+02 NO DATA 1.96E+02 NO DATA 1.28E+03 NO DATA 1.32E+04 RU-106 1.11E+04 NO DATA 1.38E+03 NO DATA 1.49E+04 NO DATA 1.72E+05 AG-110m 2.50E+07 1.69E+07 1.35E+07 NO DATA 3.15E+07 NO DATA 2.01E+09 TE-125m 8.84E+06 2.39E+06 1.18E+06 2.48E+06 NO DATA NO DATA 8.53E+06 TE-127m 2.49E+07 6.71E+06 2.96E+06 5.96E+06 7.10E+07 NO DATA 2.02E+07 TE-129m 3.24E+07 9.06E+06 5.03E+06 1.05E+07 9.52E+07 NO DATA 3.96E+07 1-130 2.06E+06 4.17E+06 2.15E+06 4.59E+08 6.23E+06 NO DATA 1.95E+06 1-131 1.56E+09 1.57E+09 8.94E+08 5.20E+11 2.58E+09 NO DATA 1.40E+08 1-132 8.32E-01 1.52E+00 7.03E-01 7.09E+01 2.34E+00 NO DATA 1.80E+0O 1-133 2.06E+07 2.55E+07 9.64E+06 4.73E+09 4.25E+07 NO DATA 1.03E+07 1-134 9.51E-12 1.77E-11 8.13E-12 4.06E-10 2.70E-11 NO DATA 1.17E-11 1-135 6.53E+04 1.17E+05 5.56E+04 1.04E+07 1.80E+05 NO DATA 8.95E+04 CS-134 6.76E+10 1.11E+11 2.34E+10 NO DATA 3.44E+10 1.23E+10 5.98E+08 CS-136 3.03E+09 8.33E+09 5.39E+09 NO DATA 4.44E+09 6.62E+08 2.93E+08 CS-137 9.65E+10 9.23E+10 1.36E+10 NO DATA 3.01E+10 1.08E+10 5.78E+08 BA-140 1.40E+07 1.22E+04 8.15E+05 NO DATA 3.98E+03 7.29E+03 7.07E+06 CE-141 2.62E+03 1.31E+03 1.94E+02 NO DATA 5.73E+02 NO DATA 1.63E+06 CE-144 1.94E+05 6.10E+04 1.04E+04 NO DATA 3.38E+04 NO DATA 1.59E+07 PR-143 8.61E+01 2.58E+01 4.27E+00 NO DATA 1.40E+01 NO DATA 9.29E+04 ND-147 5.33E+01 4.32E+01 3.34E+OO NO DATA 2.37E+01 NO DATA 6.84E+04

mrem/yr per µCi/m 3 Page 152

CY-CL-170-301 Revision 26 September 2022 TABLE 5-26 GOAT MILK PATHWAY FACTORS - Rcaii (TEEN)

(m2mrem/yr per µCi)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 2.02E+03*

2.02E+03*

C-14 6.70E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 1.34E+05 P-32 3.78E+10 2.34E+09 1.47E+09 NO DATA NO DATA NO DATA 3.18E+09 CR-51 NO DATA NO DATA 5.94E+03 3.30E+03 1.30E+03 8.48E+03 9.98E+05 MN-54 NO DATA 1.68E+06 3.32E+05 NO DATA 5.00E+05 NO DATA 3.44E+06 FE-55 5.79E+05 4.11E+05 9.57E+04 NO DATA NO DATA 2.60E+05 1.78E+05 FE-59 6.75E+05 1.58E+06 6.08E+05 NO DATA NO DATA 4.97E+05 3.73E+06 C0-58 NO DATA 9.51 E+05 2.19E+06 NO DATA NO DATA NO DATA 1.31E+07 C0-60 NO DATA 3.32E+06 7.47E+06 NO DATA NO DATA NO DATA 4.32E+07 Nl-63 1.42E+09 1.00E+08 4.81E+07 NO DATA NO DATA NO DATA 1.60E+07 ZN-65 2.52E+08 8.76E+08 4.09E+08 NO DATA 5.61 E+08 NO DATA 3.71E+08 RB-86 NO DATA 5.66E+08 2.66E+08 NO DATA NO DATA NO DATA 8.38E+07 SR-89 5.59E+09 NO DATA 1.60E+08 NO DATA NO DATA NO DATA 6.65E+08 SR-90 1.38E+11 NO DATA 3.40E+10 NO DATA NO DATA NO DATA 3.87E+09 Y-90 1.56E+01 NO DATA 4.21E-01 NO DATA NO DATA NO DATA 1.29E+05 Y-91 1.89E+03 NO DATA 5.07E+01 NO DATA NO DATA NO DATA 7.75E+05 ZR-95 1.98E+02 6.24E+01 4.29E+01 NO DATA 9.17E+01 NO DATA 1.44E+05 NB-95 1.69E+04 9.37E+03 5.16E+03 NO DATA 9.08E+03 NO DATA 4.01E+07 M0-99 NO DATA 5.33E+06 1.02E+06 NO DATA 1.22E+07 NO DATA 9.55E+06 TC-99m 6.87E-01 1.92E+OO 2.48E+01 NO DATA 2.86E+01 1.06E+OO 1.26E+03 RU-103 2.17E+02 NO DATA 9.27E+01 NO DATA 7.64E+02 NO DATA 1.81E+04 RU-106 4.47E+03 NO DATA 5.63E+02 NO DATA 8.62E+03 NO DATA 2.14E+05 AG-110m 1.15E+07 1.09E+07 6.62E+06 NO-DATA 2.08E+07 NO DATA 3.06E+09 TE-125m 3.59E+06 1.29E+06 4.80E+05 1.00E+06 NO DATA NO DATA 1.06E+07 TE-127m 1.01E+07 3.57E+06 1.20E+06 2.39E+06 4.08E+07 NO DATA 2.51E+07 TE-129m 1.32E+07 4.89E+06 2.08E+06 4.25E+06 5.51 E+07 NO DATA 4.94E+07 1-130 8.82E+05 2.55E+06 1.02E+06 2.08E+08 3.93E+06 NO DATA 1.96E+06 1-131 6.44E+08 9.01 E+08 4.84E+08 2.63E+11 1.55E+09 NO DATA 1.78E+08 1-132 3.52E-01 9.20E-01 3.30E-01 3.10E+01 1.45E+OO NO DATA 4.01 E-01 1-133 8.48E+06 1.44E+07 4.39E+06 2.01E+09 2.52E+07 NO DATA 1.09E+07 1-134 4.03E-12 1.0?E-11 3.84E-12 1.78E-10 1.68E-11 NO DATA 1.41E-13 1-135 2.75E+04 7.08E+04 2.62E+04 4.56E+06 1.12E+05 NO DATA 7.85E+04 CS-134 2.94E+10 6.91 E+10 3.21E+10 NO DATA 2.20E+10 8.39E+09 8.60E+08 CS-136 1.34E+09 5.27E+09 3.54E+09 NO DATA 2.87E+09 4.52E+08 4.24E+08 CS-137 4.01 E+10 5.33E+10 1.86E+10 NO DATA 1.82E+10 7.05E+09 7.59E+08 BA-140 5.82E+06 7.13E+03 3.75E+05 NO DATA 2.42E+03 4.80E+03 8.98E+06 CE-141 1.07E+03 7.12E+02 8.17E+01 NO DATA 3.35E+02 NO DATA 2.04E+D6 CE-144 7.86E+04 3.25E+04 4.23E+03 NO DATA 1.94E+04 NO DATA 1.98E+07 PR-143 3.47E+01 1.39E+01 1.73E+OO NO DATA 8.06E+OO NO DATA 1.14E+05 ND-147 2.17E+01 2.36E+01 1.41E+OO NO DATA 1.38E+01 NO DATA 8.50E+04

mrem/yr per µCi/m 3 Page 153

CY-CL-170-301 Revision 26 September 2022 TABLE 5-27 GOAT MILK PATHWAY FACTORS - Rcaij (ADULT)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 1.55E+03*

1.55E+03*

C-14 3.63E+05 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 7.26E+04 P-32 2.05E+10 1.27E+09 7.91 E+08 NO DATA NO DATA NO DATA 2.30E+09 CR-51 NO DATA NO DATA 3.43E+03 2.05E+03 7.56E+02 4.55E+03 8.63E+05 MN-54 NO DATA 1.01E+06 1.92E+05 NO DATA 2.99E+05 NO DATA 3.08E+06 FE-55 3.27E+05 2.26E+05 5.27E+04 NO DATA NO DATA 1.26E+05 1.30E+05 FE-59 3.85E+05 9.06E+05 3.47E+05 NO DATA NO DATA 2.53E+05 3.02E+06 C0-58 NO DATA 5.62E+05 1.26E+06 NO DATA NO DATA NO DATA 1.14E+07 C0-60 NO DATA 1.96E+06 4.33E+06 NO DATA NO DATA NO DATA 3.69E+07 Nl-63 8.05E+08 5.58E+07 2.70E+07 NO DATA NO DATA NO DATA 1.16E+07 ZN-65 1.64E+08 5.22E+08 2.36E+08 NO DATA 3.49E+08 NO DATA 3.29E+08 RB-86 NO DATA 3.10E+08 1.45E+08 NO DATA NO DATA NO DATA 6.12E+07 SR-89 3.04E+09 NO DATA 8.73E+07 NO DATA NO DATA NO DATA 4.88E+08 SR-90 9.78E+10 NO DATA 2.40E+10 NO DATA NO DATA NO DATA 2.83E+09 Y-90 8.48E+OO NO DATA 2.28E-01 NO DATA NO DATA NO DATA 9.00E+04 Y-91 1.03E+03 NO DATA 2.75E+01 NO DATA NO DATA NO DATA 5.66E+05 ZR-95 1.13E+02 3.63E+01 2.46E+01 NO DATA 5.69E+01 NO DATA 1.15E+05 NB-95 9.90E+03 5.51E+03 2.96E+03 NO DATA 5.45E+03 NO DATA 3.34E+07 M0-99 NO DATA 2.96E+06 5.63E+05 NO DATA 6.71E+06 NO DATA 6.86E+06 TC-99m 3.95E-01 1.12E+OO 1.42E+01 NO DATA 1.70E+01 5.47E-01 6.61E+02 RU-103 1.22E+02 NO DATA 5.24E+01 NO DATA 4.64E+02 NO DATA 1.42E+04 RU-106 2.44E+03 NO DATA 3.09E+02 NO DATA 4.72E+03 NO DATA 1.58E+05 AG-110m 6.96E+06 6.44E+06 3.821;:+06 NO DATA 1.27E+07 NO DATA 2.63E+09 TE-125m 1.95E+06 7.07E+05 2.61E+05 5.87E+05 7.94E+06 NO DATA 7.79E+06 TE-127m 5.46E+06 1.95E+06 6.66E+05 1.40E+06 2.22E+07 NO DATA 2.83E+07 TE-129m 7.21E+06 2.69E+06 1.14E+06 2.48E+06 3.01E+07 NO DATA 3.63E+07 1-130 5.00E+05 1.47E+06 5.82E+05 1.25E+08 2.30E+06 NO DATA 1.27E+06 1-131 3.54E+08 5.06E+08 2.90E+08 1.66E+11 8.68E+08 NO DATA 1.34E+08 1-132 1.98E-01 5.29E-01 1.85E-01 1.85E+01 8.43E-01 NO DATA 9.93E-02 1-133 4.62E+06 8.03E+06 2.45E+06 1.18E+09 1.40E+07 NO DATA 7.22E+06 1-134 2.27E+12 6.16E-12 2.20E-12 1.0?E-10 9.BOE-12 NO DATA 5.37E-15 1-135 1.55E+04 4.06E+04 1.50E+04 2.68E+06 6.51E+04 NO DATA 4.59E+04 CS-134 1.69E+10 4.03E+10 3.29E+10 NO DATA 1.30E+10 4.32E+09 7.04E+08 CS-136 7.88E+08 3.11E+09 2.24E+09 NO DATA 1.73E+09 2.37E+08 3.53E+08 CS-137 2.21E+10 3.03E+10 1.98E+10 NO DATA 1.02E+10 3.41E+09 5.84E+08 BA-140 3.23E+06 4.05E+03 2.11E+05 NO DATA 1.38E+03 2.32E+03 6.65E+06 CE-141 5.80E+02 3.92E+02 4.45E+01 NO DATA 1.82E+02 NO DATA 1.50E+06 CE-144 4.29E+04 1.79E+04 2.30E+03 NO DATA 1.06E+04 NO DATA 1.45E+07 PR-143 1.89E+01 7.56E+OO 9.35E-01 NO DATA 4.37E+OO NO DATA 8.26E+04 ND-147 1.13E+01 1.30E+01 7.79E-01 NO DATA 7.64E+OO NO DATA 6.25E+04

mrem/yr per µCi/m3 Page 154

CY-CL-170-301 Revision 26 September 2022 TABLE 5-28 MEAT PATHWAY FACTORS - RMaij (CHILD)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU ISOTOPE H-3 NO DATA 2.33E+02*

2.33E+02*

C-14 5.29E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 P-32 7.43E+09 3.47E+08 2.86E+08 NO DATA NO DATA NO DATA 2.05E+08 CR-51 NO DATA NO DATA 8.78E+03 4.88E+03 1.33E+03 8.90E+03 4.66E+05 MN-54 NO DATA 8.03E+06 2.14E+06 NO DATA 2.25E+06 NO DATA 6.74E+06 FE-55 4.58E+08 2.43E+08 7.52E+07 NO DATA NO DATA 1.37E+08 4.50E+07 FE-59 3.76E+08 6.09E+08 3.03E+08 NO DATA NO DATA 1.76E+08 6.34E+08 CO-58 NO DATA 1.64E+07 5.03E+07 NO DATA NO DATA NO DATA 9.58E+07 CO-60 NO DATA 6.93E+07 2.04E+08 NO DATA NO DATA NO DATA 3.84E+08 Nl-63 2.91E+10 1.56E+09 9.90E+08 NO DATA NO DATA NO DATA 1.05E+08 ZN-65 3.75E+08 1.00E+09 6.22E+08 NO DATA 6.30E+08 NO DATA 1.76E+08 RB-86 NO DATA 5.76E+08 3.54E+08 NO DATA NO DATA NO DATA 3.71 E+07 SR-89 4.80E+08 NO DATA 1.37E+07 NO DATA NO DATA NO DATA 1.86E+07 SR-90 1.04E+10 NO DATA 2.64E+09 NO DATA NO DATA NO DATA 1.40E+08 Y-90 1.73E+02 NO DATA 4.62E+00 NO DATA NO DATA NO DATA 4.91E+05 Y-91 1.80E+06 NO DATA 4.81E+04 NO DATA NO DATA NO DATA 2.40E+08 ZR-95 2.67E+06 5.87E+05 5.22E+05 NO DATA 8.40E+05 NO DATA 6.12E+08 NB-95 3.10E+06 1.21E+06 8.61 E+05 NO DATA 1.13E+06 NO DATA 2.23E+09 MO-99 NO DATA 1.14E+05 2.83E+04 NO DATA 2.44E+05 NO DATA 9.45E+04 TC-99m 6.01 E-21 1.18E-20 1.95E-19 NO DATA 1.71E-19 5.98E-21 6.71E-18 RU-103 1.55E+08 NO DATA 5.96E+07 NO DATA 3.90E+08 NO DATA 4.01 E+09 RU-106 4.43E+09 NO DATA 5.53E+08 NO DATA 5.99E+09 NO DATA 6.90E+10 AG-110m 8.41E+06 5.68E+06 4.54E+06 NO DATA 1.06E+07 NO DATA 6.75E+08 TE-125m 5.69E+08 1.54E+08 7.58E+07 1.60E+08 NO DATA NO DATA 5.49E+08 TE-127m 1.77E+09 4.78E+08 2.11E+08 4.24E+08 5.06E+09 NO DATA 1.44E+09 TE-129m 1.79E+09 4.99E+08 2.77E+08 5.76E+08 5.25E+09 NO DATA 2.18E+09 1-130 2.91 E-06 5.89E-06 3.03E-06 6.49E-04 8.80E-06 NO DATA 2.75E-06 1-131 1.65E+07 1.66E+07 9.46E+06 5.50E+09 2.73E+07 NO DATA 1.48E+06 1-132 1.0SE-58 1.93E-58 8.86E-59 8.93E-57 2.95E-58 NO DATA 2.27E-58 1-133 5.75E-01 7.10E-01 2.69E-01 1.32E+02 1.18E+00 NO DATA 2.86E-01 1-134 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 1-135 6.86E-17 1.23E-16 5.83E-17 1.09E-14 1.89E-16 NO DATA 9.38E-17 CS-134 9.20E+08 1.51E+09 3.18E+08 NO DATA 4.68E+08 1.68E+08 8.14E+06 CS-136 1.62E+07 4.45E+07 2.88E+07 NO DATA 2.37E+07 3.53E+06 1.56E+06 CS-137 1.33E+09 1.27E+09 1.88E+08 NO DATA 4.15E+08 1.49E+08 7.98E+06 BA-140 4.38E+07 3.84E+04 2.56E+06 NO DATA 1.25E+04 2.29E+04 2.22E+07 CE-141 2.22E+04 1.11E+04 1.64E+03 NO DATA 4.85E+03 NO DATA 1.38E+07 CE-144 2.31 E+06 7.24E+05 1.23E+05 NO DATA 4.01E+05 NO DATA 1.89E+08 PR-143 3.34E+04 1.00E+04 1.66E+03 NO DATA 5.43E+03 NO DATA 3.60E+07 ND-147 1.17E+04 9.47E+03 7.33E+02 NO DATA 5.20E+03 NO DATA 1.50E+07

mrem/yr per µCitm3 Page 155

CY-CL-170-301 Revision 26 September 2022 TABLE 5-29 MEAT PATHWAY FACTORS - RMaii (TEEN)

(m2mrem/yr per µCi)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 1.93E+02*

1.93E+02*

C-14 2.81E+05 5.62E+04 5.62E+04 5.62E+04 5.62E+04 5.62E+04 5.62E+04 P-32 3.95E+09 2.45E+08 1.53E+08 NO DATA NO DATA NO DATA 3.32E+08 CR-51 NO DATA NO DATA 5.65E+03 3.14E+03 1.24E+03 8.07E+03 9.50E+05 MN-54 NO DATA 7.02E+06 1.39E+06 NO DATA 2.09E+06 NO DATA 1.44E+07 FE-55 2.38E+08 1.69E+08 3.94E+07 NO DATA NO DATA 1.07E+08 7.31E+07 FE-59 2.12E+08 4.95E+08 1.91E+08 NO DATA NO DATA 1.56E+08 1.17E+09 CO-58 NO DATA 1.41E+07 3.25E+07 NO DATA NO DATA NO DATA 1.94E+08 CO-60 NO DATA 5.84E+07 1.32E+08 NO DATA NO DATA NO DATA 7.61 E+08 Nl-63 1.52E+10 1.07E+09 5.15E+08 NO DATA NO DATA NO DATA 1.71E+08 ZN-65 2.50E+08 8.69E+08 4.05E+08 NO DATA 5.56E+08 NO DATA 3.68E+08 RB-86 NO DATA 4.05E+08 1.90E+08 NO DATA NO DATA NO DATA 6.00E+07 SR-89 2.54E+08 NO DATA 7.27E+06 NO DATA NO DATA NO DATA 3.02E+07 SR-90 8.04E+09 NO DATA 1.99E+09 NO DATA NO DATA NO DATA 2.26E+08 Y-90 9.11E+01 NO DATA 2.45E+00 NO DATA NO DATA NO DATA 7.51E+05 Y-91 9.55E+05 NO DATA 2.56E+04 NO DATA NO DATA NO DATA 3.91E+08 ZR-95 1.50E+06 4.74E+05 3.25E+05 NO DATA 6.93E+05 NO DATA 1.09E+09 NB-95 1.79E+06 9.94E+05 5.47E+05 NO DATA 9.64E+05 NO DATA 4.25E+09 MO-99 NO DATA 8.20E+04 1.56E+04 NO DATA 1.88E+05 NO DATA 1.47E+05 TC-99m 3.42E-21 9.54E-21 1.24E-19 NO DATA 1.42E-19 5.29E-21 6.26E-18 RU-103 8.57E+07 NO DATA 3.66E+07 NO DATA 3.02E+08 NO DATA 7.16E+09 RU-106 2.36E+09 NO DATA 2.97E+08 NO DATA 4.54E+09 NO DATA 1.13E+11 AG-110m 5.04E+06 4.77E+06 2.90E+06 NO DATA 9.10E+06 NO DATA 1.34E+09 TE-125m 3.03E+08 1.09E+08 4.06E+07 8.47E+07 NO DATA NO DATA 8.95E+08 TE-127m 9.40E+08 3.33E+08 1.12E+08 2.24E+08 3.81E+09 NO DATA 2.34E+09 TE-129m 9.49E+08 3.52E+08 1.50E+08 3.06E+08 3.97E+09 NO DATA 3.56E+09 1-130 1.63E-06 4.71E-06 1.88E-06 3.84E-04 7.25E-06 NO DATA 3.62E-06 1-131 8.89E+06 1.24E+07 6.69E+06 3.63E+09 2.14E+07 NO DATA 2.46E+06 1-132 5.78E-59 1.51E-58 5.42E-59 5.09E-57 2.38E-58 NO DATA 6.58E-59 1-133 3.09E-01 5.25E-01 1.60E-01 7.32E+01 9.20E+01 NO DATA 3.97E-01 1-134 0.00E+00 0.00E+OO 0.00E+00 0.00E+00 0.00E+O0 NO DATA 0.00E+00 1-135 3.79E-17 9.75E-17 3.61 E-17 6.27E-15 1.54E-16 NO DATA 1.0BE-16 CS-134 5.22E+08 1.23E+09 5.70E+08 NO DATA 3.91E+08 1.49E+08 1.53E+07 CS-136 9.36E+06 3.68E+07 2.47E+07 NO DATA 2.01E+07 3.16E+06 2.96E+06 CS-137 7.24E+08 9.63E+08 3.35E+08 NO DATA 3.28E+08 1.27E+08 1.37E+07 BA-140 2.37E+07 2.91E+04 1.53E+06 NO DATA 9.86E+03 1.96E+04 3.66E+07 CE-141 1.17E+04 7.83E+03 9.00E+02 NO DATA 3.69E+03 NO DATA 2.24E+07 CE-144 1.23E+06 5.10E+05 6.62E+04 NO DATA 3.04E+05 NO DATA 3.10E+08 PR-143 1.77E+04 7.06E+03 8.80E+02 NO DATA 4.10E+03 NO DATA 5.82E+07 ND-147 6.22E+03 6.76E+03 4.05E+02 NO DATA 3.97E+03 NO DATA 2.44E+07

mrem/yr per µCi/m 3 Page 156

CY-CL-170-301 Revision 26 September 2022 TABLE 5-30 MEAT PATHWAY FACTORS - RMaii (ADULT)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 3.24E+02*

3.24E+02*

C-14 3.33E+05 6.66E+04 6.66E+04 6.66E+04 6.66E+04 6.66E+04 6.66E+04 P-32 4.65E+09 2.89E+08 1.80E+08 NO DATA NO DATA NO DATA 5.23E+08 CR-51 NO DATA NO DATA 7.05E+03 4.21 E+03 1.55E+03 9.35E+03 1.77E+06 MN-54 NO DATA 9.19E+06 1.75E+06 NO DATA 2.73E+06 NO DATA -

2.81 E+07 FE-55 2.94E+08 2.03E+08 4.74E+07 NO DATA NO DATA 1.13E+08 1.17E+08 FE-59 2.66E+08 6.24E+08 2.39E+08 NO DATA NO DATA 1.74E+08 2.08E+09 CO-58 NO DATA 1.83E+07 4.09E+07 NO DATA NO DATA NO DATA 3.70E+08 CO-60 NO DATA 7.51 E+07 1.66E+08 NO DATA NO DATA NO DATA 1.41E+09 Nl-63 1.89E+10 1.31E+09 6.32E+08 NO DATA NO DATA NO DATA 2.73E+08 ZN-65 3.56E+08 1.13E+09 5.12E+08 NO DATA 7.57E+08 NO DATA 7.13E+08 RB-86 NO DATA 4.87E+08 2.27E+08 NO DATA NO DATA NO DATA 9.61E+07 SR-89 3.01E+08 NO DATA 8.64E+06 NO DATA NO DATA NO DATA 4.83E+07 SR-90 1.24E+10 NO DATA 3.05E+09 NO DATA NO DATA NO DATA 3.59E+08 Y-90 1.09E+02 NO DATA 2.92E+00 NO DATA NO DATA NO DATA 1.15E+06 Y-91 1.13E+06 NO DATA 3.03E+04 NO DATA NO DATA NO DATA 6.23E+08 ZR-95 1.87E+06 6.00E+05 4.06E+05 NO DATA 9.41E+05 NO DATA 1.90E+09 NB-95 2.30E+06 1.28E+06 6.86E+05 NO DATA 1.26E+06 NO DATA 7.75E+09 MO-99 NO DATA 9.91E+04 1.89E+04 NO DATA 2.24E+05 NO DATA 2.30E+05 TC-99m 4.32E-21 1.22E-20 1.56E-19 NO DATA 1.86E-19 5.99E-21 7.23E-18 RU-103 1.05E+08 NO DATA 4.53E+07 NO DATA 4.02E+08 NO DATA 1.23E+10 RU-106 2.81 E+09 NO DATA 3.55E+08 NO DATA 5.42E+09 NO DATA 1.82E+11 AG-110m 6.67E+06 6.17E+06 3.67E+06 NO DATA 1.21E+07 NO DATA 2.52E+09 TE-125m 3.59E+08 1.30E+08 4.81 E+07 1.08E+08 1.46E+09 NO DATA 1.43E+09 TE-127m 1.12E+09 3.99E+08 1.36E+08 2.85E+08 4.54E+09 NO DATA 3.75E+09 TE-129m 1.13E+09 4.22E+08 1.79E+08 3.89E+08 4.73E+09 NO DATA 5.70E+09 1-130 2.03E-06 5.98E-06 2.36E-06 5.0?E-04 9.33E-06 NO DATA 5.15E-06 1-131 1.07E+07 1.54E+07 8.80E+06 5.03E+09 2.63E+07 NO DATA 4.05E+06 1-132 7.13E-59 1.91 E-58 6.67E-59 6.67E-57 3.04E-58 NO DATA 3.58E-59 1-133 3.?0E-01 6.43E-01 1.96E-01 9.45E+01 1.12E+00 NO DATA 5.78E-01 1-134 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 NO DATA 0.00E+00 1-135 4.65E-17 1.22E-16 4.49E-17 8.03E-15 1.95E-16 NO DATA 1.38E-16 CS-134 6.53E+08 1.55E+09 1.27E+09 NO DATA 5.03E+08 1.67E+08 2.72E+07 CS-136 1.20E+07 4.75E+07 3.42E+07 NO DATA 2.65E+07 3.63E+06 5.40E+06 CS-137 8.69E+08 1.19E+09 7.78E+08 NO DATA 4.03E+08 1.34E+08 2.30E+07 BA-140 2.88E+07 3.62E+04 1.89E+06 NO DATA 1.23E+04 2.07E+04 5.94E+07 CE-141 1.39E+04 9.43E+03 1.07E+03 NO DATA 4.38E+03 NO DATA 3.61E+07 CE-144 1.46E+06 6.10E+05 7.83E+04 NO DATA 3.62E+05 NO DATA 4.93E+08 PR-143 2.09E+04 8.40E+03 1.04E+03 NO DATA 4.85E+03 NO DATA 9.17E+07 ND-147 7.04E+03 8.14E+03 4.87E+02 NO DATA 4.76E+03 NO DATA 3.91 E+07

mrem/yr per µCi/m 3 Page 157

CY-CL-170-301 Revision 26 September 2022 TABLE.5-31 VEGETATION PATHWAY FACTORS - Rvaii (CHILD)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU ISOTOPE H-3 NO DATA 4.01E+03*

4.01E+03*

C-14 3.50E+06 7.01E+05 7.01E+05 7.01E+05 7.01 E+05 7.01E+05 7.01E+05 P-32 3.37E+09 1.57E+08 1.30E+08 NO DATA NO DATA NO DATA 9.30E+07 CR-51 NO DATA NO DATA 1.17E+05 6.49E+04 1.77E+04 1.18E+05 6.20E+06 MN-54 NO DATA 6.64E+08 1.77E+08 NO DATA 1.86E+08 NO DATA 5.58E+08 FE-55 8.02E+08 4.25E+08 1.32E+08 NO DATA NO DATA 2.40E+08 7.88E+07 FE-59 3.98E+08 6.43E+08 3.21E+08 NO DATA NO DATA 1.87E+08 6.70E+08 CO-58 NO DATA 6.44E+07 1.97E+08 NO DATA NO DATA NO DATA 3.76E+08 CO-60 NO DATA 3.79E+08 1.12E+09 NO DATA NO DATA NO DATA 2.10E+09 Nl-63 3.95E+10 2.11 E+09 1.34E+09 NO DATA NO DATA NO DATA 1.42E+08 ZN-65 8.11 E+08 2.16E+09 1.34E+09 NO DATA 1.36E+09 NO DATA 3.79E+08 RB-86 NO DATA 4.53E+08 2.79E+08 NO DATA NO DATA NO DATA 2.91 E+07 SR-89 3.59E+10 NO DATA 1.03E+09 NO DATA NO DATA NO DATA 1.39E+09 SR-90 1.24E+12 NO DATA 3.14E+11 NO DATA NO DATA NO DATA 1.67E+10 Y-90 2.31E+04 NO DATA 6.18E+02 NO DATA NO DATA NO DATA 6.58E+07 Y-91 1.86E+07 NO DATA 4.97E+05 NO DATA NO DATA NO DATA 2.48E.+09 ZR-95 3.86E+06 8.49E+05 7.56E+05 NO DATA 1.22E+06 NO DATA 8.86E+08 NB-95 4.10E+05 1.60E+05 1.14E+05 NO DATA 1.50E+05 NO DATA 2.95E+08 MO-99 NO DATA 7.67E+06 1.90E+06 NO DATA 1.64E+07 NO DATA 6.35E+06 TC-99m 4.70E+00 9.21E+00 1.53E+02 NO DATA 1.34E+02 4.68E+00 5.24E+0;3 RU-103 1.54E+07 NO DATA 5.90E+06 NO DATA 3.86E+07 NO DATA 3.97E+08 RU-106 7.45E+08 NO DATA 9.30E+07 NO DATA 1.01E+09 NO DATA 1.16E+10 AG-110m 3.21E+07 2.17E+07 1.73E+07 NO DATA 4.04E+07 NO DATA 2.58E+09 TE-125m 3.51E+08 9.52E+07 4.68E+07 9.86E+07 NO DATA NO DATA 3.39E+08 TE-127m 1.32E+09 3.56E+08 1.57E+08 3.16E+08 3.77E+09 NO DATA 1.07E+09 TE-129m 8.43E+08 2.35E+08 1.31E+08 2.72E+08 2.47E+09 NO DATA 1.03E+09 1-130 6.10E+05 1.23E+06 6.35E+05 1.36E+08 1.84E+06 NO DATA 5.77E+05 1-131 1.43E+08 1.44E+08 8.16E+07 4.75E+10 2.36E+08 NO DATA 1.28E+07 1-132 9.20E+01 1.69E+02 7.77E+01 7.84E+03 2.59E+02 NO DATA 1.99E+02 1-133 3.53E+06 4.36E+06 1.65E+06 8.11E+08 7.27E+06 NO DATA 1.76E+06 1-134 1.50E-04 2.79E-04 1.28E-04 6.41E-03 4.26E-04 NO DATA 1.85E-04 1-135 6.28E+04 1.13E+05 5.34E+04 1.00E+07 1.73E+05 NO DATA 8.61E+04 CS-134 1.60E+10 2.63E+10 5.55E+09 NO DATA 8.15E+09 2.92E+09 1.42E+08 CS-136 8.23E+07 2.26E+08 1.46E+08 NO DATA 1.20E+08 1.80E+07 7.95E+06 CS-137 2.39E+10 2.29E+10 3.38E+09 NO DATA 7.46E+09 2.68E+09 1.43E+08 BA-140 2.77E+08 2.42E+05 1.62E+07 NO DATA 7.89E+04 1.45E+05 1.40E+08 CE-141 6.56E+05 3.27E+05 4.85E+04 NO DATA 1.43E+05 NO DATA 4.08E+08 CE-144 1.27E+08 3.99E+07 6.79E+06 NO DATA 2.21E+07 NO DATA 1.04E+10 PR-143 1.45E+05 4.37E+04 7.22E+03 NO DATA 2.36E+04 NO DATA 1.57E+08 ND-147 7.16E+04 5.80E+04 4.49E+03 NO DATA 3.18E+04 NO DATA 9.18E+07

mrem/yr per µCi/m 3 Page 158

CY-CL-170-301 Revision 26 September 2022 TABLE 5-32 VEGETATION PATHWAY FACTORS - R\ii (TEEN)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LU ISOTOPE H-3 NO DATA 2.59E+03*

2.59E+03*

C-14 1.45E+06 2.91E+05 2.91 E+05 2.91 E+05 2.91 E+05 2.91 E+05 2.91 E+05 P-32 1.61E+09 9.97E+07 6.24E+07 NO DATA NO DATA NO DATA 1.35E+08 CR-51 NO DATA NO DATA 6.12E+04 3.40E+04 1.34E+04 8.74E+04 1.03E+07 MN-54 NO DATA 4.54E+08 9.01 E+07 NO DATA 1.36E+08 NO DATA 9.32E+08 FE-55 3.26E+08 2.31 E+08 5.39E+07 NO DATA NO DATA 1.46E+08 1.00E+08 FE-59 1.79E+08 4.18E+08 1.61E+08 NO DATA NO DATA 1.32E+08 9.88E+08 C0-58 NO DATA 4.36E+07 1.01E+08 NO DATA NO DATA NO DATA 6.02E+08 C0-60 NO DATA 2.49E+08 5.60E+08 NO DATA NO DATA NO DATA 3.24E+09 Nl-63 1.61E+10 1.14E+09 5.46E+08 NO DATA NO DATA NO DATA 1.81E+08 ZN-65 4.23E+08 1.47E+09 6.86E+08 NO DATA 9.41E+08 NO DATA 6.23E+08 RB-86 NO DATA 2.72E+08 1.28E+08 NO DATA NO DATA NO DATA 4.02E+07 SR-89 1.51E+10 NO DATA 4.32E+08 NO DATA NO DATA NO DATA 1.80E+09 SR-90 7.50E+11 NO DATA 1.85E+11 NO DATA NO DATA NO DATA 2.11E+10 Y-90 1.25E+04 NO DATA 3.37E+02 NO DATA NO DATA NO DATA 1.03E+08 Y-91 7.84E+06 NO DATA 2.10E+05 NO DATA NO DATA NO DATA 3.21 E+09 ZR-95 1.73E+06 5.46E+05 3.75E+05 NO DATA 8.02E+05 NO DATA 1.26E+09 NB-95 1.92E+05 1.07E+05 5.86E+04 NO DATA 1.03E+05 NO DATA 4.56E+08 M0-99 NO DATA 5.64E+06 1.08E+06 NO DATA 1.29E+07 NO DATA 1.01E+07 TC-99m 2.73E+OO 7.61 E+OO 9.86E+01 NO DATA 1.13E+02 4.23E+OO 5.00E+03 RU-103 6.81 E+06 NO DATA 2.91 E+06 NO DATA 2.40E+07 NO DATA 5.69E+08 RU-106 3.09E+08 NO DATA 3.89E+07 NO DATA 5.95E+08 NO DATA 1.48E+10 AG-110m 1.51 E+07 1.43E+07 8.72E+06 NO DATA 2.72E+07 NO DATA 4.03E+09 TE-125m 1.49E+08 5.35E+07 1.99E+07 4.15E+07 NO DATA NO DATA 4.38E+08 TE-127m 5.52E+08 1.96E+08 6.57E+07 1.31 E+08 2.24E+09 NO DATA 1.38E+09 TE-129m 3.60E+08 1.34E+08 5.70E+07 1.16E+08 1.51E+09 NO DATA 1.35E+09 1-130 3.50E+05 1.01E+06 4.05E+05 8.26E+07 1.56E+06 NO DATA 7.79E+05 1-131 7.66E+07 1.07E+08 5.76E+07 3.13E+10 1.85E+08 NO DATA 2.12E+07 1-132 5.19E+01 1.36E+02 4.87E+01 4.58E+03 2.14E+02 NO DATA 5.91E+01 1-133 1.93E+06 3.28E+06 1.00E+06 4.58E+08 5.75E+06 NO DATA 2.48E+06 1-134 8.44E-05 2.24E-04 8.03E-05 3.73E-03 3.53E-04 NO DATA 2.95E-06 1-135 3.53E+04 9.09E+04 3.37E+04 5.85E+06 1.44E+05 NO DATA 1.01E+05 CS-134 7.10E+09 1.67E+10 7.75E+09 NO DATA 5.31 E+09 2.03E+09 2.08E+08 CS-136 4.37E+07 1.72E+08 1.16E+08 NO DATA 9.37E+07 1.48E+07 1.38E+07 CS-137 1.01E+10 1.35E+10 4.70E+09 NO DATA 4.59E+09 1.78E+09 1.92E+08 BA-140 1.38E+08

-1.69E+05 8.89E+06 NO DATA 5.73E+04 1.14E+05 2.13E+08 CE-141 2.83E+05 1.89E+05 2.17E+04 NO DATA 8.90E+04 NO DATA 5.41E+08 CE-144 5.29E+07 2.19E+07 2.84E+06 NO DATA 1.31E+07 NO DATA 1.33E+10 PR-143 7.00E+04 2.79E+04 3.48E+03 NO DATA 1.62E+04 NO DATA 2.30E+08 ND-147 3.62E+04 3.94E+04 2.36E+03 NO DATA 2.31E+04 NO DATA 1.42E+08

mrem/yr per µCi/m 3 Page 159

CY-C L-170-301 Revision 26 September 2022 TABLE 5-33 VEGETATION PATHWAY FACTORS - Rvaii (ADULT)

(m2mrem/yr per µCi/sec)

ORGAN:

BONE LIVER T.BODY THYROID KIDNEY LUNG GI-LLI ISOTOPE H-3 NO DATA 2.26E+03*

2.26E+03*

C-14 8.97E+05 1.79E+05 1.79E+05 1.79E+05 1.79E+05 1.79E+05 1.79E+05 P-32 1.40E+09 8.70E+07 5.41E+07 NO DATA NO DATA NO DATA 1.57E+08 CR-51 NO DATA NO DATA 4.60E+04 2.75E+04 1.01E+04 6.11E+04 1.16E+07 MN-54 NO DATA 3.13E+08 5.96E+07 NO DATA 9.30E+07 NO DATA 9.58E+08 FE-55 2.10E+08 1.45E+08 3.38E+07 NO DATA NO DATA 8.10E+07 8.33E+07 FE-59 1.26E+08 2.96E+08 1-.13E+08 NO DATA NO DATA 8.27E+07 9.86E+08 CO-58 NO DATA 3.08E+07 6.90E+07 NO DATA NO DATA NO DATA 6.24E+08 CO-60 NO DATA 1.67E+08 3.69E+08 NO DATA NO DATA NO DATA 3.14E+09 Nl-63 1.04E+10 7.21 E+08 3.49E+08 NO DATA NO DATA NO DATA 1.50E+08 ZN-65 3.18E+08 1.01E+09 4.57E+08 NO DATA 6.76E+08 NO DATA 6.36E+08 RB-86 NO DATA 2.19E+08 1.02E+08 NO DATA NO DATA NO DATA 4.33E+07 SR-89 9.95E+09 NO DATA 2.86E+08 NO DATA NO DATA NO DATA 1.60E+09 SR-90 6.04E+11 NO DATA 1.48E+11 NO DATA NO DATA NO DATA 1.75E+10 Y-90 1.33E+04 NO DATA 3.56E+02 NO DATA NO DATA NO DATA 1.41E+08 Y-91 5.12E+06 NO DATA 1.37E+05 NO DATA NO DATA NO DATA 2.82E+09 ZR-95 1.18E+06 3.79E+05 2.56E+05 NO DATA 5.94E+05 NO DATA 1.20E+09 NB-95 1.42E+05 7.91 E+04 4.25E+04 NO DATA 7.82E+04 NO DATA 4.80E+08 MO-99 NO DATA 6.12E+06 1.16E+06 NO DATA 1.39E+07 NO DATA 1.42E+07 TC-99m 3.09E+00 8.73E+00 1.11E+02 NO DATA 1.33E+02 4.28E+00 5.16E+03 RU-103 4.77E+06 NO DATA 2.06E+06 NO DATA 1.82E+07 NO DATA 5.57E+08 RU-106 1.93E+08 NO DATA 2.44E+07 NO DATA 3.73E+08 NO DATA 1.25E+10 AG-110m 1.05E+07 9.75E+06 5.79E+06 NO DATA 1.92E+07 NO DATA 3.98E+09 TE-125m 9.67E+07 3.51E+07 1.30E+07 2.91E+07 3.93E+08 NO DATA 3.86E+08 TE-127m 3.49E+08 1.25E+08 4.26E+07 8.93E+07 1.42E+09 NO DATA 1.17E+09 TE-129m 2.51 E+08 9.35E+07 3.97E+07 8.61 E+07 1.05E+09 NO DATA 1.26E+09 1-130 3.91 E+05 1.15E+06 4.55E+05 9.77E+07 1.80E+06 NO DATA 9.93E+05 1-131 8.07E+07 1.15E+08 6.62E+07 3.78E+10 1.98E+08 NO DATA 3.05E+07 1-132 5.77E+01 1.54E+02 5.40E+01 5.40E+03 2.46E+02 NO DATA 2.90E+01 1-133 2.09E+06 3.63E+06 1.11 E+06 5.34E+08 6.34E+06 NO DATA 3.26E+06 1-134 9.33E-05 2.53E-04 9.06E-05 4.39E-03 4.03E-04 NO DATA 2.12E-07 1-135 3.91 E+04 1.02E+05 3.77E+04 6.75E+06 1.64E+05 NO DATA 1.16E+05 CS-134 4.67E+09 1.11E+10 9.08E+09 NO DATA 3.59E+09 1.19E+09 1.94E+08 CS-136 4.26E+07 1.68E+08 1.21E+08 NO DATA 9.35E+07 1.28E+07 1.91E+07 CS-137 6.36E+09 8.70E+09 5.70E+09 NO DATA 2.95E+09 9.82E+08 1.68E+08 BA-140 1.29E+08 1.62E+05 8.43E+06 NO DATA 5.50E+04 9.26E+04 2.65E+08 CE-141 1.97E+05 1.33E+05 1.51E+04 NO DATA 6.19E+04 NO DATA 5.09E+08 CE-144 3.28E+07 1.37E+07 1.76E+06 NO DATA 8.14E+06 NO DATA 1.11E+10 PR-143 6.26E+04 2.51E+04 3.10E+03 NO DATA 1.45E+04 NO DATA 2.74E+08 ND-147 3.33E+04 3.85E+04 2.31 E+03 NO DATA 2.25E+04 NO DATA 1.85E+08

mrem/yr per µCi/m 3 Page 160

CY-CL-170-301 Revision 26 September 2022 TABLE 5-34 GROUND PLANE PATHWAY FACTORS - R8 i (m2mrem/yr per µCi/sec)

ISOTOPE TOTAL SKIN ISOTOPE TOTAL SKIN BODY BODY H-3 0.00E+00 0.00E+00 1-134 4.46E+05 5.30E+05 C-14 0.00E+00 0.00E+00 Y-90 4.50E+03 5.31 E+03 P-32 0.00E+00 0.00E+00 Y-91 1.07E+06 1.21 E+06 CR-51 4.65E+06 5.50E+06 ZR-95 2.45E+08 2.85E+08 MN-54 1.38E+09 1.62E+09 NB-95 1.37E+08 1.61E+08 MO-99 3.99E+06 4.62E+06 TC-99m 1.84E+05 2.11E+05 FE-55 0.00E+00 0.00E+00 RU-103 1.08E+0B 1.26E+0B FE-59 2.73E+08 3.20E+08 RU-106 4.22E+08 5.06E+0B CO-58 3.80E+08 4.45E+0B TE-127m 9.16E+04 1.08E+05 CO-60 2.32E+10 2.73E+10 1-131 1.72E+07 2.09E+07 Nl-63 0.00E+00 0.00E+00 1-132 1.25E+06 1.47E+06 AG-110m 3.44E+09 4.01 E+09 1-135 2.53E+06 2.95E+06 TE-125m 1.56E+06 2.13E+06 CS-134 6.87E+09 8.01 E+09 ZN-65 7.48E+0B 8.60E+08 CS-136 1.51E+08 1.71E+08 TE-129m 1.98E+07 2.31 E+07 BA-140 2.05E+07 2.35E+07 RB-86 8.98E+06 1.03E+07 CE-141 1.37E+07 1.54E+07 1-130 5.50E+06 6.6BE+06 CE-144 6.96E+07 8.05E+07 SR-89 2.16E+04 2.50E+04 PR-143 0.00E+00 0.00E+00 SR-90 NO DATA NO DATA ND-147 8.39E+06 1.01E+07 1-133 2.45E+06 2.98E+06 Page 161

TABLE 5-35 XIQ, DIQ AT THE SITE BOUNDARY 5-YEAR AVERAGE VALUES FROM 2017-2021 MET DATA No Decay 8 Day Decay Undepleted Depleted Range X/Q X/Q Direction (m)

(sec/m"3)

Site Boundary N

1400 1.40E-07 1.28E-07 Site Boundary NNE 1341 1.79E-07 1.63E-07 Site Boundary NE 1097 1.04E-07 9.49E-08 Site Boundary ENE 1219 8.01E-08 7.34E-08 Site Boundary E

1219 9.69E-08 8.86E-08 Site Boundarv ESE 4816 5.49E-08 5.12E-08 Site Boundary SE 3842 6.01E-08 5.61E-08 Site Boundary SSE 3353 4.56E-08 4.28E-08 Site Boundary s

3343 4.45E-08 4.19E-08 Site Boundary SSW 4633 3.50E-08 3.29E-08 Site Boundary SW 5121 4.71E-08 4.43E-08 Site Boundary WSW 3414 3.95E-08 3.75E-08 Site Boundary w

2256 3.91E-08 3.69E-08 Site Boundarv WNW 1097 4.72E-08 4.35E-08 Site Boundary NW 1463 5.07E-08 4.70E-08 Site Boundary NNW 1585 8.10E-08 7.47E-08 Page 162 CY-CL-170-301 Revision 26 September 2022 D/Q (1/m"2) 1.93E-09 2.68E-09 1.66E-09 1.35E-09 1.84E-09 3.79E-10 5.07E-10 4.06E-10 3.80E-10 2.00E-10 2.32E-10 2.60E-10 3.40E-10 6.47E-10 7.02E-10 9.54E-10

TABLE 5-36 CY-CL-170-301 Revision 26 September 2022 XIQ, D/Q AT SPECIFIC LOCATIONS WITHIN THE CPS SITE BOUNDARY*

5-YEAR AVERAGE VALUES FROM 2017-2021 MET DATA No Decay 8 Day Decay Undepleted Depleted Range X/Q XIQ D/Q Direction m

sec/m/\3 sec/mA3 1/m/\2 ESE 1287 1.26E-07 1.15E-07 2.36E-09 NW 335 2.72E-07 2.60E-07 2.98E-09 SE 495 3.51E-07 3.31E-07 6.66E-09 SE 2736 5.09E-08 4.78E-08 5.22E-10 SSW 1372 6.27E-08 5.75E-08 9.41E-10 SW 1219 9.59E-08 8.79E-08 1.43E-09 WSW 2414 4.38E-08 4.13E-08 4.02E-10

Refer to Table 5-3, LOCATION OF MEMBERS OF THE PUBLIC WITHIN THE CPS SITE BOUNDARY AND THEIR ASSOCIATED OCCUPANCY FACTORS for descriptions of the specific locations Page 163

residence residence residence residence residence residence residence residence residence residence residence residence residence residence residence residence TABLE 5-37 CY-CL-170-301 Revision 26 September 2022 XIQ, D/Q AT RESIDENCES IN EACH SECTOR 5-YEAR AVERAGE VALUES FROM 2017-2021 MET DATA*

No Decay 8 Day Decay Undepleted Depleted Range XIQ X/Q DIQ Direction m

secfmA3 secfmA3 1/m"2 N

1500 1.33E-07 1.22E-07 1.78E-09 NNE 1500 1.63E-07 1.48E-07 2.34E-09 NE 2070 6.76E-08 6.27E-08 7.58E-10 ENE 2860 4.88E-08 4.55E-08 4.35E-10 E

1670 7.54E-08 6.92E-08 1.24E-09 ESE 5140 5.22E-08 4.86E-08 3.43E-10 SE 4440 5.42E-08 5.06E-08 4.12E-10 SSE 2900 4.94E-08 4.64E-08 4.82E-10 s

4780 3.53E-08 3.31E-08 2.33E-10 SSW 4680 3.48E-08 3.27E-08 1.97E-10 SW 1170 9.94E-08 9.12E-08 1.49E-09 WSW 3620 3.85E-08 3.66E-08 2.41E-10 w

1950 3.93E-08 3.68E-08 4.08E-10 WNW 2630 4.10E-08 3.91E-08 2.59E-10 NW 2650 4.72E-08 4.48E-08 3.32E-10 NNW 2050 7.51E-08 7.00E-08 6.98E-10

The residence identified in each sector was that household having the highest dose commitment as identified by the 2021 Annual Land Use Census.

Page 164

6.0 TOTAL DOSE CY-CL-170-301 Revision 26 September 2022 The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of radioactivity and to radiation from uranium fuel cycle sources shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem.

Total dose requirements are further discussed in Part I RECS Section 3/4.5.

Page 165

7.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM CY-CL-170-301 Revision 26 September 2022 The primary requirements for the Clinton Power Station Radiological Environmental Monitoring Program (REMP) are set forth in Part I RECS Table 4.6-1 and shown by location in Figure 7-1 through Figure 7-4. In addition to the required sampling program, CPS will perform supplemental periodic and long-term sampling analyses in order to better monitor environmental exposure pathways. These samples will not be listed in this manual.

Page 166

FIGURE 7-1 REMP LOCATIONS WITHIN 1 MILE OF CPS CLINTON LAKE 15*

75 Page 167 CY-CL-170-301 Revision 26 September 2022

FIGURE 7-2 REMP LOCATIONS 1-2 MILES FROM CPS Page 168 CY-CL-170-301 Revision 26 September 2022 ILL RT 54

12

FIGURE 7-3 REMP LOCATIONS 2-5 MILES FROM CPS Page 169 CY-CL-170-301 Revision 26 September 2022

FIGURE 7-4 REMP LOCATIONS GREATER THAN 5 MILES FROM CPS Page 170 CY-CL-170-301 Revision 26 September 2022

8.0 LAND USE CENSUS CY-CL-170-301 Revision 26 September 2022 A land use census shall be conducted and shall identify within a distance of 8 km (5 miles) the location in each of the 16 meteorological sectors of the nearest milk animal, the nearest residence and the nearest garden* of greater than 50 m2 (500 ft2) producing broad leaf vegetation. For elevated or mixed-mode releases as defined in Regulatory Guide 1.111, Revision 1, July 1977, the land use census shall also identify within a distance of 5 km (3 miles} the location in each of the 16 meteorological sectors of all milk animals and all gardens of greater than 50 m2 producing broad leaf vegetation. This requirement is further discussed in Part I RECS Section 3/4.7.

Page 171

9.0 INTERLABORATORY COMPARISON PROGRAM CY-CL-170-301 Revision 26 September 2022 All analyses for CPS Radiological Environmental Monitoring Program are performed by a corporate approved contractor laboratory. The contractor laboratory takes part in an interlaboratory comparison (cross-check) program. This is a program operated by agencies/laboratories which supply environmental-type samples (e.g., milk or water) containing concentrations of radionuclides known to the issuing laboratory but not to the participant laboratory. The purpose of such a program is to provide an independent check on the contractor laboratory's analytical procedures and to alert it to any possible problems.

Any issues identified through the interlaboratory comparison program are investigated by the contractor laboratory. The results of the investigation and the corrective actions are reported in the Annual Radiological Environmental Operating Report.

Operation and Surveillance Requirements for the lnterlaboratory Comparison Program are prescribed in Part I RECS Section 3/4.8.

Page 172

10.0 ATMOSPHERIC TRANSPORT AND DISPERSION MODEL

10.1 INTRODUCTION

CY-CL-170-301 Revision 26 September 2022 The atmospheric transport and dispersion model used by Clinton Power Station is a straight-line, sector-averaged Gaussian model designed to estimate average relative concentrations at various receptor points. The model was developed in accordance with routine release analysis procedures specified by Regulatory Guide 1.111 (Revision 1 July 1977), Section C.1.c "Constant Mean Wind Direction Models".

All meteorological and dose calculations prescribed in this manual are based on meteorological data concurrent with the time of release or the annual average values. Near-real time meteorological data processing is described in Section 10.2.

10.2 CONCURRENT METEOROLOGICAL DATA PROCESSING Meteorological data is acquired and processed through a model which utilizes bi-level hourly meteorological tower data or single level joint frequency data to perform the required analysis. Three distinct release modes are treated: elevated, ground and mixed. A set of four output arrays are generated for each dose receptor location as follows:

a.

Relative undecayed, undepleted plume concentration (X/Q)

b.

Relative decayed and depleted radioiodine and particulate concentration (D2DPXQ) [8 day decay]

c.

Relative decayed noble gas concentration (D1 XQ) [2.26 day decay]

d.

Relative particulate and radioiodine deposition (D/Q)

Since the Regulatory Guide 1.111 depletion and deposition curves are defined only within the range encompassing 100 to 200,000 meters, analysis results are not considered valid outside this range. The following sections describe the calculations performed by the transport and dispersion model for a one hour time interval.

Page 173

10.2.1 CY-CL-170-301 Revision 26 September 2022 Determination of Pasquill Stability Class The Pasquill Stability Class is determined by categorizing the temperature gradient, LlT, into one of several ranges between -0.900 and 0.900 °C/meter according to the following equation:

Ll T = (Tu - T L)/(Hu - HL), °C/meter (10-1)

Where:

Tu

=

Meteorological (met) tower upper level temperature, °C TL

=

Meteorological tower lower level temperature, °C Hu

=

Meteorological tower upper level instrumentation height

=

60 meters HL

=

Meteorological tower level instrumentation height

=

10 meters LlT is then classified according to the following scheme:

Pasauill Stabilitv Definina Condition A (Extremely Unstable)

-0.900 < Ll T ~ -0.019 B

-0.019 < LlT ~ -0.017 C

-0.017 <AT< -0.015 D (Neutral)

-0.015 < Ll T < -0.005 E

-0.005 < Ll T < 0.015 F

0.015 <AT~ 0.040 G (Extremely Stable) 0.040 < AT< 0.900 Invalid AT~ -0.900 or LlT > 0.900 10.2.2 Calculation of Stack Height Wind Speed The wind speed at the release point (HVAC Exhaust Stack or Standby Gas Treatment System Exhaust Stack) height, STACWS, is calculated using the expressions:

STACWS = WSPu (STACKH/Hut, meter/sec (10-2)

Where:

WSPu =

Upper met tower level wind speed, meter/sec WSPL =

Lower met tower level wind speed, meter/sec STACKH =

Physical release point stack height P

=

Wind power law exponent, 0.25 for stabilities A, B, C; 0.33 for stability D; 0.5 for stabilities E, F, G, dimensionless. These coefficients come from The Recommended Guide for the Prediction of the Dispersion of Airborne Effluents, May 1968.

Page 174

All other parameters are as defined for equation (10-1 ).

10.2.3 Determination of Release Mode and the Entrainment Coefficient CY-CL-170-301 Revision 26 September 2022 The mode of release can be elevated, ground or mixed; the latter being a combination of the first two. The mode of release, as well as an entrainment coefficient, TCORR, are determined from the stack height, STACH, building height, BLDGHT, stack exit velocity, EXITV, and wind speed at the stack height, STACWS.

For effluents exhausted from release points that are higher than twice the height of adjacent solid structures, STACKH > 2 (BLDGHT), TCORR = 0.0 (10-3) the release is considered completely elevated and the entrainment coefficient is zero. For effluents released from points less than the height of adjacent solid structures, a ground-level release is assumed STACKH < BLDGHT, TCORR = 1.0 (10-4) and the entrainment coefficient is unity. For effluents released from points or vents at the level of, or above, adjacent solid structures, but lower than elevated release

points, 2(BLDGHT) > STACKH > BLDGHT (10-5) the release is treated as elevated, ground or mixed according to the following relationships:

ELEVATED: TCORR = 0.00 if EXITV >5(STACWS)

GROUND: TCORR = 1.0 if EXITV < STACWS MIXED: TCORR = 0.30-0.06(EXITV/STACWS) if 5(STACWS).::, EXITV > 1.5 (STACWS)

TCORR = 2.58-1.58(EXITV/STACWS) if 1.5(STACWS)

> EXITV > (STACWS)

(10-6)

(10-7)

(10-8)

(10-9)

In the mixed mode, the release is considered to occur as an elevated release 100 (1-TCORR) percent of the time and as a ground release 100 (TCORR) percent of the time. Each of these cases are then evaluated separately and the concentration X/Q calculated according to the fraction of the time each release occurs.

Page 175

10.2.4 Calculation of Vertical Standard Deviation CY-CL-170-301 Revision 26 September 2022 The vertical plume spread (vertical standard deviation), crz is a function of the distance from the release point to the reception point for a given Pasquill stability class. The numerical value of crz is obtained by linear interpolation of the values in the following table which are taken from Regulatory Guide 1.145:

TABLE 10.2-1 crz Values Distance Stability Class (meters)

A B

C D

E F

G 200 31 21 15 10 6

4 3

500 120 55 34 19 13 8

5 1000 530 124 64 32 21 13 8

2000 1000 340 120 52 34 20 13 3000 1000 800 170 68 44 25 16 6000 1000 1000 300 110 71 35 23 10000 1000 1000 450 147 85 45 28 30000 1000 1000 1000 275 130 65 40 50000 1000 1000 1000 350 155 75 50 80000 1000 1000 1000 460 180 85 55 The values in this table are limited by the "mixing height lid" which is specified at 1000m.

10.2.5 Calculation of the Building Wake Correction For ground-based and mixed-mode releases, an adjustment is made in the calculation of X/Q that takes into consideration initial mixing of the effluent plume within the building wake. This adjustment is an additional factor added in quadrature to the vertical plume spread equation (10-10):

(10-10) with the requirement that tz is restricted to values (10-11)

Page 176

10.2.6 Calculation of Momentum Plume Rise CY-CL-170-301 Revision 26 September 2022 For elevated or mixed-mode releases only, the amount of plume rise due to the initial vertical momentum of the exhausted effluent, ~H, is calculated. For Pasquill stability classes A,B,C and D, ~H is calculated per section 10.2.6.1; for classes E,F and G, section 10.2.6.2 is used.

10.2.6.1 ~H For Pasquill Class A,B,C and D

~H is calculated using both equations (10-12) and (10-13) and the minimum value is selected for use.

~H 1 = 1.44(STACD)(EXITV/STACWS)2'3(X/STACD) 113

~H2 = 3.0(STACD)(EXITV/STACWS), meter Where: STACD =

Internal release point stack diameter

=

3.77 meters (HVAC Exhaust Stack)

=

0.44 meters (SGTS Exhaust Stack)

EXITV =

Stack exit velocity, meter/second X

=

Distance to specified receptor, meter All other parameters are as defined previously.

10.2.6.2 ~H For Pasquill Class E,F and G (10-12)

(10-13)

~His determined by selecting the minimum value calculated by equations (10-12) and (10-13) above and equations (10-14) and (10-15) below:

~H3 = 4.0[(0.5(EXITV)(STACD))21Sf, meter (10-14)

(10-15)

~H4 = 1.5[(0.5(EXITV)(STACD))2/STACWS]1'3(Sr1'6, meter Where: s

=

Tz

=

Tz

=

Tz

=

Tamb

=

Restoring acceleration per unit vertical displacement for adiabatic motion, sec-2 9.8

Tz/(273+ T amb) 0.025 (E stability - default value) 0.05 (F stability - default vall!e) 0.075 (G stability - default value)

Ambient air temperature (°C) [If temperature is missing, the default value will be used]

Page 177

All other parameters are as defined in section 10.2.6.1.

10.2.7 Calculation of the Effective Plume Height CY-CL-170-301 Revision 26 September 2022 The effective plume height, H, is determined using section 10.2.6 results for the momentum plume rise, LlH, and the terrain height, TERAIN:

H = STACKH + t'lH - TERAIN, meter (10-16)

Where: TERAIN = Difference between the plant base height above mean sea level (MSL) and the receptor point height above MSL, meter.:::0.0.

10.2.8 Determination of Affected Sectors The wind direction for the hour determined which sector will be affected. Sectors are 22.5° arcs and are classified according to the following scheme:

Sector Number 1

2 3

4 5

6 7

8 9

10 11 12 13 14 15 16 TABLE 10.2-2 WIND DIRECTION TABLE Compass Direction N

NNE NE ENE E

ESE SE SSE s

SSW SW WSW w

WNW NW NNW Wind Direction (WD) 0.0° ~ WD < 11.25° or 348. 75° ~ WD ~ 360.00° 11.25° ~ WD < 33.75° 33.75° ~ WD < 56.25° 56.25° ~ WD < 78.75° 78.75° ~ WD < 101.25° 101.25° ~ WD < 123.75° 123.75° ~ WD < 146.25° 146.25° ~ WD < 168.75° 168.75° ~ WD < 191.25° 191.25° ~ WD < 213.75° 213.75° ~ WD < 236.25° 236.25° ~ WD < 258. 75° 258.75° ~ WD < 281.25° 281.25° ~ WD < 303.75° 303.75° ~ WD < 326.25° 326.25° ~ WD < 348.75° For elevated releases, the wind speed at the upper met tower level is used; ground releases use the speed of the wind at the lower met tower level. The wind direction is the same at both levels~ During periods of calm wind, the wind speed is set at 0.5 meters/second the anemometer threshold value and assigned the direction measured for the hour.

Page 178

10.2.9 Calculation of Depletion and Deposition Factors CY-CL-170-301 Revision 26 September 2022 The depletion, DPF, and deposition, DPSF, factors are taken from the tables below which have been derived from curves found in Regulatory Guide 1.111. Both the DPF and DPSF values depend on the effective plume height, H, the stability class, S, and the distance, X, to the receptor.

The Regulatory Guide 1.111 curves represent plumes that are 100, 60, 30, and 0 (ground-level) meters above the ground. For plume heights and receptor distances other than those listed, the factors are interpolated from the tables. The model assumes that, after full plume rise is achieved, the plume cannot get higher from the ground. The derivation of these curves assumed no change in terrain height with downwind distance. Since topography does change with distance, as does the vertical distance between the plume centerline and the ground, use more than one depletion or deposition value as the plume travels away from the plant with distance.

Page 179

Height of Pasquill Release (m)

Stability Class Ground All 30 A,B,C, 30 D

30 E,F,G 60 A,B,C 60 D

60 E,F,G 100 A,B,C 100 D

100 E,F,G TABLE 10.2-3 DPF - DEPLETION FACTORS FROM FIGURES 2 THROUGH 5 OF REGULATORY GUIDE 1.111 Distance (meters) 200 500 1,000 2,000 3,000

6,000 10,000 0.970 0.936 0.900 0.860 0.832 0.770 0.714 0.990 0.964 0.935 0.900 0.875 0.828 0.793 1.000 0.985 0.960 0.920 0.900 0.850 0.810 1.000 1.000 1.000 1.000 1.000 1.000 0.970 1.000 0.985 0.967 0.942 0.928 0.878 0.839 1.000 1.000 1.000 0.970 0.950 0.910 0.870 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.978 0.950 0.932 0.885 0.850 1.000 1.000 1.000 0.989 0.982 0.946 0.910 1.000 1.000 1.000 1.000 1.000 1.000 1.000 Page 180 30,000 0.590 0.680 0.707 0.792 0.700 0.767 1.000 0.725 0.807 1.000 CY-CL-170-301 Revision 26 September 2022 50,000 80,000 0.517 0.440 0.590 0.478 0.650 0.593 0.664 0.546 0.617 0.500 0.707 0.646 1.000 0.977 0.628 0.500 0.746 0.685 1.000 1.000

Height of Pasquill Release (m)

Stability Class Ground All 30 All 30 A,B,C, 30 D

60 E,F,G 60 A,B,C 60 D

100 E,F,G 100 A,B,C 100 D

100 E,F,G TABLE 10.2-4 DPSF - DEPOSITION FACTORS FROM FIGURES 6 THROUGH 9 OF REGULATORY GUIDE 1.111 (m-1)*

Distance (meters) 200 500 1,000 2,000 3,000 6,000 10,000 30,000 1.25E-04 8.00E-05 5.40E-05 3.20E-05 2.60E-05 1.50E-05 9.90E-06 4.50E-06 1.10E-04 8.00E-05 4.20E-05 2.40E-05 1.S0E-05 1.10E-05 8.00E-06 4.S0E-06 5.50E-06 4.1 0E-06 4.S0E-05 3.00E-05 2.40E-05 1.30E-05 8.00E-06 3.40E-06 1.00E-11 1.00E-10 1.00E-09 1.00E-08 1.00E-07 2.00E-06 6.30E-06 8.S0E-06 1.S0E-05 4.40E-05 3.S0E-05 2.40E-05 1.S0E-05 1.10E-05 8.20E-06 5.00E-06 2.S0E-07 5.50E-06 1.60E-05 2.00E-05 1.S0E-05 1.30E-05 8.90E-06 3.60E-06 1.00E-14 1.00E-13 1.00E-12 1.00E-11 1.00E-10 1.00E-09 1.00E-08 1.60E-08 4.00E-06 2.60E-05 3.30E-05 2.40E-05 1.70E-05 1.10E-05 8.10E-06 5.00E-06 1.00E-08 2.60E-07 2.S0E-06 9.00E-06 1.10E-05 1.00E-05 7.50E-06 3.90E-06 1.00E-08 2.60E-07 2.S0E-06 9.00E-06 1.1 0E-05 1.00E-05 7.50E-06 3.90E-06 1.00E-15 1.00E-15 1.00E-18 1.00E-15 1.00E-15 1.00E-15 1.00E-15 1.00E-15 Page 181 CY-CL-170-301 Revision 26 September 2022 50,000 80,000 3.00E-06 2.00E-06 4.00E-06 3.50E-06 2.30E-06 1.60E-06 5.30E-06 3.00E-06 4.20E-06 3.50E-06 2.50E-06 1.70E-06 2.00E-07 6.S0E-07 4.50E-06 3.70E-06 2.S0E-06 1.90E-06 2.S0E-06 1.90E-06 1.00E-15 1.00E-15

10.2.10 Ground Level X/Q, D2DPXQ, D1XQ, D/Q Analysis 10.2.10.1 Undecayed, Undepleted Plume Relative Concentration, X/Q CY-CL-170-301 Revision 26 September 2022

The atmospheric concentration of effluent at ground level, normalized by the source term Q, is given by the following equation:

XJQ = 2.032(TCORR)/WSPL(X)Amin, sec/m3 (10-17)

Where: Amin

=

The lesser of the two values obtained by equations (10-10) and (10-11), meter 2.032

=

The constant (2ht) divided by the width in radians of a 22.5° sector (i.e., 1t/8, dimensionless X

=

Distance between release point to receptor, meter 10.2.10.2 Decayed, Depleted Radioiodine and Particulate Relative Concentration, D2DPXQ The decayed, depleted radioiodine concentration, D2DPXQ, is calculated in accordance with the following equation:

D2DPXQ = DPF(DC2)X/Q, sec/m3 (10-18)

Where: DPF

=

The depletion factor calculated per section 10.2.9, dimensionless DC2

=

The radioiodine 8 day decay factor, dimensionless

=

exp[-0.693(X)/t<<(WSPL)]

=

exp[-0.693(X)/(8 day)(24 hr/day)(3600 sec/hr)(WSPL)]

=

exp[-1.00E-06(X/WSPL)]

10.2.10.3 Decayed Noble Gas Plume Relative Concentration, D1XQ The decayed noble g~s plume relative concentration, D1 XQ, is calculated in accordance with the following equation:

D1XQ = DC1 (X/Q), sec/m3 (10-19)

Where: DC1

=

The noble gas decay factor, dimensionless

=

exp [-0.693{X)/t<<(WSPL)]

=

exp [-0.693(X)/(2.26 day)(24 hr/day) {3600 sec/hr)(WSPL)]

=

exp [-3.55E-06 (X/WSPL)]

Page 182

10.2.10.4 Radioiodine and Particulate Relative Deposition, D/Q CY-CL-170-301 Revision 26 September 2022 The relative deposition for radioiodines and particulates, D/Q is calculated in accordance with the following equation:

D/Q = [DPSF(DC2)(TCORR)]/[(2n/16)X], m-2 (10-20)

Where: DPSF =

The deposition factor calculated per section 10.2.9, m-1 10.2.11 Elevated X/Q, D2DPXQ, D1XQ, D/Q Analysis 10.2.11.1 Undecayed, Undepleted Plume Relative Concentration, X/Q The atmospheric concentration of effluent at elevated level, normalized by the source term Q, is given by the following equation:

X/Q = [2.032(1-TCORR)exp[-0.5(H/cr2}2))t[STACWS(X) crz], sec/m3 (10-21)

Where: All parameters are as previously defined.

10.2.11.2 Decayed, Depleted Radioiodine and Particulate Relative Concentration, D2DPXQ The calculation of D2DPXQ for elevated releases follows section 10.2.10.2 methodology with the exception that the WSPL value used in the calculation of DC2 in equation (10-21) is replaced by the STACWS value and the equation (10-24) X/Q is used.

D2DPXQ = DPF(DC2)X/Q, sec/m3 (10-22)

Where: DPF

=

The depletion factor calculated per section 10.2.9, dimension less DC2

=

The radioiodine 8 day decay factor, dimensionless

=

exp[-0.693(X)/t<<(STACWS)]

=

exp[-0.693(X)/(8 day)(24 hr/day)(3600 sec/hr) ( STACWS)]

=

exp[-1.00E-06(X/ STACWS)]

Page 183

10.2.11.3 Decayed Noble Gas Plume Relative Concentration, D1XQ CY-CL-170-301 Revision 26 September 2022 The calculation of D1XQ for elevated releases follows section 10.2.10.3 methodology by substituting the equation (10-24) X/Q value into equation (10-22) and STACWS for WSPL in the calculation of DC1.

D1XQ = DC1 (X/Q), sec/m3 (10-23)

Where: DC1

=

The noble gas decay factor, dimensionless

=

exp [-0.693(X)/t<<(STACWS)]

=

exp [-0.693(X)/(2.26 day)(24 hr/day (3600 sec/hr)(

STACWS}]

=

exp [-3.55E-06 (X/STACWS)]

10.2.11.4 Radioiodine and Particulate Relative Deposition, D/Q The calculation of D/Q for elevated releases follows section 10.2.10.4 methodology by substituting (1-TCORR} for the TCORR term in equation (10-23) and STACWS for WSPL in the calculation of DC2.

D/Q = [DPSF(1-TCORR)]/[(21t/16)X], m*2 (10-24)

Where: DPSF =

The deposition factor calculated per section 10.2.9, m*1 Page 184

. Table 10.2-5 CY-CL-170-301 Revision 26 September 2022 GASEOUS EFFLUENT RELEASE POINT CHARACTERISTICS FUS. BUIUllNO.

ROOF EL 800'0" TURBINE BULOING ROOF EL 875'0" RADWASTE AND MACHINE SHOP BUILDING ROOF EL 781'0" CONTROL ROOM AIR HANDLJHQ UNITS SQTI FUm UNITS 00: EL 710'0")

Release Point Height (m)

Building Height (m)

HVAC Exhaust Stack 61 SGTS Exhaust Stack 61 Release Point Geometry Release Point Area (m2)

Release Point Diameter (m)

Annual Average Flow Rate (m3tsec)

Vertical Exit Velocity (m/sec)

Effective 2(A/rc) << diameter Page 185 58 Duct 11.15 3.77*

111.71 10.02 58 Pipe 0.15 0.44 1.89 12.49 7

Person / Time
ML23122A066
Site:	Clinton (NPF-062)
Issue date:	09/30/2022
From:	Exelon Generation Co
To:	Office of Nuclear Reactor Regulation
References
U-604760 CY-CL-170-301, Rev 26
Download: ML23122A066 (1)
v • d • e

ML23122A066

Text

10.1 INTRODUCTION

Navigation menu

Search